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Summary.
Enterococcus faecalis causes 5-15% of cases of infective endocarditis, and is a 
particularly difficult organism to treat. In previous studies, three surface antigens (37, 
40 and 73 kDa) have been identified, which appear specific for E. faecalis infective 
endocarditis (EFIE). Antibodies against these antigens were detected only in serum 
from patients with EFIE and not in serum from patients with endocarditis due to other 
organisms, or E. faecalis infections at other sites.
A AZAPII library, constructed from E. faecalis EBH1 genomic DNA, was 
screened using serum from an EFIE patient with high titres of antibodies against the 
37, 40 and 73 kDa antigens. Antibody affinity purification using one strongly reacting 
plaque revealed that DNA encoding a protein cross reactive with both the 37 and 40 
kDa antigens had been cloned. Sequence analysis of the insert showed the presence of 
an open reading frame comprising 308 codons encoding a polypeptide of molecular 
weight 34768 Da which was designated Enterococcus faecalis antigen A (EfaA). 
Amino acid sequence alignment revealed 55-60% homology with the adhesins FimA, 
SsaB, ScaA and PsaA from S. parasanguis, S. sanguis, S. gordonii and 
S. pneumoniae, respectively. A 0.4 kb Hindlll fragment of efaA hybridised to all 
E. faecalis strains tested, but failed to hybridise to genomic DNA from other 
streptococci. Northern analysis revealed that efaA was transcribed on an approx 3 kb 
message, and that expression was regulated by some component(s) of serum.
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Infective endocarditis is the result of microbial colonisation of the 
endocardium. The valves are most commonly affected, although the disease can also 
affect the mural endocardium or septal defects. Healthy heart tissue is not normally 
susceptible to infection, however damage to the endocardium initiates a chain of 
events leading to the formation of a non-bacterial thrombotic endocarditis (NBTE) 
which pre-disposes to colonisation. Patients with prosthetic heart valves are also at 
risk. The disease has been classified according to its progression as acute (death in less 
than 6 weeks), subacute (death in 6 weeks to three months) and chronic (death in 
greater than three months). However, these terms have more recently given way to 
classification according to aetiologic agent, which has more bearing on the appropriate 
treatment (Scheld and Sande, 1990).
1.1.1. Aetiology.
Infective endocarditis can be caused by a range of micro-organisms including 
mycobacteria, fungi, chlamydiae, rickettsiae, viruses and Gram-negative bacteria. 
However, aetiologic diagnosis of infective endocarditis, as determined by blood 
cultures reveals that the vast majority of cases arise due to infection by Gram-positive 
cocci. Figures vary according to the surveys used, but streptococci (mainly S. sanguis, 
S. bovis, S. mutans and S. mitior) usually account for at least half of all cases, 
staphylococci for 20-30% (predominantly coagulase positive S. aureus), and 
enterococci (mainly E. faecalis) for 5-18% of cases (Scheld and Sande, 1990; Barco, 
1991; Watanakunakom and Burkert, 1993). Gram-negative bacteria, which are rarely 
isolated (<5% of cases), include E. coli, Salmonella sp. and the HACEK group
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(Haemophilus, Actinobacillus, Cardiobacterium, Eikenella and Kingella; Scheld and 
Sande, 1990).
1.1.2. Incidence.
Most surveys of infective endocarditis report that its incidence has not changed 
for 30 to 40 years. It is difficult to assign a definite figure for the incidence of the 
condition since diagnostic criteria vary. Indeed, applying strict criteria has revealed 
that as few as 20% of clinically diagnosed cases can be categorised as definite (Scheld 
and Sande, 1990). Incidences quoted recently include, in England and Wales, 1000- 
2000 cases per year or 20 cases per million of the population (Littler and Shanson, 
1989), 10,000-15,000 new cases per year in the USA (Bayer, 1993), or 4.9 cases per 
100,000 person-years (Steckelberg et al, 1990). Endocarditis is most likely to affect 
the left side of the heart, the mitral valve being affected more often than the aortic 
valve. Combined aortic and mitral valve infection is less common (Watanakunakom 
and Burkert, 1993).
1.1.3. Mortality.
The mortality of endocarditis depends upon the site of involvement, the 
aetiologic organism, host risk factors and the number of complications (Lukes and 
Durack, 1993). A ten year study of infective endocarditis by Watanakunakom and 
Burkert (1993) showed an overall mortality of 21.4%, with most deaths being due to 
S. aureus. Mortality was significantly higher among the elderly (10.1% under 60 years, 
31.5% over 60 years), and was lower among patients with prosthetic valve 
endocarditis (PVE) than with native valve endocarditis (NVE). The lower mortality 
among cases of PVE has also been noted in studies of enterococcal endocarditis 
(Almirante et al, 1991; Rice et al, 1991), and has been attributed to the shorter period 
of disease before diagnosis of PVE. Aortic valve involvement is regularly associated 
with unfavourable prognosis, and the need for surgery (Rice et al, 1991; Almirante et 
al, 1991; Lukes and Durack, 1993). The effect of antimicrobial therapy on the
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outcome of enterococcal endocarditis in severall studies was examined by Megran 
(1992), who found that with standard therapy (p-llactam plus aminoglycoside) average 
mortality was 17% (0-43%). However, in cases where non-standard or inappropriate 
therapy was used, 46% (17-100%) of patients died. These findings highlight the effect 
that antimicrobial therapy has had upon the mortality of infective endocarditis, and 
underline the need to select the appropriate treatment.
The work described in this thesis involves Enterococcus faecalis endocarditis 
therefore the literature relating to endocarditis caused by E. faecalis and associated 
organisms will be discussed below.
1.2 The streptococci.
Streptococci are facultatively anaerobic, Gram-positive, spherical or ovoid 
bacteria (0.5-2.0 |im in diameter), which grow as pairs or chains in liquid media. 
Streptococci commonly attack erythrocytes (haemolysis), and may be characterised as 
a-, p- or y-haemolytic, according to their appearance on blood agar. Alpha-haemolytic 
streptococci produce partial haemolysis (viridans streptococci), beta-haemolytic 
streptococci produce a clear zone of complete haemolysis, whilst gamma-streptococci 
are non haemolytic (Holt et al, 1994). Following her discovery of group specific 
antigens, Lancefield (1933) used serological typing to divide the genus into 
approximately 20 groups, each of which were assigned a letter of the alphabet. This 
system is no longer considered altogether reliable, with many serological groups 
overlapping (Gallis, 1990; Holt et al, 1994).
1.2.1. Group D streptococci.
Group D streptococci are mainly non-haemolytic, and are distinct from other 
streptococcal groups in their ability to grow in medium containing 40% bile, and to 
cleave esculin. Traditionally, group D streptococci were separated into enterococcal
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(eg S. faecalis, S.faecium and S. durans), and non-enterococcal strains (eg S. bovis 
and S. equinus) (Musher, 1990). Enterococci are further distinguished from other 
streptococci by their ability to grow between 10°C and 45°C, at pH 9.6 and in the 
presence of 6.5% NaCl (Holt et al, 1994). The genus streptococcus was eventually 
divided into three genera, streptococcus, enterococcus and lactococcus, such that 
S. faecalis and S.faecium became Enterococcus faecalis and Enterococcus faecium, 
respectively (Schleifer and Kilpper-Balz, 1984).
1.3. The Enterococci.
The genus Enterococcus includes the strains shown in table 1.1. Of these 
strains, only two are routinely isolated, namely E. faecalis (85%-90%) and E. faecium 
(5%-10%) (Moellering, 1992).
Table 1.1. Currently accepted species of enterococci (Moellering, 1992).
E. faecalis E. avium
E. faecium E. raffinosus
E. casseliflavus E. pseudoavium
E. gallinarum E. malodoratus
E. mundtii E. durans
E. solitarus E. hirae
Enterococci are found in the gut and faeces of virtually all healthy humans. 
They are less commonly isolated from the oral cavity, gallbladder, urethra and vagina. 
Although once thought of as harmless commensals, the frequency of enterococcal 
infections has increased, and enterococci are now recognised as significant pathogens 
(Moellering, 1992). The 1991 National Nosocomial Infection Survey of the USA 
named enterococci as the second most common cause of infection (behind E. coli, and 
ahead of Pseudomonas aeruginosa and Staph, aureus), responsible for 12% of 
nosocomial infections in the USA between 1986 and 1989 (Schaberg et al, 1991). The
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enterococci are known to cause a number of infections, including wound infections, 
soft tissue infections, and rare cases of meningitis and pneumonia (Tailor et al, 1993). 
The more significant enterococcal infections are detailed below.
1.3.1. Enterococcal endocarditis.
Enterococci are the third most common cause of endocarditis, accounting for 
up to 5-18% of cases (Scheld and Sande, 1990; Megran, 1992). Those most at risk 
from enterococcal endocarditis are the elderly (mostly males over 60 years), and 
intravenous drug abusers (Tailor et al, 1993). As discussed in section 1.3.4., the most 
commonly identified source of bacteraemia prior to enterococcal endocarditis is the 
genitourinary tract (Megran, 1992). The prevalence amongst elderly men is apparently 
due to the increased number of genitourinary procedures performed, whilst in women, 
risk factors also include gynaecological procedures (Tailor et al, 1993).
Whilst bacteraemia is a prerequisite for endocarditis, only a small proportion 
of patients with significant enterococcaemia have endocarditis. Of the 153 cases of 
enterococcal bacteraemia reviewed by Maki and Agger (1988), only 13 developed 
endocarditis. Of these, all had previous heart murmur and 77% had underlying 
valvular heart disease. Most significantly, 12 of the 13 cases were community- 
acquired, and none were associated with polymicrobial bacteraemia. The explanation 
for this may be that community-acquired enterococcal bacteraemia evades detection 
longer than an equivalent nosocomial infection, allowing greater opportunity for the 
development of endocarditis. Conversely, polymicrobial bacteraemia is associated 
with high and rapid mortality such that patients may die before endocarditis is 
established (Maki and Agger, 1988).
Native valve enterococcal endocarditis (NVE) is most commonly a subacute 
infection, and presents in a manner similar to subacute endocarditis of other causes. 
The infection is usually left sided, even in intravenous drug abusers, affecting the 
mitral or aortic valves, or less commonly both together (Murray, 1990; Megran, 1992).
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Aortic infection frequently requires both aggresisive antibiotic therapy and surgical 
intervention to maximise cure rates. Estimates of the overall mortality due to NVE 
range from 15-40%, with higher mortality amongst patients with aortic and combined 
mitral and aortic valve involvement than in those with mitral valve infection alone 
(Rice et al, 1991; Almirante et al, 1991; Megran, 1992). In contrast, prosthetic valve 
enterococcal endocarditis (PVE) appears to have a relatively good prognosis. Recently, 
two studies were performed, comparing enterococcal infection of native and prosthetic 
valves. In each case, PVE responded more favourably to antibiotic therapy, and was 
associated with significantly lower mortality than patients with NVE. The mean 
duration of symptoms prior to clinical diagnoses were 17.4-18.5 days for PVE and 
29.4-31.2 days for NVE. This difference reflects a heightened awareness of risk of 
endocarditis among patients with prosthetic valves, and may explain the difference in 
severity between the two forms of the disease, since a prolonged period of disease 
prior to diagnosis is associated with an increased incidence of relapse and death (Rice 
e ta ly 1991; Almirante et al, 1991).
1.3.2. Intraabdominal infections.
Enterococci are a major part of the normal intestinal flora, and as such are 
often isolated from intraabdominal abscesses, usually in combination with other 
organisms (Murray, 1990). Their role in the pathogenesis of such infections is unclear, 
however, it has been shown that enterococci can translocate from the intestinal lumen 
and cause abdominal infection in mice (Wells et al, 1990), and in another study, the 
presence of E. faecalis in polymicrobial abdominal infections appeared to be 
associated with increased morbidity and mortality (Matlow et al, 1989), thus E. 
faecalis appears to play a significant role in these infections. Furthermore, the 
presence of E. faecalis abscesses represents a significant risk factor for development 
of a potentially more serious bacteraemia (Graninger and Ragette, 1992).
18
1.3.3. Urinary tract infection.
The most common enterococcal infection is of the urinary tract, usually 
nosocomial and associated with instrumentation such as urethral catheterisation. 
E. faecalis strains isolated from urinary tract infections (UTIs) appear to have adhesins 
specific to urinary tract cells, which may allow more efficient colonisation (Guzman et 
al, 1989). Over the course of a 20 year study by Felmingham et al, (1992), the 
frequency of isolation of enterococci from UTIs in hospitals rose from 4% in 1971 to 
12.6% in 1990, and the 1991 National Nosocomial Infection Survey of the USA listed 
enterococcus as the second most common cause of UTIs, isolated from 16% of cases 
(Schaberg et al, 1991). The apparent increase in frequency of nosocomial enterococcal 
urinary tract infection is likely to be linked to the increasing use of catheterisation, 
prior administration of antibiotics which select for resistant enterococci, and the 
transmission of resistant organisms by contaminated hospital equipment and personnel 
(Murray, 1990). Felmingham et al, (1992) found that urethral catheterisation preceded 
infection in 95% of cases. Although most cases of enterococcal UTI are asymptomatic 
colonisation, the presence of enterococci in the urinary tract is also a risk factor for the 
development of bacteraemia (Graninger and Ragette, 1992).
1.3.4. Enterococcal bacteraemia.
According to a 14 year study by Maki and Agger, (1988), enterococcal 
bacteraemia is most likely nosocomial (77% of cases), and usually occurs in 
significantly compromised patients (86%). Other risk factors include the presence of 
an indwelling urethral or vascular catheter (76%) and prior administration of 
antimicrobial therapy (63%). The most commonly identified source of infection is the 
genitourinary tract, being the primary infection site in 21% of cases, followed by the 
intraabdominal cavity and wound infections (Graninger and Ragette, 1992; Megran, 
1992). The mortality of patients with enterococcal bacteraemia is 43-46% (Maki and 
Agger, 1988; Noskin et al, 1991; Graninger and Ragette, 1992), however, mortality is
19
significantly higher among patients with polymicrobial bacteraemia, and in cases 
where septic shock occurs (Noskin et al, 1991). It is often difficult to establish the 
contribution of enterococcal bacteraemia to the cause of death, since most patients 
have severe underlying disease, or concomitant infection by other organisms. (Maki 
and Agger, 1988).
1.4. Problems in therapy of enterococcal infections.
Enterococci are not considered particularly virulent organisms. Most 
enterococcal infections are nosocomial and opportunistic. However, enterococci are 
still considered significant pathogens because of their ability to resist antimicrobial 
agents directed against them, by both intrinsic and acquired mechanisms (Moellering, 
1991; Moellering, 1992). The nosocomial nature of most enterococcal infections 
compounds the problem, selecting for resistant strains by the large scale use of 
antibiotics, and providing routes for rapid dissemination (Murray, 1990). The 
emergence and spread of such antibiotic resistance over the last decade has narrowed 
the already limited options for treatment of serious enterococcal infections such that 
even with the best current options, antibiotic failures are becoming commonplace 
(Moellering, 1992; Eliopoulos, 1993a; Swartz, 1994). Resistance may be acquired or 
intrinsic; the various mechanisms of enterococcal resistance to antibiotics are 
discussed below.
1.4.1. Intrinsic resistance.
Enterococci are intrinsically resistant to a number of antimicrobial agents, 
including P-lactams and aminoglycosides. P-Lactam resistance (especially to 
cephalosporins) is a characteristic of enterococci (Musher, 1990) and appears to be a 
result of the low affinity of certain enterococcal penicillin binding proteins for P- 
lactams (Williamson et al, 1985; Fontana et al, 1992). This resistance is present in all
20
strains of enterococci, including those never previously exposed to antibiotics, 
however, resistance is enhanced following exposure of the cells to stepwise increases 
in penicillin concentration, suggesting that treatment regimen may significantly affect 
response to P-lactam therapy (Hodges et al, 1992). Low-level resistance to 
aminoglycosides is also a characteristic of enterococci, apparently due to poor uptake 
through the cell wall (Moellering and Weinberg, 1971; Murray, 1990). This relatively 
low level resistance precludes the use of aminoglycoside monotherapy, since the 
required MICs exceed achievable serum levels (Musher, 1990). The lack of sensitivity 
to p-lactams and aminoglycosides individually has not caused clinical problems in the 
past because of the synergistic effect observed when these agents are used in 
combination. This effect is apparently due to enhanced uptake of aminoglycosides by 
enterococci when grown in the presence of any cell wall active drug, including p- 
lactams and glycopeptides (Moellering and Weinberg, 1971; Zimmerman et al, 1971). 
Enterococci also exhibit low-level intrinsic resistance to clindamycin, and to the 
normally synergistic combination of trimethoprim and sulfamethoxazole (Moellering, 
1992).
1.4.2. Acquired resistance.
Enterococci have the ability to gain resistance to a number of antibiotics by the 
acquisition of exogenous DNA. Mechanisms of acquisition include inter- and intra­
generic transfer of broad host-range plasmids, (eg the macrolide resistance plasmid 
pAM pl, Schaberg and Zervos, 1986), high efficiency plasmid transfer via the 
pheromone-inducible conjugation system of E. faecalis (discussed in section 1.5.) and 
via transposons such as Tn916 and Tn917 (Clewell and Gawron-Burke, 1986; 
Schaberg and Zervos, 1986). Such mechanisms have lead to widespread enterococcal 
resistance to tetracyclines, macrolides and chloramphenicol, (Moellering, 1991). 
However, of greater significance is the emergence of high level resistance to 
aminoglycosides, p-lactams and glycopeptides.
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1.4.3. High level aminoglycoside resistance.
Since the 1950s, treatment of serious enterococcal infections has exploited the 
bactericidal synergy between p-lactams and aminoglycosides, originally combining 
penicillin and streptomycin. However, by the 1970s, 25-50% of enterococci showed 
high level resistance to streptomycin and kanamycin (Swartz, 1994), preventing their 
use in synergy, and consequently gentamicin replaced streptomycin in the 
combination. Gentamicin resistant strains of enterococci were first identified in 1979 
(Horodniceanu et al, 1979), and have since been isolated world-wide. In some centres 
up to 70% of strains have shown high level (MIC >2000jig/ml) resistance to 
gentamicin (Moellering, 1991; Swartz, 1994), and thus were also resistant to 
penicillin/aminoglycoside synergy. Aminoglycoside resistance may be due to 
chromosomal mutations which alter ribosomal binding or affect drug transport, or 
more commonly, due to acquired genes coding for enzymes which degrade the drugs 
(Moellering, 1991; Leclercq et al, 1992). Among the most frequently isolated enzymes 
are adenylyltransferases, which deactivate streptomycin and 3f-phosphotransferases, 
which deactivate kanamycin. Gentamicin resistance is determined by a single 
bifunctional 6'-acetyltransferase-2"-phosphotransferase enzyme, which effectively 
confers resistance to all aminoglycosides except streptomycin (Ferretti et al, 1986; 
Moellering, 1991). Thus when treating serious enterococcal infections, it is important 
to screen for resistance to streptomycin, kanamycin and gentamicin before beginning 
therapy (Leclercq etal, 1992)
1.4.4. High level P-lactam resistance.
To compound the problem of aminoglycoside resistance, high level resistance 
to p-lactams has emerged among enterococci, both by an enhancement of intrinsic 
resistance, especially in E. faecium, through increased production of low affinity 
penicillin binding proteins (Boyce et al, 1992 Chirurgi et al, 1992; Fontana et al, 
1992), or by the acquisition of p-lactamase genes on plasmids (Murray et al, 1986)
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and transposable elements which insert into the chromosome (Rice et al, 1991). 
Hybridisation and biochemical studies have suggested that the |3-lactamase produced 
by resistant enterococci is closely related to that previously isolated from S. aureus, 
suggesting that the resistance may have originated in staphylococci and spread to 
enterococci (Murray et al, 1986a). Some success in treating these resistant organisms 
has been demonstrated with imipenem, or with combinations of ampicillin with the 13- 
lactamase inhibitor sulbactam (Patterson and Zervos, 1989; Markowitz et al, 1991). 
However, many strains of (3-lactam-resistant enterococci also possess high level 
gentamicin resistance, making infections by these organisms extremely difficult to 
eradicate, as illustrated by a recent report of an outbreak of infections due to (3- 
lactamase-producing, gentamicin-resistant E. faecalis (Wells et al, 1992). Urinary tract 
infections are less problematic, since drug accumulation in the urine can give rise to 
concentrations high enough to overcome resistance mechanisms (Wells et al, 1992) 
however, bacteraemias and endocarditis remain a significant problem. Penicillin 
resistance due to P-lactamase production is still uncommon, however it presents a 
major threat, especially since conjugative transfer has been demonstrated (Coudron et 
al, 1992; Swartz, 1994).
1.4.5. Glycopeptide resistance.
Because of their reliable activity against enterococci, the glycopeptide drugs 
vancomycin and teicoplanin have proved useful alternatives for treatment of severe 
enterococcal infections in cases of penicillin allergy or p-lactam resistance (Leclercq 
et al, 1992). They are normally used in synergy with an aminoglycoside, although 
some reports claim 71% cure of E. faecalis endocarditis with teicoplanin alone 
(Schmit, 1992). However, the cure rate was higher in combination with an 
aminoglycoside. The first strains of enterococci resistant to vancomycin and 
teicoplanin emerged in the late 1980's (Leclercq et al, 1988; Uttley et al, 1988). 
Glycopeptide resistant enterococci have since been reported world-wide (Leclercq et 
al, 1992) and the rate of isolation of resistant strains appears to be increasing. The
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percentage of nosocomial enterococci resistant to vancomycin in U.S.A. hospitals 
increased from 0.3% in 1989 to 7.9% in 1993, and the rate was higher (13.6%) among 
isolates from patients in intensive care units (Centres for Disease Control, 1993). The 
true figure may be even higher, since some glycopeptide resistant enterococci will not 
grow in the absence of vancomycin, and so may be missed in routine screening 
(Woodford et al, 1994). In one outbreak in an intensive care unit, vancomycin- 
resistant E. faecium were spread to numerous patients via non-disposable handles of 
rectal thermometers (Livornese et al, 1992), in another, the organisms spread from a 
hospital ward to a local nursing home, where patients were received after hospital 
discharge (Frankel, 1994). The problem is being addressed by providing clinicians 
with a limited list of situations where vancomycin therapy is appropriate or acceptable 
(Frankel, 1994) to reduce the likelihood of selection of vancomycin-resistant strains.
Glycopeptide resistance can occur through three phenotypes, Van A, VanB and 
VanC, although only VanA and VanB have been noted in E.faecalis (Arthur and 
Courvalin, 1993). The genes for expression of the VanA phenotype are carried upon a 
transposon designated Tn1546 (Arthur et al, 1993), which has been found to insert 
both chromosomally and on plasmid DNA (Woodford et al, 1993). VanA enterococci 
are resistant to both vancomycin and teicoplanin apparently because of a modification 
of the target site for these drugs, namely the D-alanyl-D-alanine terminus of stem 
pentapeptides in bacterial peptidoglycan. Analysis of the cytoplasmic precursors of 
peptidoglycan in VanA strains of enterococci suggests that the D-alanyl-D-alanine 
moiety is altered to D-alanyl-D-lactate (Billot-Klein et al, 1992; Handwerger et al, 
1992; Messer and Reynolds, 1992), resulting in reduced affinity for glycopeptides. 
Enterococci expressing the VanB phenotype are moderately resistant to vancomycin, 
but generally sensitive to teicoplanin (Arthur and Courvalin, 1993), although a recent 
report suggests that increasing numbers of teicoplanin resistant VanB enterococci are 
being isolated (Dean et al, 1994). The vanB gene cluster is transferred by 
chromosomal insertion of a large (90-250 kb) transposable element (Quintiliani and
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Courvalin, 1994). Cloning of the vanB gene has revealed significant homology to 
vanA (Evers et al, 1993; 1994), and modified peptidoglycan precursors ending in D- 
ala-D-lactate, identical to those seen in VanA enterococci, have been detected in VanB 
strains (Billot-Klein et al, 1994). The lower level of resistance to glycopeptides of 
VanB strains, as compared to VanA strains is probably related to the presence of a 
pool of residual D-alanyl-D-alanine precursors detected in VanB enterococci (Billot- 
Klein et al, 1994).
1.4.6. Treatment o f infections due to resistant enterococci.
The emergence of high level resistance to glycopeptides has worsened the 
already difficult clinical problem of therapy of serious enterococcal infections such as 
endocarditis. Current recommendations for the treatment of enterococcal endocarditis 
specify the combination of a P-lactam with an aminoglycoside for at least 4-6 weeks, 
with substitution of a glycopeptide where the use of P-lactams is inappropriate (Tailor 
et al, 1993). Successful treatment of a case of aminoglycoside-resistant E.faecalis 
endocarditis with high dose ampicillin has been reported (Jones, 1994), however, the 
susceptibility of individual strains varies. In cases where all aminoglycosides are 
resisted, the clinician must select the most active single drug regimen available, based 
on MIC reports for the isolate (Tailor et al, 1993).
Similarly, in cases where enterococci are resistant both to P-lactams and 
glycopeptides, serious problems arise, and the situation may be worsened by 
concomitant gentamicin resistance (Sader et al, 1994). In view of this real problem of 
increasing enterococcal resistance, the efficacy of other antibacterial combinations has 
been investigated. Some instances of vancomycin-ampicillin synergy in vitro have 
been suggested, but reports are conflicting, and susceptibility testing for individual 
strains is recommended (Cercenado et al, 1992; Eliopoulos, 1993; 1993a). High dose 
ciprofloxacin has been shown to be bactericidal, however its use in monotherapy is not 
recommended because of the high risk of selection of resistant organisms
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(Bauemfeind, 1992). However, combining ciprofloxacin with gentamicin, rifampicin 
or both has been shown to be effective in a rat model of enterococcal endocarditis 
(Whitman et al, 1993). Evaluation of trospectomycin, a new aminocyclitol antibiotic, 
has shown bactericidal activity against some enterococci when used in combination 
with ampicillin in vitro, however, this combination is yet to be tested in vivo 
(Mobarakai et al, 1994). Another new drug, levofloxacin, has also shown bactericidal 
activity against multidrug resistant E.faecalis, when used in combination with 
ampicillin in vitro, however individual strain susceptibility varies (Smith and Fu, 
1994).
There is concern that multiply resistant enterococci may serve as a pool of 
resistance genes for spread to other genera. Of particular concern is the ability of 
enterococci to transfer high level vancomycin resistance to staphylococci (Noble et al, 
1992), raising the possibility of glycopeptide resistance in S. aureus. If resistance to 
currently available antibiotics continues to emerge, then effective treatment of 
enterococcal infections may require the development of a new generation of 
antimicrobial drugs (Eliopoulos, 1993a). Thus a detailed understanding of the 
pathogenic mechanisms of enterococci is essential. Despite their being the third most 
common aetiologic agents in infective endocarditis, little is known of the pathogenic 
mechanisms of enterococci in this respect, with most research having been directed at 
viridans streptococci and staphylococci.
1.5. Pheromone-induced plasmid transfer in E.faecalis.
A feature apparently unique to enterococci is the ability to acquire conjugative 
plasmids at very high efficiency (enhanced by 105-106-fold for broth matings), in 
response to sex pheromones released by plasmid-free strains (Clewell, 1993).
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Early evidence of the ability of E.faecalis to transfer resistance plasmids by 
conjugation was provided by Jacob and Hobbs (1974), who later showed that 
haemolysin determinants transferred in a similar manner (Jacob et al, 1975). Since 
then, the pheromone-inducible plasmid transfer system of E.faecalis has been well 
characterised (Clewell, 1993; Wirth, 1994). E.faecalis strains harbouring sex 
pheromone plasmids (donor cells) clump when mixed with cells not containing that 
particular plasmid (recipient cells), whereas both strains show normal behaviour when 
incubated alone (Dunny et al, 1978). During this clumping stage, plasmid transfer 
occurs from donors to recipients. Once transfer is complete, the clumps disperse, the 
population having shifted to one almost entirely of donors (Wirth, 1994). Some of the 
E. faecalis sex pheromone plasmids carry bacteriocin/haemolysin determinants, which 
have been shown to contribute to virulence (Ike et al, 1984; Jett et al, 1992; Chow et 
al, 1993), others encode antibiotic resistance (Murray et al, 1988).
At least 19 pheromone-responsive plasmids are known to exist, each one 
responding to a particular pheromone (Wirth, 1994). The sex pheromones are hepta- 
or octa-peptides, secreted by recipient strains, indicating to donors that they do not 
possess the corresponding plasmid (Clewell and Weaver, 1989). When donor cells 
sense the corresponding pheromone, a plasmid-encoded aggregation substance (AS) is 
synthesised, which mediates bacterial clumping by adhesion to a chromosomally- 
encoded binding substance (BS) present on all other E. faecalis strains (Clewell and 
Weaver, 1989). Since donor cells also express BS, they bind to each other as well as to 
recipient strains (Dunny et al, 1978). Free lipoteichoic acid was found to inhibit the 
clumping response, suggesting that cell surface LTA may represent BS (Ehrenfield et 
al, 1986). However, more recent mutagenesis studies suggest that the situation is more 
complex, involving surface proteins as well as LTA (Bensing and Dunny, 1993).
Aggregation allows plasmid transfer events to occur, however the adhesion is 
independent of the transfer process* which requires other plasmid directed proteins 
(Olmsted et al, 1991). During aggregation, donor cells produce a surface exclusion
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protein, which prevents transfer of plasmids ffrom donor to donor (Weidlich et al,
1992), increasing the efficiency of conjugation. When a cell acquires a certain 
plasmid, it shuts off production of the inducing pheromone, and initiates production of 
a pheromone inhibitor, to prevent auto-aggregation in response to any residual 
pheromone production (Clewell, 1993). Different sex pheromone plasmids operate 
independently of each other, since when an acquired plasmid directs shut off secretion 
of the corresponding pheromone, other pheromones are unaffected. Furthermore, when 
a donor containing multiple plasmids is induced by a single pheromone, only the 
corresponding plasmid is transferred (Ehrenfield, 1986).
1.5.1. The dual role o f aggregation substance.
The AS produced by donor cells in response to pheromone has been visualised 
on the cell surface as a dense mat of hair-like structures (Galli et al, 1989; Wanner et 
aly 1989) directly involved in cell-cell interactions (Olmsted et aly 1993). The 
aggregation substances of all known sex pheromone plasmids, with one exception, are 
homologous (Galli and Wirth, 1991), and have been shown to include the RGD motifs 
Arg-Gly-Asp-Ser, and Arg-Gly-Asp-Val (Galli et alt 1990; Kao et a/, 1991), which are 
found in proteins mediating adhesion to eukaryotic cells via specific receptors 
(Ruoslahti, 1991). This finding led to the hypothesis that AS might mediate 
attachment to host cells, and thus act as a virulence factor. This was confirmed by 
Kreft et al, (1992) who not only demonstrated E.faecalis attachment to eukaryotic 
cells via the RGD motifs, but also found that synthesis of AS was induced by some 
component(s) of serum. This suggests that E. faecalis may be able to sense transition 
into the host, and respond by colonising tissues through expression of AS (Wirth, 
1994). Aggregation substance also appears to have a role in the virulence of E.faecalis 
in endocarditis, contributing to the size of vegetations, but not to infectivity (Chow, et 
aly 1993).
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1.6. Other organisms in infective endocarditis.
A list of aetiologic agents in endocarditis is shown in table 1.2. The 
pathogenesis of infective endocarditis is presumed to start with the adherence to, and 
colonisation of cardiac tissues by organisms which gain access to the circulation 
during brief bacteraemias. The relatively narrow spectrum of organisms which 
routinely cause endocarditis, as compared to the large number of organisms frequently 
isolated from blood cultures suggests that the events leading to the colonisation of the 
heart valve are not random (Johnson, 1993). It is probable that the difference in ability 
of organisms to cause endocarditis rests, at least in part, with their ability to adhere to 
cardiac tissues (Barco, 1991). The mechanisms by which these events occur are 
discussed in section 1.12.
Table 1.2. Aetiologic agents in infective endocarditis. Figures indicate percent of
cases.___________________________________________________________________
Causative Scheld and Sande, Watanakunakom
agent._____________ ________ 1990 andBurkert, 1993_________________
Streptococci 60-80% 44%
Viridans streptococci 30-40% 35%
Enterococci 5-18% 8%










1.7. Antimicrobial therapy of endocarditis.
1.7.1. General considerations.
Even when treating endocarditis due to organisms which are highly sensitive to 
antimicrobials in vitro, complete eradication requires antimicrobial chemotherapy of 
up to 6-8 weeks, and relapse is not uncommon. This apparent anomaly reflects the 
difficulty in delivery of antimicrobial agents to the infected platelet-fibrin vegetation 
(Scheld and Sande, 1990). Bacteria within the endocardial vegetation are separated 
from plasma by layers of fibrin and platelets, and the drug levels achieved within the 
vegetation are inferior to those measured in plasma. Furthermore the large numbers of 
bacteria within the vegetation and their relative metabolic inactivity contribute to the 
difficulty of eradicating such infections (Carbon et al, 1993). This is particularly true 
for (3-lactam antibiotics, which require cell growth in order to be bactericidal. 
Furthermore, with some organisms, large concentrations of P-lactamase can occur 
within the vegetation, which can inactivate P-lactams, even when used in combination 
with p-lactamase inhibitors (Carbon et al, 1993).
7.7.2. Choice o f drugs.
In general, parenteral therapy is preferred to oral therapy, because of more 
controllable and reliable plasma levels, and extended drug administration is required 
to reduce the chances of relapse. Bacteriostatic drugs, such as tetracyclines and 
erythromycin should be avoided in favour of antibiotic combinations which produce a 
rapid bactericidal effect, such as the combination of p-lactam with aminoglycoside 
(Scheld and Sande, 1990). For appropriate therapy, the causative organism must be 
isolated before the initiation of antibiotic treatment, and its susceptibility to antibiotics 
determined. In the case of p-lactam resistance, vancomycin can be substituted, and in 
the case of streptomycin resistance, gentamicin is often effective (Eliopoulos, 1993). A 
typical therapeutic regimen for treating streptococcal endocarditis may consist of 
aqueous penicillin G, 10-20 million units daily, (by intravenous infusion) every six
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hours for four weeks, combined with streptomycin, 500mg (or gentamicin 80mg) 
intramuscularly every 12 hours for the first two weeks (Scheld and Sande, 1990). 
Alternatively, the final two weeks of therapy may be by way of oral amoxycillin 
(Littler and Shanson, 1989).
When treating penicillin-resistant streptococci or enterococci, which are 
intrinsically resistant to many commonly used drugs, treatment should be in 
combination with aminoglycosides for 4-6 weeks, with monitoring for aminoglycoside 
toxicity (Scheld and Sande, 1990).
Studies on the treatment of S. aureus endocarditis with combined P-lactam and 
aminoglycoside regimens indicate that an enhanced effect is not evident after 5 days of 
treatment, beyond which the risk of nephrotoxicity outweighs the clinical benefits 
which may be achieved through continued use of these drugs (Bayer, 1993).
1.7.3. Surgery.
Cardiac surgery, particularly valve replacement has considerably reduced 
mortality in infective endocarditis in patients with serious haemodynamic or infective 
complications and where medical treatment alone is insufficient to control the disease 
(Littler and Shanson, 1989).
1.8. Prophylaxis of infective endocarditis.
1.8.1. General principles.
Any surgical or dental procedure which damages a mucosal surface can cause a 
bacteraemia which may last in excess of 15 minutes. During this time, bacteria may 
lodge upon the myocardium, resulting in infection. Certain cardiac conditions pre­
dispose to endocarditis, and furthermore certain dental and surgical procedures cause 
bacteraemia with organisms more likely to cause endocarditis than other procedures.
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Thus, prophylactic therapy is recommended for those at risk of endocarditis, who are 
undergoing procedures likely to produce bacteraemia with endocarditis-causing 
organisms, such as dental procedures and genito-urinary tract or gastro-intestinal 
surgery (Dajani et al, 1990).
1.8.2. Antibiotic prophylaxis.
The aim of antibiotic prophylaxis is to provide adequate serum antibiotic levels 
during and after the risk procedure. Only in cases of prolonged bleeding should the 
treatment be continued beyond the procedure itself, to avoid the likelihood of 
resistance emerging. The prophylactic therapy is directed towards those organisms 
most likely to cause endocarditis from a given site. Thus, prophylaxis prior to dental 
procedures is aimed at viridans streptococci, whilst that prior to gastro-intestinal or 
genito-urinary tract surgery is directed towards enterococci. The recommended 
prophylactic regimen for dental procedures is either amoxycillin 3g, erythromycin lg 
or clindamycin 300mg orally prior to procedure, followed by half the initial dose 6 
hours later. If the oral route is not acceptable, ampicillin or clindamycin may be given 
parenterally. For genitourinary or gastrointestinal procedures, ampicillin 2g, plus 
gentamicin 1.5 mg/kg should be given intravenously 20 minutes before the procedure, 
followed by amoxycillin 1.5g, 6 hours later. In the case of penicillin allergy, 
vancomycin lg (intravenous) may be substituted for ampicillin (Dajani et al, 1990).
Because of the prevalence of endocarditis-causing viridans streptococci in the 
oral cavity, patients undergoing dental procedures are particularly at risk. Accordingly, 
the American Heart Association recommends that risk patients should establish and 
maintain the best possible oral health. Furthermore, the application of chlorhexidine 
mouthwash prior to dental procedures as an adjunct to antibiotic prophylaxis is 
suggested (Dajani etal, 1990).
The antibiotic prophylaxis of endocarditis has been the subject of some 
controversy. A proportion of patients develop endocarditis, even if they have no
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known predisposing heart lesion, and so are not targeted for therapy, and there is no 
direct clinical trial evidence to support the effectiveness of antibiotic prophylaxis 
(Littler and Shanson, 1989). Indeed, such a trial would encounter major ethical issues. 
The rationale behind antibiotic prophylaxis is sound, but the fact that the number of 
cases of endocarditis has not dropped since the introduction of systemic antibiotics, 
and that some cases of endocarditis have still occurred despite appropriate prophylaxis 
raises questions over the efficacy of such treatments (Barco, 1991). Antibiotics do not 
prevent transient bacteraemia following surgical procedures, but rather they serve to 
eradicate the organisms once in the bloodstream, and because the sensitivity of 
bacteria to antibiotics can be variable (Barco, 1991), treatment with a single antibiotic 
may be inappropriate. However, without sound clinical evidence that such treatments 
are effective, it would be inappropriate to subject a patient to the risk of toxicity 
associated with more aggressive therapy.
1.9. Pathology of infective endocarditis.
If left untreated, the infection causes severe damage to the heart valves and 
surrounding tissue, can cause constant bacteraemia by release of infecting organisms 
into the circulation, and can lead to other systemic complications. Bacteraemia 
produces symptoms of fever, rigors, anaemia and anorexia (Littler and Shanson, 
1989). Activation of host defence mechanisms leads to the presence of circulating 
immune complexes, which can become lodged in the vasculature (Kaye, 1985), 
leading to a range of systemic events including renal dysfunction, splenic infarction 
and cerebral haemorrhage (Watanakunakorn and Burkert, 1993). During active 
infective endocarditis, renal architecture is always altered, even in the absence of 
clinical or biochemical evidence of renal dysfunction (Scheld and Sande, 1990).
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1.9.1. Cardiac damage.
Local invasion of cardiac tissue leads to valve damage, often resulting in 
incompetence, and sometimes perforation, presenting as congestive heart failure in up 
to half of endocarditis cases (Megran, 1992). Perivalvular extension of infection 
(PVEI), ie the spread of infection from the heart valve to the surrounding tissues is a 
major, potentially fatal complication of endocarditis. Prosthetic valves are particularly 
at risk. Extension of infection most commonly occurs into the cardiac tissue 
immediately adjacent to the valve ring, causing perivalvular abscess, aneurysms, 
intracardiac fistulas and valve dehiscence. Furthermore, extension into conduction 
fibres can cause partial or complete heart block (Carpenter, 1991).
1.9.2. Embolic phenomena.
Sections of an infected cardiac vegetation can be dislodged from the site of 
infection and be carried in the circulation, leading to the formation of septic emboli 
and abscesses. Embolic phenomena are common in infective endocarditis, being 
detected in 45-65% of cases at autopsy, most commonly affecting the renal, splenic, 
coronary or cerebral circulation. Renal defects are invariably present, cerebral emboli 
occur in at least one third of all cases, and in cases where the right side of the heart is 
involved, pulmonary emboli are common (Scheld and Sande, 1990). If abscesses form, 
they can serve as sources for re-infection of the heart valve, leading to failure of 
therapy. If left untreated, the infection is almost invariably fatal.
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1.10. Clinical presentation.
Infective endocarditis is a systemic disease which can present with unusual or 
important symptoms in virtually every organ system of the body. However, according 
to two recent surveys of endocarditis cases, the most common clinical manifestations 
of infective endocarditis are fever and heart murmur (Megran, 1992; Watanakunakorn 
and Burkert, 1993). The other symptoms and physical findings of infective 
endocarditis are listed according to frequency in table 1.3. The presentation of 
endocarditis is varied and in some cases, the presenting symptoms are so vague that it 
is not possible to establish infective endocarditis until autopsy (Watanakunakorn and 
Burkert, 1993).
Many of the clinical symptoms listed in table 1.3. are the result of peripheral 
embolisation or the presence of circulating immune complexes (Maisch, 1989). 
Ostlers nodes are small painful lesions found in the pads of fingers or toes, and arise 
from immune complexes in dermal blood vessels. Roth spots are retinal lesions 
surrounded by oedema and haemorrhage, splinter haemorrhages are seen in the finger 
or toe nails, and petechiae, resulting from local vasculitis or emboli usually occur on 
the conjunctiva or buccal mucosa. Janeway lesions, subcutaneous abscesses due to 
septic emboli, are relatively uncommon in endocarditis (Megran, 1992). The 
presentation of infective endocarditis depends very much upon the course of the 
infection. Enterococcal endocarditis generally presents in the subacute form, allowing 
many of the above symptoms to occur. Infection by S. aureus however is more often 
acute and fulminant, presenting with fever and sepsis symptoms (Bayer, 1993)
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Table 1.3. Clinical features and manifestations of infective endocarditis (adapted from 
Scheld and Sande, 1990; Megran, 1992).______________________________________
Symptom % of cases Clinical Findings % of cases
Fever 80-100 ESR > 30 mm/hr 90-100
Chills 40 Heart Murmur 85-100
Weakness 40 Embolic phenomena >50
Dyspnoea 40 Skin manifestations 18-50
Sweats 25 Ostler nodes 10-23
Anorexia/weight loss 25 Splinter haemorrhages 15
Malaise 25 Petechiae 20-40
Cough 25 Janeway lesions <10
Skin lesions 20 Splenomegaly 20-68
Stroke 20 Septic emboli 20
Nausea/vomiting 20 Mycotic aneurysms 20
Headache 15 Clubbing 12-52
Myalgia/arthralgia 15 Roth spots 2-10
Oedema 15 Renal dysfunction 10-50






The clinical and aetiological diagnosis of infective endocarditis is of 
paramount importance for optimal treatment, since rational antimicrobial therapy can 
only be applied once the infecting organism has been identified, and its susceptibility 
to antibiotics determined. In its full blown state, clinical diagnosis of endocarditis is 
straight forward, especially when the classic manifestations such as emboli, heart 
murmurs and immunologic phenomena, along with positive blood cultures, are present 
(Bayer, 1993). However, these signs are not always displayed, especially in acute 
cases, and many of the symptoms of endocarditis are non-specific (Lukes et al, 1993).
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A major problem is that the primary lesion in endocarditis is inaccessible, with open 
heart surgery or autopsy required for direct examination. Thus the clinician must be 
aware of the risk groups for endocarditis, and of the non-specific nature of 
presentation. Recently, a set of guidelines has been proposed, based upon major and 
minor diagnostic criteria (Bayer et al, 1994) which have greatly improved the accuracy 
of diagnosis of endocarditis.
1.11.1. Standard diagnostic procedures.
Transoesophageal echocardiography can identify and characterise up to 90% of 
cardiac vegetations (Bayer, 1993), and is recommended for all patients with suspected 
endocarditis (Lukes and Durack, 1993). Echocardiographic findings are not diagnostic 
alone, and so blood cultures should be taken as soon as infective endocarditis is 
suspected, before initiation of antibiotic therapy. Most cases of endocarditis are blood 
culture positive, however, up to 30% of cases can be culture negative (Tunkel and 
Kaye, 1992). This is usually due to prior antibiotic therapy, but other reasons for 
negative blood cultures include incorrect diagnosis, and infection by organisms which 
are difficult to subculture, such as members of the HACEK {Haemophilus, 
Actinobacillus, Cardiobacterium, Eikenella and Kingella sp.) group, and some 
nutritionally variant streptococci (Tunkel and Kaye, 1992).
1.11.2. Alternative diagnostic methods.
An alternative to aetiological diagnosis of endocarditis by blood culture is 
serodiagnosis, which relies upon detection of host antibodies to specific bacterial 
surface components. Whereas blood culture results can take over 24 hours, and in 
some cases may be negative, serodiagnosis is rapid, and can often distinguish between 
bacteraemia and endocarditis for a particular organism. Bumie and Clark, (1989) 
reported the use of a 112 kDa E. faecalis antigen in the diagnosis of enterococcal 
endocarditis. The test was capable of distinguishing E. faecalis endocarditis from that 
caused by staphylococci or other streptococci. Shorrock et al, (1990) subsequently
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reported the use of three antigens, 37, 40 and 73 kDa in an ELISA which not only 
distinguished between E. faecalis and that caused by other streptococci, but also 
between E. faecalis endocarditis and other E. faecalis infections, such as urinary tract 
infections, intra-peritoneal infections and septicaemia. Serodiagnosis of S. aureus 
endocarditis among patients with S. aureus septicaemia, by detection of antibodies 
against capsular polysaccharide has been reported (Christensson et al, 1991).
1.12. Pathogenesis of infective endocarditis.
The establishment of a bacterial infection on the endocardium requires certain 
pre-disposing factors. These factors include the susceptibility of the heart valve to 
infection, the presence of a bacterial population capable of colonising the valve, the 
adhesion of bacteria to the valve and finally the survival of the adhering bacteria, with 
propagation of the endocardial vegetation (Sullam et al, 1985).
1.12.1. Non-bacterial thrombotic endocarditis.
It is generally accepted that normal healthy heart valves are refractory to 
infection, and that some form of pre-existing damage to the heart valve is required 
prior to infection (Sullam et al, 1985; Rice et al, 1991; Baddour, 1994). In animal 
models of endocarditis, it is well established that the formation of bacteraemia by 
intravenous injection of pathogenic bacteria is insufficient to cause endocarditis, and 
that some other form of trauma, usually in the form of a catheter across the heart 
valve, is required in order to produce endocarditis (Garrison and Freedman, 1970; 
Gutschik, 1993; Baddour, 1994). Examination of infected vegetations revealed that 
endocardial trauma in the form of microscopic thrombi served as the nidus for 
initiation of endocardial infection. In the presence of these thrombi, since termed non- 
bacterial thrombotic endocarditis (NBTE), bacteraemia uniformly produced infective 
endocarditis (Garrison and Freedman, 1970).
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Normal cardiac endothelial cells are not thrombogenic, so the formation of a 
non-bacterial thrombotic endocarditis must follow damage to the endothelium. An 
accepted theory for the formation of the NBTE (Hamill, 1987), begins with some form 
of endothelial damage which traumatises or removes endothelial cells, exposing 
components of the extracellular matrix such as collagen, laminin and fibronectin. 
Circulating platelets become lodged in the area of damage and aggregate along with 
fibrin and fibronectin, which become interwoven with the adherent platelets. The 
vegetation (NBTE) grows as fibrin and platelets continue to bind. Circulating bacteria 
adhere to the NBTE, and become coated with more fibrous material and bacteria. The 
role of fibronectin in the formation of NBTE is significant, and will be discussed 
below. It is becoming increasingly apparent that numerous bacteria, whilst unable to 
colonise healthy endocardium, can exploit the wound healing process at the site of 
NBTE by interacting with various host tissues such as fibronectin (Hamill, 1987), 
platelets (Herzberg et al, 1992; Hermann et al, 1993), and laminin (Sommer et al,
1992).
1.12.2. Risk factors.
As discussed in section 1.12.1., healthy heart valves are refractory to infection; 
the formation of an NBTE is required prior to infection (Rice et al, 1991; Steckelberg 
and Wilson, 1993; Baddour, 1994). Endothelial trauma, inducing formation of an 
NBTE, and bacteraemia are the two major risk factors in infective endocarditis. A list 
of conditions predisposing to such trauma is shown in table 1.4.
Damage may result from previous rheumatic heart disease, where an auto 
immune response is directed toward heart tissue elicited by group A streptococcal 
antigens (Kil et al, 1994), or from congenital heart defects, which produce abnormally 
turbulent blood flow in the vicinity of the heart valve (Sullam et al, 1985; Fowler and 
Durack, 1994). The predominant underlying condition in endocarditis has shifted away 
from rheumatic heart disease, towards mitral valve prolapse, infection of prosthetic
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Table 1.4. Risk factors in endocarditis (Littler and Shanson, 1989; Dajani et al, 1990)
Cardiac Factors Extracardiac Factors
Rheumatic heart disease (15-40%) 
Congenital heart disease (15-20%) 
Atherosclerotic heart disease (20-30%) 
Prosthetic valve,
Dental sepsis and manipulations 
Genitourinary/gastrointestinal surgery 
Intravenous drug abuse 
Intravenous cannulae 
Haemodialysis 
Septicaemia (from any site)
Endoscopy
Tonsillectomy and/or adrenoidectomy.
or other cardiac surgery (10-35%) 
Mitral valve prolapse 
Hypertrophic obstructive cardiomyopthy 
Previous Endocarditis
heart valves, degenerative heart disease and damage caused by intravenous drug abuse 
(Bayer, 1993). This shift is due in part to the decreased incidence of rheumatic heart 
disease, and partly to increased life expectancy and the frequency with which major 
surgery is performed (Bayer, 1993). There is also an increased incidence of neonatal 
endocarditis, associated with the use of central venous catheters to deliver total 
parenteral nutrition to premature infants of extreme low birth weight (Mecrow and 
Ladusans, 1994).
Some studies maintain that infection can occur on normal valves as well as 
those with pre-existing damage (Megran, 1992; Steckelberg and Wilson, 1993). 
Indeed in the study of enterococcal endocarditis by Rice et al, (1991), 7 of 21 patients 
(33%) had no apparent predisposing valvular heart disease. Furthermore, in the study 
by Watanakunakorn and Burkert, (1993), the figure was 46%. It is likely, however, 
that in these cases, some valvular damage was present, which evaded detection by 
conventional means.
1.12.3. Bacteraemia.
Bacteria can enter the blood stream from many sites, often when a mucosal 
surface, colonised with bacteria, becomes traumatised. The most likely portal of 
infection depends upon the infecting organism. a-Haemolytic streptococci (including 
S. sanguis, S, gordonii and S. mitis), are present in high numbers in the oral cavity.
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These bacteria can enter the blood stream through breaks in the blood vessels of oral 
tissues caused by dental procedures such as extractions, oral infections and oral 
hygiene procedures. In a study of rats with periodontitis and catheter-induced aortic 
vegetations, all animals which underwent dental extraction displayed polymicrobial 
bacteraemia one minute later, and within three days 90% had endocarditis (Moreillon 
et al, 1988). A 13-year survey of enterococcal bacteraemia lists the most common 
sources of infection as the gastro-intestinal tract (following surgery or intraabdominal 
infection), the urinary tract (also following surgical intervention, such as urethral 
catheterisation), bum wounds and vascular catheter-related infections (Maki and 
Agger, 1988). Staphylococcal endocarditis is common following heart surgery, 
S. aureus and S. epidermidis being the predominant organisms in prosthetic valve 
endocarditis. The source of infection may be the prosthesis itself, contaminated 
surgical equipment, or post operative wound infection (Littler and Shanson, 1989). 
Intravenous drug abuse is also a common source of S. aureus bacteraemia (Bayer, 
1993, Lukes and Durack, 1993).
1.12.4. The role o f platelets in the pathogenesis o f infective endocarditis.
Platelets play a central role in the pathogenesis of endocarditis. It is uncertain, 
however, if platelets serve to enhance or limit propagation of the infected vegetation. 
A substantial proportion of the NBTE, the focus of bacterial infection, consists of 
aggregated platelets, and endocarditis models using animals with clotting disorders 
have shown that normal platelet function is an important determinant in the 
pathogenesis of the disease (Johnson and Bowie, 1992). Certain strains of S. sanguis, 
have been shown to bind to, and activate, platelets via protein determinants on the 
bacterial cell surface (Herzberg et al, 1983; 1983a). The platelet interaction is 
mediated via at least two S. sanguis fibrillar antigens, one of which mediates 
adherence to platelets, the other triggering aggregation (Erickson and Herzberg, 1993; 
Ford et al, 1993). Aggregation appears to be mediated via interaction with plasma
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components, rather than by direct association with platelet receptors (Ford et al, 
1993a).
In a clinical study, 70% of severe cases of infective endocarditis were caused 
by platelet-aggregating streptococci, compared to 14% of mild cases (Greaves et al,
1993). In a rabbit model, S. sanguis strains which expressed platelet aggregation- 
associated protein (PAAP) (Agg+ strains) caused endocarditis with significantly larger 
vegetations, a more severe clinical course and greater mortality than mutants deficient 
in PAAP expression (Agg“ strains), or Agg+ strains incubated with anti-PAAP 
antibody (Herzberg et al, 1992). The investigators thus proposed that the PAAP was 
an important virulence factor in infective endocarditis. Platelets have also been 
proposed as important mediators of S. aureus adhesion in endocarditis and device­
associated infections. Adherence of S. aureus to inert supports was shown to be 
enhanced by the presence of adherent platelets, along with other plasma proteins, 
particularly fibronectin (Herrmann et al, 1993).
In contrast to the studies detailed above, a study by Sullam et al, (1993), 
concluded that platelets limit the progression of streptococcal infective endocarditis. In 
this study, the role of platelets was analysed by comparing S. sanguis endocarditis in 
normal and thrombocytopaenic rabbits (in which thrombocytopaenia was induced with 
antiplatelet serum). Vegetations from thrombocytopaenic rabbits weighed significantly 
less than those from normal rabbits, but contained more bacteria, suggesting that 
platelets in the vegetation can limit microbial proliferation. The authors suggest that 
platelets may attenuate disease progression by release of platelet microbicidal proteins 
in the vegetation. During clotting, platelets release antibacterial proteins which can kill 
or exert non-lethal antiadherence affects on Gram-positive organisms including some 
strains of viridans streptococci and staphylococci (Yeaman et al, 1994). Resistance to 
such antibacterial agents may represent a virulence factor in infective endocarditis 
(Yeaman et al, 1992). Platelets may similarly interact with bloodbome organisms, 
reducing the number of bacteria available to colonise the vegetation (Sullam et al,
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1993). Thus the role of platelets in the pathogenesis is far from clear. They appear to 
be vital for the pre-disposition to infection, but subsequently may reduce the severity 
of endocarditis.
1.12.5. The role o f fibronectin in the pathogenesis o f endocarditis.
Fibronectin, an adhesive glycoprotein, is a major component of the 
extracellular matrix, where it serves to promote adhesion of cells and other matrix 
macromolecules, having binding sites for eukaryotic cells, collagen and other matrix 
components (Alberts et al, 1989). Fibronectin can exist as plasma fibronectin, a 
circulating soluble dimeric form or as matrix fibronectin, highly insoluble fibrils in the 
extracellular matrix. It is not present on the lumenal surface of endothelial cells, 
however at sites of endothelial damage it is exposed, and promotes thrombogenicity of 
the site of injury by binding platelets and fibrin. Plasma fibronectin further enhances 
clot formation by binding to the NBTE, ultimately constituting 4.4% of the blood clot 
mass (Hamill, 1987). Thus fibronectin has a substantial role in formation of sterile 
vegetations. However, of equal importance is the capacity of micro-organisms to bind 
specifically to fibronectin.
1.12.6. Bacterial adhesion to fibronectin.
Many bacteria which are known to cause endocarditis, can bind fibronectin 
(Baddour, 1994). The ability of S. sanguis and S. aureus to bind to fibronectin-coated 
surfaces has been demonstrated (Lowrance et al, 1988; Herrmann et al, 1988; 
Vaudaux et al, 1992). These organisms are amongst the most common endocarditis 
pathogens, and their ability to bind fibronectin is considered central to their 
pathogenesis. It would appear that S. sanguis selectively binds immobilised 
fibronectin, rather than soluble fibronectin (Lowrance et al, 1988), a property which 
may result from an activation of fibronectin when it becomes bound to other 
molecules or substrates. The importance of fibronectin binding in S. sanguis 
endocarditis has been demonstrated by Lowrance et al, (1990), who compared the
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virulence of non-fibronectin-binding S. sanguis mutants with that of the parent strain. 
In a rat model, non-fibronectin-binding mutants rarely produced endocarditis, whilst 
parent strains had infection rates of 90% or higher, with a low inoculum. Similarly in 
S. aureus, mutants defective in production of certain cell surface proteins involved in 
adhesion to fibronectin and fibrinogen had reduced virulence in an endocarditis model 
(Cheung et al, 1994). Thus, fibronectin has a significant role in the pathogenesis of 
endocarditis. Bacterial fibronectin binding proteins are discussed in section 4.5.18.
1.12.7. Bacterial adhesion to other extracellular matrix components.
The ability of endocarditis-associated streptococci to bind to other matrix 
components exposed at the damaged endocardium has been reported. Laminin binding 
is common among endocarditis isolates, but less common among the same bacterial 
species isolated from the oral cavity (Switalski et al, 1987). Laminin binding proteins 
of S. gordonii have been identified, and appear to be inducible by components of the 
extracellular matrix (Sommer et al, 1992). Furthermore, S. pyogenes appears to 
express proteins with affinity for connective tissue proteoglycans in basal laminae of 
cardiac muscle and other tissues (Winters et al, 1993). The relative importance of such 
interactions is difficult to establish, since even for major binding processes, such as 
fibronectin binding, eliminating the binding ability does not completely abrogate the 
ability of the organism to produce infection (Lowrance et al, 1990; Cheung et al,
1994). Thus the pathogenesis of infective endocarditis is likely to be multifactorial and 
may involve many as yet uncharacterised ligand receptor interactions, as well as other 
types of virulence factors.
1.12.8. Glycocalyx production.
The platelet interactive proteins and extracellular matrix binding proteins of 
Gram-positive organisms described above are virulence factors in endocarditis. There
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are reports of several other bacterial cell products which appear to enhance the ability 
of the bacterium to cause endocarditis, and so may be classified along with the 
extracellular matrix-, and platelet-binding proteins as virulence factors. Of particular 
interest is the presence of an extracellular polysaccharide coat (glycocalyx) on certain 
endocarditis-causing bacteria. An association between surface glucan production and 
the ability of streptococci to bind to heart valves in vitro is well established (Scheld et 
al, 1978; Ramirez-Ronda, 1978), and the presence of a glycocalyx has since been 
considered a virulence factor in endocarditis. Viridans streptococci, including 
S. sanguis and S. mutans, produce exopolysaccharide. A comparison of glycocalyx 
production by endocarditis and non-endocarditis streptococci by Dali and Herndon, 
(1990), suggested an association between expression of a glycocalyx and the ability of 
viridans streptococci to cause endocarditis. This was confirmed by Munro and 
Macrina (1993), who demonstrated that exopolysaccharide production by S. mutans 
V403 was associated with an enhanced ability to cause endocarditis in a rat model, and 
resistance to phagocytosis. The production of exopolysaccharide appeared to enhance 
adherence to fibrin, which may provide an explanation for the enhanced virulence of 
these strains. However, in a similar study using S. gordonii, the virulence of mutants 
defective in exopolymer production was no different to that of the parent strain (Wells 
et al, 1993). Indeed, the effect of glycocalyx appears to vary according to the organism 
concerned. In a rat model, S. aureus strains lacking a microcapsule produced 
endocarditis at lower inocula than encapsulated strains, suggesting that capsule 
expression, rather than being a virulence factor, actually reduces virulence (Baddour et 
al, 1992). Thus, generalisations about the contribution of exopolysaccharide to 
virulence of viridans streptococci in endocarditis appear to be inappropriate. A recent 
report by Vacca-Smith et al, (1994), may provide some explanation of the disparate 
findings of the studies described above. The investigators found that a 
glucosyltransferase (GTF) enzyme, of the type responsible for production of 
exopolysaccharide, mediated adhesion of S. gordonii to human umbilical vein 
endothelial cells. This is consistent with the association between exopolysaccharide
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production and virulence in endocarditis (Dali and Herndon, 1990). It was this type of 
enzyme which was inactivated in order to produce exopolysaccharide-deficient 
mutants in the studies by Munro and Macrina, (1993) and Wells et al, (1993). Vacca- 
Smith et al, (1994), reported that both bacterial adhesion and glucosyltransferase 
enzyme activity decreased rapidly during stationary phase growth, thus GTF mutants 
may behave similarly to stationary phase parent cells. Furthermore, it is not known 
whether the cells inoculated by Wells et al, (1993), adhered to endothelial cells, (the 
target for adhesion of the GTF enzyme), or pre-existing catheter induced thrombi.
The virulence-enhancing mechanism of the glycocalyx has mainly been 
attributed to its ability to enhance binding to platelet-fibrin vegetations, and to produce 
larger vegetations, restricting susceptibility to antimicrobial agents (Dali and Herndon, 
1989; Dali et al, 1990). However, Sullam et al, (1993a), found that streptococcal 
glycocalyx production correlated with reduced binding to platelets, and that 
exopolysaccharide itself could inhibit platelet aggregation. In the light of previous 
findings that platelet interactions may be detrimental to the invading pathogens 
(Yeaman et al, 1992; 1994; Sullam et al, 1993), the authors postulated that this 
avoidance of platelets may represent an additional mechanism by which the glycocalyx 
can contribute to virulence in endocarditis. Further studies may be needed to clarify 
the relative importance of exopolysaccharide production and GTF activity in the 
pathogenesis of infective endocarditis.
1.12.9. Autolysin production.
The production of autolytic enzymes by Gram-positive organisms has been 
linked to virulence. Autolytic enzymes appear to degrade the peptidoglycan cell wall, 
possibly functioning in wall growth, cell separation, wall turnover, and extrusion of 
flagella. Their role in pathogenicity has been demonstrated in S. pneumoniae, where 
autolysin-defective mutants were less virulent than parent strains. Furthermore, 
immunisation with purified autolysin protected mice from S. pneumoniae challenge
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(Berry et al, 1989). Autolysin-defective mutants of S. aureus have been isolated (Mani 
et al, 1993), and compared with a parent strain in a rat model of endocarditis. Six of 
nine rats challenged with the parent strain developed endocarditis, whereas none of the 
eight inoculated with autolysin-defective mutants were infected (Mani et al, 1994). 
The reduced virulence of the mutants may have been related to alterations in cell wall 
morphology, as detected by electron microscopy, rather than any direct effect upon the 
host.
1.13. Pathogenesis of E. faecalis in endocarditis.
Early work by Gould et al (1975) showed that E.faecalis bound to heart valve 
tissue more avidly than most other streptococci and staphylococci, suggesting that the 
species may possess specific binding determinants. Guzman et al, (1989), 
demonstrated that the ability of E. faecalis to adhere to heart cells was dependent upon 
its growth medium, and later showed that enhanced adhesion was due to serum- 
dependent expression of D-galactose and L-fucose containing moieties (Guzman et al, 
1991b). Growth in serum was also associated with decreased hydrophobicity, which 
may be responsible for reduced association with human polymorphonuclear leukocytes 
noted in serum-grown strains of E.faecalis (Guzman et al, 1991a).
Enterococcus faecalis strains bearing certain pheromone-responsive plasmids, 
such as pADl, express a haemolysin/bacteriocin protein, also referred to as cytolysin, 
which has been reported to contribute to virulence in intraperitoneal infections of mice 
(Ike et al, 1984), human parenteral infections (Ike et al, 1987), and experimental 
endophthalmitis (Jett et al, 1992). E. faecalis strains bearing these plasmids also 
express aggregation substance. The role of the plasmid-associated haemolysin and 
aggregation substance, both separately, and in combination in E. faecalis endocarditis 
has been investigated (Chow et al, 1993). The ability of E.faecalis to cause 
endocarditis was not affected by expression of aggregation substance or haemolysin.
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However, mean vegetation weight was greater when animals were inoculated with 
cells expressing aggregation substance, whilst morbidity and mortality were 
significantly enhanced in animals infected with cells expressing haemolysin and 
aggregation substance in combination. This suggests that conjugative haemolysin 
plasmids of E.faecalis such as pADl are virulence factors in E.faecalis endocarditis 
(Chow et al, 1993).
In examining the complex antigenic composition of E. faecalis strains causing 
endocarditis, Aitchison et al, (1986) investigated two antigens, 37 and 43 kDa, which 
reacted strongly with an asparagus pea lectin-peroxidase conjugate on immunoblots, 
suggesting the presence of fucosyl residues. Antibodies to these antigens (later re­
calculated as 37 and 40 kDa) along with a 73 kDa antigen were detected only in sera 
from patients with E. faecalis endocarditis, and not from other aetiological agents in 
infective endocarditis or in patients with E. faecalis infections other than endocarditis 
(Aitchison et al, 1987). Expression of the 37 and 40 kDa antigens appeared to be 
dependent upon growth medium, being expressed strongly in serum and to a lesser 
extent in brain heart infusion broth, but not in chemically-defined media. Furthermore, 
expression was demonstrated in vivo in a rabbit model (Lambert et al, 1990). A 
serodiagnostic ELISA based upon the partially purified 37, 40 and 73 kDa antigens 
successfully diagnosed 15 of 16 (94%) cases of E.faecalis endocarditis, and gave 
negative results in 9 of 10 cases of endocarditis due to other streptococci and 8 of 10 
E.faecalis infections other than endocarditis (Shorrock et al, 1990). Thus the 37, 40 
and 73 kDa antigens appear to be specific to E.faecalis endocarditis. Aside from 
being useful in diagnosis, the specificity of the antigens to endocarditis, and their 
expression in response to serum suggests a specific role in pathogenicity. Growth in 
serum mimics the environment the cells would encounter during bacteraemia, and may 
prime the cells for colonisation of the myocardium. Guzman et al, (1989; 1991a; 
1991b) demonstrated that growth in serum increased adhesion to heart cells, and 
reduced interaction with polymorphonuclear leukocytes. These functions may be
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associated with the serum-dependent changes in antigenic profile of E. faecalis noted 
by Lambert et al, (1990).
1.14. Aims and Objectives.
The aim of this project is to characterise the 37 and 40 kDa endocarditis 
specific antigens of E. faecalis identified by Aitchison et al, (1986). In doing so, it is 
hoped to gain further understanding of the pathogenic mechanisms of E. faecalis in 
infective endocarditis. E. faecalis endocarditis is increasingly difficult to treat, because 
of its ability to gain resistance to many of the currently available antimicrobial drugs. 
Identification of a function for the antigens may provide new therapeutic targets for 
the prevention or treatment of E. faecalis endocarditis.
Screening an E. faecalis genomic XZAP II library with antiserum from a 
patient with E. faecalis endocarditis (containing a high titre of antibodies against the 
37 and 40 kDa antigens) will allow isolation of the structural gene(s) encoding the 37 
and 40 kDa antigens. Cloning and nucleotide sequencing of the gene(s) will provide 
the inferred amino-acid sequence of the proteins, and computerised analysis of the 
these sequences may provide some insight into their structure and function.
The regulation of expression of the genes will be investigated by northern blot 
analysis of E. faecalis RNA, using a specific probe constructed from the cloned 
gene(s). Previous work has suggested that expression of the 37 and 40 kDa antigens is 
regulated by growth environment, in particular the presence of serum. Northern blot 
analysis will determine whether this effect is mediated at the transcriptional level. The 
nature of the inducing factor will also be investigated.
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Chapter 2: Materials and Methods.
2.1. Bacterial strains
E. faecalis EBH1 was isolated from a patient (GP) with a severe case of 
enterococcal endocarditis at Birmingham Heartlands Hospital, Birmingham UK 
(Aitchison et al, 1986). Serum from this patient (GP serum), containing a high titre of 
antibodies against E. faecalis, was used to probe immunoblots and plaque lifts 
throughout. E. faecalis cells were grown in brain heart infusion (BHI, Difco) or 1% 
yeast extract (YE, Difco).
General cloning procedures were performed using the host strain E. coli XL1- 
Blue (recAl, endAl, gyrA96, thi-1, hsdR17, supE44, relAl, lac, [F ,proAB, lacfl, ZA 
M l 5, Tni0(tetr)]; Stratagene). Plaque screening was performed using E. coli SURE 
(el4-(mcrA), A (mcrCB-hsdSMR-mrr) 171, sbcC, recB, recJ umuC::Tn5(kanT), uvrC, 
supE44, lac, gyrA96, relAl, thi-1, endAl, [F proAB, lacfi, ZA M l5]; Stratagene). 
These strains are designed to allow use of blue/white selection for recombinants, and 
contain a recA mutation, which enhances the stability of cloned inserts. E. coli XL1- 
Blue also contains the F  episome, which contains genes for expression of F  pili, 
which are required for filamentous phage infection during single stranded DNA 
production. Bacterial growth media and other solutions are defined in appendix D.
2.2. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE).
Separation of E. faecalis proteins was carried out by electrophoresis in the Bio- 
Rad Protean and Mini Protean system, using denaturing 12% polyacrylamide gels 
(Lugtenberg et al, 1975) prepared as shown in table 2.1.
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Whole cell extracts were prepared by boiling cell suspensions with an equal 
volume of sample buffer for 10 minutes. Electrophoresis was carried out at 200V until 
the tracking dye, or appropriate prestained marker (see appendix C) reached the 
bottom of the gel.
Table 2.1. Composition Of Running Gel And Stacking Gel For SDS-PAGE._________
Constituent Running Gel (12%) Stacking Gel______ Sample buffer____________
Stock 1 5 ml -
Stock 2 - 2.5 ml
SDS 10% w/v 0.5 ml 0.15 ml 5 ml
1.5M Tris pH 8.8 6 ml
0.5M Tris pH 6.8 3.75 ml 2.5 ml
Dist, Water 8 ml 8 ml 5 ml
TEMED 50 pi 40 pi
AMPS 10% w/v 70 pi 50 pi
Glycerol 2.5 ml
2-mercaptoethanol 0.25 ml
5% Bromophenol blue 0.2 ml
Stock 1: 44% w/v acrylamide and 0.8% w/v N,N'-methylene-bis-acrylamide (Bis) 
Stock 2: 30% w/v acrylamide and 0.8% w/v N,N'-methylene-bis-acrylamide (Bis)
Final acrylamide concentration = 12% in the running gel and 3% in the stacking gel.
2.2.1. Visualisation o f protein.
After electrophoresis, the gels were removed from the glass plates, and 
proteins either stained directly or transferred to nitrocellulose for subsequent probing 
with antisera (see Immunoblotting).
Directly stained gels were soaked with gentle agitation in 0.1% Coomassie 
Brilliant Blue R-250 (w/v) in 50% methanol/10% acetic acid for 30-60 mins. Gels 
were then destained in 10% methanol/20% acetic acid until background stain was 
removed. Gels could then be dried onto filter paper.
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2.3. Immunoblotting.
Following separation by SDS-PAGE, cell components were transferred onto 
nitrocellulose membranes (0.45 pm pore size, Bio-Rad) according to the western 
blotting method of Towbin et al (1979). Transfer was carried out in a Mini Trans-Blot 
cell (Bio-Rad), in transblot buffer (25 mM Tris, 192 mM glycine and 20% v/v 
methanol, pH 8.3), at 100V for one hour. Transfer efficiency was determined by 
Coomassie staining gels after transfer, or by staining nitrocellulose with naphthol blue 
black (0.7% w/v in acetic acid).
Transferred proteins were immunodetected using serum from an endocarditis 
patient (GP) with a high IgG titre against E. faecalis. Blots were first washed for one 
hour with gentle agitation in TBS containing 1% bovine serum albumin (BSA). This 
blocked unbound sites on the nitrocellulose. Following this, blots were probed for at 
least three hours at 4°C with appropriate antisera diluted in TBS. Blots were then 
rinsed thoroughly in TBS three times, and soaked with gentle agitation in TBS/1 % 
BSA containing 0.25 pg/ml protein-A conjugated either to horse radish peroxidase or 
alkaline phosphatase (Sigma) for 3 hours at 4°C. This solution was removed, and the 
blots rinsed again in TBS. Blots were visualised with freshly-prepared developing 
solutions. In the case of peroxidase conjugates, this was 0.01% H2O2 v/v and 4- 
chloro-1-naphthol 25 pg/ml in 10 mM Tris. HC1 pH 7.4). This solution could be 
warmed slightly to speed the reaction. Colour development was stopped with distilled 
water. For alkaline phosphatase conjugates, blots were first washed for 2 mins in 
colour development solution (100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM 
MgCl2), then incubated in the dark without shaking, in colour development solution 
containing NBT (0.3 mg/ml) and BCIP (0.15 mg/ml). Colour development usually 
took in excess of 30 minutes, and was stopped, to avoid high background, by washing 
with 20 mM Tris-HCl pH 2.9 containing 1 mM EDTA.
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2.4. Isolation and purification of chromosomal DNA.
The method of Skjold et al (1987) was used. Cells from 50 ml overnight 
cultures of E. faecalis in Difco BHI were washed twice in 20 ml ice-cold 0.2M sodium 
acetate, centrifuged for 10 min at 2000 rpm and resuspended in 5 ml TE glucose. This 
cell suspension was incubated with mutanolysin (Sigma) 20 pg/ml for 2 hours at 
37°C. This solution was centrifuged at 10,000 rpm for 15 minutes and the pellet gently 
resuspended in TE. N-Lauroylsarcosine (Sarkosyl) was added to 1% w/v and the 
solution incubated at 37°C for 30 minutes. RNAase was added to 100 pg/ml and the 
incubation continued for 30 mins. Pronase (self digested) was added to 500 pg/ml and 
the incubation continued for a further 60 min. The resulting solution of cell contents 
was extracted repeatedly with phenol:chloroform (see appendix D) until no precipitate 
formed at the interface. The solution was then extracted once with chloroform:isoamyl 
alcohol (see appendix D.)
DNA was precipitated by addition of sodium acetate pH 5.2 to 0.3M, followed 
by two volumes of ethanol at -20°C. DNA was allowed to precipitate for 5 mins at 
room temperature and removed from solution by winding the thread-like precipitate 
onto a sterile pasteur pipette. The DNA was washed in 70% alcohol, dried under 
vacuum, and resuspended in TE.
2.5. Spectrophotometric determination of nucleic acid concentration.
For quantification of DNA or RNA, readings were taken at 260nm and 280nm. 
An OD of 1 at 260nm corresponds to a solution at 50 pg/ml for double stranded DNA, 
40 pg/ml for single stranded DNA and RNA and -20 pg/ml for single stranded 
oligonucleotides. Contaminating phenol and protein absorbs at 280nm. Nucleic acid 
solutions with a 260nm:280nm absorbance ratio of less than 1.8 were considered too 
impure for this method of quantification.
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2.6. Digestion of DNA with restriction endonucleases.
DNA restrictions were performed using Pharmacia restriction enzymes and 
buffers, in accordance with manufacturer's instructions. For complete plasmid 
digestion, reaction mixtures were allowed to incubate at 37°C for 1 hour. Complete 
chromosomal digests were incubated for at least 4 hours. Partial digests are described 
in section 2.10.1.
2.7. Purification of DNA using Geneclean.
DNA was purified from agarose gels using the Geneclean system (Bio-101). 
Following agarose gel electrophoresis, the section(s) of the gel containing restriction 
fragment(s) of interest were excised. Four and a half volumes of 6M Nal and 0.5 vols 
of Geneclean-TBE modifier were added to the gel slice, and incubated at 50°C until 
the agarose melted. Five microlitres of Geneclean glassmilk suspension were added 
and the mixture incubated on ice for 5 minutes to allow DNA to adsorb onto the glass 
beads. Glassmilk beads were pelleted at 13,000 rpm for 5 seconds and washed three 
times with Geneclean 'NEW' wash. DNA was eluted from the beads into water or TE 
at 50°C for 5 minutes.
DNA in solution was purified by adding 3 volumes of 6M Nal and 5 pi of 
Geneclean glassmilk. After incubating on ice for 5 minutes, the glassmilk was pelleted 
at 13,000 rpm for 5 seconds, washed 3 times with Geneclean NEW wash, and the 
DNA was eluted into water or TE at 50°C for 5 minutes.
2.8. Ligation of DNA fragments into plasmid vectors.
The pBluescript phagemids are high copy number, ampicillin resistance 
plasmids. The polylinker is present in the N-terminal portion of a LacZ gene fragment,
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such that strains containing plasmids with no inserts will grow as blue colonies on X- 
Gal agar, whereas plasmids with inserts give white colonies, due to disruption of the 
coding region of the LacZ gene fragment. pBluescript plasmids are available with two 
polylinker orientations, designated KS or SK. In the KS orientation, the restriction site 
closest to the LacZ promoter is Kpn I, and in the SK orientation, the first site is Sac I. 
Each version of the plasmid is also available as (+) or (-), according to which strand of 
the plasmid is produced as a single stranded copy, during infection by helper phage.
Plasmid vectors were linearised by restriction at a single site within the vector 
polylinker as described in section 2.6., and recovered from agarose gels using 
Geneclean as described in section 2.7. Fragments to be subcloned were similarly 
recovered to ensure purity. The DNA samples were mixed together, with a two to 
three fold molar excess of insert DNA over vector, and made up to 44 pi with water. 
To this was added 5 pi lOx ligase buffer, 0.5 pi 10 mM ATP and 0.5 pi (2 units) T4 
DNA ligase. The mixture was incubated at 37°C for one hour in the case of sticky end 
ligations, or 12-20°C overnight for blunt end ligations.
2.9. Preparation of a horizontal agarose gel.
Agarose gels were cast and run in Bio-Rad DNA sub-cells. Ultrapure agarose 
(Bethesda Research Laboratories) was dissolved in 0.5x TBE buffer at 100°C. The 
solution was allowed to cool to approximately 60°C, and ethidium bromide was added 
to 0.5 pg/ml. The gel was poured and allowed to set at room temperature for 45 
minutes. Once set, gels were submersed in 0.5x TBE. DNA samples were mixed with 
0.2 vol 6x DNA loading buffer and electrophoresis was carried out at 70-200V until 
the tracking dye reached the end of the gel. Molecular weight markers were used 
where appropriate (see appendix C) DNA bands were visualised on a UV light box. 
Photographs were taken using Polaroid 655 film in a Polaroid MP4 camera.
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2.10. Preparation of AZAP II library.
AZAPII is a cloning vector which will accept insert of up to 10 kb, and allows 
blue/white selection of recombinants. This system also simplifies subcloning, since 
cloned inserts can be rapidly converted into pBluescript phagemids.
To create a complete chromosomal library in AZAP II (linearised with EcoRI), 
it was necessary to digest partially the chromosome with Alul (4 base recognition site), 
then ligate EcoRL linkers (Stratagene) to the Alul digested blunt ended chromosomal 
DNA. Cutting the ligated linkers with IscoRI reveals the required sticky ends for 
ligation into AZAP n. Prior to cutting the linkers with EcoRI it was necessary to 
protect any EcoKl sites within the chromosomal digest by methylation.
2.10.1. Partial digestion o f E. faecalis DNA with Alul.
To 60 |ig of chromosomal DNA were added 12 pi of lOx reaction buffer 
(Stratagene) and 2 pi of Alul (Stratagene 10 units/pl). Total volume was made up to 
120 pi with sterile water and the reaction mixture mixed by pipetting and incubated at 
37°C. 20 pi aliquots were removed at 10 minute intervals and the reactions stopped 
with 4 pi of DNA loading buffer. Samples were stored on ice until needed. After the 
final sample had been removed, all samples were run on a 0.8% agarose gel. 
Fragments between 2 kb and 10 kb were recovered.
2.10.2. Methylation ofEcoRI sites within Alul digested DNA.
To 8 pg of recovered DNA was added 10 pi of 1 Ox methylase buffer, 10 pi of 
1M Tris buffer pH 8.0 and sterile water to 100 pi. Two 2 pi samples (labelled 1 and 2) 
were removed at this stage and stored on ice. To the bulk of the reaction was added 2 
pi methylase (Stratagene 40 units/pl), then two more 2 pi samples, labelled 3 and 4, 
were removed. One hundred nanogrammes of pUC18 linearised with Seal was added 
to all four control samples, then all five tubes were incubated at 37°C for 1 hour. 
Control samples were analysed as follows. To all four samples were added: 2 pi 0.1M
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MgCl2, 2 fil EcoKl reaction buffer and H20  to 20 pi. To tubes 2 and 4 was added 1 pi 
of EcoKL 10 units/pl. All four tubes were incubated at 37°C for 1 hour, then analysed 
on a 1% agarose gel. If methylation and cutting were successful, lanes 1, 3 and 4 
showed a single 2.69 kb band, whilst lane 2 showed bands at 1.72 and 0.96 kb.
2.10.3. Ligation o f EcoRl linkers.
The EcoKl linkers used were double-stranded phosphorylated 12mers 
(Stratagene: dCCGGAATTCCGG). To 1 pg of blunt-ended methylated DNA were 
added 1 pi of linkers, 3 pi lOx ligase buffer, 3 pi 10 mM ATP pH 7.5, sterile water to 
27 pi, and 3 pi DNA ligase (10 units/pl). The mixture was incubated at room 
temperature overnight. The DNA was then ethanol precipitated, resuspended in 10 pi 
of water and cut with 10 units EcoKL for 1 hour at 37°C. Excess linkers and cut 
fragments were removed by recovery from a 1% agarose gel.
2.10.4. Ligation into XZAPII arms.
To 1 pg of DNA were added 1 pi (1 pg) AZAP II arms, 0.5 pi lOx buffer, 0.5 
pi 10 mM ATP, 0.5 pi T4 DNA ligase (4 units/pl) and sterile water to 5 pi. The 
mixture was incubated at room temperature overnight.
2.10.5. Packaging into XZAP II.
Packaging was according to manufacturer’s instructions, using Gigapack II 
Gold packaging extracts (Stratagene). Following ligation, 4 pi of DNA was added to 
one melting 'freeze-thaw' extract. Fifteen microlitres of sonic extract was added and 
the tube contents mixed by pipetting. Packaging was allowed to continue for 2 hours 
at room temperature, then stopped with 500 pi of SM and 20 pi chloroform. The 
library was stored at 4°C. Phage were titred by plating out serial dilutions of the 
library (as described in section 2.11), and counting resulting plaques.
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2.11. Immunoscreening of AZAP II plaques.
E. coli strain SURE was grown overnight (30°C shaking) in TB/10 mM 
MgS(V0.2% maltose). Cells were spun down at 2,000 rpm for 10 minutes, 
resuspended in 10 mM MgSC>4 to an OD600 of 0.5 and divided into aliquots of 200 pi. 
To each aliquot, phage suspension containing 15xl03 pfu was added, and incubated 
for 20 min at 37°C to allow phage to attach to cells. Each mixture was then added to 
3.5 ml of molten top agar at 48°C and poured onto the surface of a pre-warmed and 
dried NZY plate. Plates were incubated for 3.5 hours at 42°C until plaques were just 
visible. Circular nitrocellulose filters (Stratagene), pre-soaked with 10 mM IPTG were 
placed onto the surface of the plates, which were allowed to incubate for several hours 
more at 37°C. At the end of this time, filters were marked (for orientation) and 
carefully removed. Plaque lifts were probed with GP antiserum diluted 1:500 in 
TBST/1% BSA at 4°C overnight. Immunoreactive clones were detected by incubating 
for three hours at room temperature with a protein A-alkaline phosphatase conjugate, 
then developing with BCIP and NBT as described in section 2.3. Colour development 
was complete within two hours. Reactive plaques were removed from plates with the 
wider end of a glass pasteur pipette and phage allowed to elute into 500 pi SM 
overnight. Phage suspensions were re-screened at low numbers to allow identification 
of discrete reactive plaques.
2.12. Verification of immunoreactive AZAP II clones.
Immunoreactive clones were characterised by affinity purification (Bumie and 
Clark, 1989). A lawn of E. coli SURE was infected with homogenous phage at 
numbers high enough to produce confluent lysis. Nitrocellulose filters were incubated 
with the lawn for 6  hours at 37°C, then washed, blocked and incubated with antiserum 
at 4°C overnight. After washing with TBS and then with 0.15M NaCl/0.05% Tween 
20, antibodies were eluted with 5 ml of a solution of 0.15M NaCl, 0.05% Tween 20
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and 0.2M glycine HC1 pH 2.8 for 30 minutes then neutralised with 0.04g Tris. This 
was then diluted 1:1 in TBST/1% BSA and used to probe immunoblots of E. faecalis 
whole cell extracts as described in section 2.3.
2.13. In vivo excision of pBluescript from AZAP II.
The AZAP II genome includes the sequence of the pBluescript plasmid SK(-), 
into which inserts are cloned. This allows rapid recovery of cloned inserts as 
pBluescript phagemids as follows. Recombinant lambda are allowed to infect cells 
which are co-infected with helper phage R408 (a 4kb, single-stranded fl-type 
bacteriophage). Inside co-infected cells, bacteriophage derived proteins recognise 
initiator and terminator domains positioned within the lambda chromosome, flanking 
the pBluescript sequence, producing copies of pBluescript containing the cloned 
insert. These are released into the culture supernatant as single stranded phagemids, 
and can then be used to transform E. coli XLl-Blue.
Immunoreactive plaques were recovered as agar plugs from NZY plates and 
the phage eluted into 500 pi SM containing 20 pi chloroform overnight at 4°C. To 
200 pi of the resulting phage suspension were added 200 pi of OD60q = 1 XLl-Blue 
cells and ~106 R408 helper phage. The mixture was incubated at 37°C for 15 minutes, 
then 70°C for a further 20 minutes. Cells were removed by centrifugation at 4000 rpm 
for 5 minutes, and the supernatant, containing packaged pBluescript, removed and 
stored at 4°C. To introduce the phagemids into XLl-Blue, 50 pi of a 10*2 dilution of 
the phage stock was mixed with 200 pi OD600 = 1 XLl-Blue at 37°C for 15 minutes, 
then plated onto LB agar containing ampicillin 100 pg/ml and tetracycline 12.5 pg/ml. 
Colonies contained double-stranded pBluescript harbouring the cloned insert.
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2.14. Small scale preparation of bacterial plasmids (Minipreps).
Solution I = 50 mM glucose/ 25 mMTris/ 10 mM EDTA.
Solution II (aseptically prepared from stock solutions of ION NaOH and 20% SDS) 
=0.2N NaOH/ 1% SDS. Both constituents were added to water to ensure that the SDS 
did not precipitate out of solution.
Solution IE = 60 ml of 5M potassium acetate/ 11.5 ml glacial acetic acid/ 28.5 ml 
water.
One ml of an overnight bacterial suspension was centrifuged at 13,000 rpm 
for 1 minute. The supernatant was removed from each tube by using a pasteur pipette, 
100 pi of solution I was added to each tube and the bacterial pellets resuspended by 
vigorous vortexing. Two hundred microlitres of freshly-prepared solution II were 
added, and the tube contents mixed by inverting gently five times. Tubes were placed 
on ice for 10 minutes, then 150 pi ice-cold solution El were added and mixed by 
gentle vortexing. The tubes were held on ice for 5 minutes and centrifuged at 13,000 
rpm for 5 minutes. Supernatants were transferred to clean microfuge tubes, and 
extracted once with an equal volume of phenol :chloroform, and once with an equal 
volume of chloroform:isoamyl alcohol. The tube contents were mixed by vortexing, 
centrifuged at 13,000 rpm for 2 minutes and the aqueous upper layers were transferred 
to clean tubes. Plasmid DNA was precipitated by addition of 2 volumes of ethanol. 
The tubes were gently mixed, chilled for 5 minutes on ice, and then centrifuged at
13,000 rpm for 5 minutes. The supernatant was discarded, and the pellet was washed 
with 1 ml 70% ethanol. The supernatant was carefully decanted from each tube so as 
not to dislodge the pellet, and any residual ethanol was evaporated from the tubes 
under vacuum in a Speedvac SVC 100 set at medium drying temperature. Dried 
plasmid DNA was resuspended in 50 pi of water containing RNAase 20 pg/ml.
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2.15. Preparation of electrocompetent E. coli XL-1 Blue cells.
The method of electroporation used was one outlined by Dower et al (1988). 
An overnight starter culture of E. coli XL-1 Blue cells was diluted 1:100 and grown to 
an OD600 of 0.5-1.0 in 500 ml LB medium. The cells were chilled briefly on ice and 
centrifuged at 4000 rpm for 15 min at 4°C. The ionic strength of the suspension was 
reduced by washing the cells in i) 500 ml ice cold sterile water, ii) 250 ml of sterile 
water, iii) 10 ml of sterile ice cold 10% glycerol, and finally resuspending in 0.5-1 ml 
of 10% glycerol. The ice-cold cell suspension was dispensed into 40 pi lots in sterile 
microfuge tubes and snap-frozen in liquid nitrogen. The electrocompetent cells were 
stored at -70°C until required.
2.16. Transformation of E. coli XL-1 Blue cells by electroporation.
The concentrated cells were thawed slowly on ice. Chilled recombinant 
plasmid DNA (up to 1 pg in water) was added, and the cell mix was pipetted into a 
sterile pre-chilled 0.2 cm electroporation cuvette (Bio-Rad Laboratories, Richmond, 
CA). The cuvette was placed in the pre-chilled cuvette carrier of a Gene Pulser and 
Pulse Controller (Bio-Rad) and subjected to a single 2.5 kV pulse, capacitance and 
resistance of the power supply having been set to 25 p Farads and 200£2, respectively, 
to produce a nominal time constant for the capacitor discharge of 5ms. Following 
electroporation, cells were allowed to recover in 1 ml SOC medium at 37°C with 
shaking for 1 hour (to allow expression of plasmid-coded antibiotic resistance). 
Transformed cells were selected by spreading onto L-agar plates containing ampicillin 
(100 pg/ml) and tetracycline (12.5 pg/ml), surface coated with 40 pi X-gal (20 mg/ml 
in DMF) and 4 pi 0.84M IPTG. After growing for 18 hours at 37°C, cells containing 
recircularised pBluescript plasmids appeared as blue colonies, recombinants grew as 
white colonies. From each transformation, several white colonies were picked with a 
sterile wire and grown overnight in LB broth containing ampicillin (100 pg/ml) and
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tetracycline (12.5 pg/ml). Plasmid DNA was recovered (see section 2.14.) and 
analysed by restriction enzyme digestion.
2.17. Nucleotide sequencing.
Nucleotide sequencing was performed by the dideoxy mediated chain 
termination method of Sanger et al (1977). Sequencing reactions were performed 
using the Sequenase system (United States Biochemical), using either single-stranded 
or double-stranded template DNA. Subsequent electrophoresis was performed using 
the Bio-Rad Sequi-Gen system (21cm x 40cm x 0.04cm).
2.17.1. Preparation of single-stranded template DNA.
Single-stranded DNA was generated using the Stratagene pBluescript 
phagemid system according to manufacturer's instructions. Briefly, cells with the 
pBluescript phagemid containing DNA to be sequenced were grown to early log phase 
(OD60o = 0.1) and infected with helper phage R408 (multiplicity of infection > 1:1). 
After at least 8 hours growth, cells were removed by centrifugation, and the culture 
supernatant removed and stored at 4°C.
To each 1.2 ml of supernatant was added 300 pi of 3.5M ammonium acetate, 
pH 7.5, 20% polyethylene glycol 8000 (Sigma). The tube contents were mixed by 
inversion and phage were allowed to precipitate at room temperature for 20 min. 
Following by centrifugation at 13,000 rpm for 20 min, the phage pellet was 
resuspended in 300 pi TE, and subjected to repeated extractions with 
phenol:chloroform until no more insoluble material was produced at the interface. 
Following one further extraction with chloroform:isoamyl alcohol, ssDNA was 
precipitated by addition of an equal volume of 7.5M ammonium acetate, pH 7.5 and 2 
volumes cold 100% ethanol, and allowed to stand at -70°C for 30 min. ssDNA was 
pelleted at 13,000 rpm for 30 minutes, washed in 70% ethanol, dried under vacuum,
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and resuspended in 20 pi water. The ssDNA was analysed on a 1% agarose gel; R408 
runs at approx. 4 kb, while pBluescript with no insert runs at approximately 1.6 kb 
when compared to a double-stranded DNA marker.
2.17.2. Preparation of double-stranded template DNA.
Double-stranded plasmid DNA was denatured in 0.2M NaOH, 0.2 mM EDTA 
at 37°C for 30 minutes, then precipitated with 0.1 vols 3M sodium acetate pH 5.2 and 
2-4 volumes of ethanol. DNA was microfuged at 13,000 rpm for 30 minutes, washed 
with 70% ethanol and dried under vacuum before resuspending in 7 pi sterile water.
2.17.3. Sequencing reactions.
Template DNA was sequenced using the Sequenase (version 2.0) kit according 
to the manufacturer's instructions. For single-stranded templates, approximately 1 pg 
of DNA was used, for double-stranded templates, 10-20 pg was used. Primers were 
17-mers, complimentary to pBluescript sequences flanking the polylinker. Half a 
picomole of primer was used per reaction.
2.17.4. Denaturing gel electrophoresis.
Polyacrylamide gel electrophoresis was performed with the Bio-Rad 
Sequi-Gen nucleic acid sequencing cell. Samples were first denatured at 75-80°C for 
three minutes, then resolved on a 7M urea, 6% polyacrylamide gel.
The Sequi-Gen apparatus was thoroughly cleaned to remove all traces of 
grease, and one plate was siliconised with 500 pi of Sigma Cote to prevent gels from 
sticking to both plates. Cells were assembled with 0.4 mm spacers, and the bottom 
sealed with a plug gel consisting of 10 ml 6% acrylamide solution (Sequagel-6 
National Diagnostics) polymerised with 50 pi of 25% w/v AMPS and 50 pi TEMED. 
Forty millilitres of acrylamide solution catalysed with 40 pi of 25% AMPS and 40 pi 
TEMED were poured between the plates. A sharktooth comb (Bio-Rad) was inserted,
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flat side first, 5mm into the gel. Once polymerisation was complete, the comb was 
removed, the top of the gel was washed with lx TBE.
Gels were pre-run at 40-50W for at least one hour, then 2-3 pi of each sample 
loaded. Electrophoresis was at constant power (40-50W) to maintain gel temperature 
at 50°C throughout the run. Once run, the apparatus was disassembled and plates 
prised apart. Gels were immersed in 5% acetic acid/15% methanol for 30 minutes (to 
remove urea), then transferred to 3mm Whatman paper, covered in cling film and 
dried under vacuum at 80°C for 45 minutes.
2.17.5. Autoradiography.
After drying, gels were exposed to Kodak X-omat AR film for 24-48 hours at 
room temperature in a light-proof cassette. After exposure, film was developed 
according to the manufacturer's protocol.
2.18. Analysis of Nucleotide sequence.
The deduced nucleotide sequence of efaA was submitted to the GenBank using 
the Authorin package. Subsequent DNA sequence analysis was performed using the 
GCG (University of Wisconsin Genetics Computer Group) package at the SERC 
Seqnet computing facility at Daresbury, UK. Genbank database searching was 
performed using the FAST A and TFASTA software, multiple sequence alignments 
were assembled using the CLUSTALV and ALIGN programs. Additional sequence 
analyses were performed using the PCGENE package (Intelligenetics).
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2.19. Preparation of 32P-Iabelled DNA probe for hybridisation reactions.
A 405 bp HindUl fragment of efaA was generated by digestion of plasmid 
pGP19 with HindTH, followed by recovery of the fragment from an agarose gel using 
Geneclean. This DNA was used as a template for generation of an [a-32P]dATP 
labelled probe using DNA polymerase primed by random hexanucleotides. 
Approximately 200 ng of purified DNA in 9 pi water were added to 2 pi random 
hexanucleotide mixture (Boehringer), 3 pi of a mixture of dTTP, dCTP and dGTP, all 
at 20 mM (Pharmacia), 5 pi [a-32P]dATP (3000 Ci/mmol, 10 pCi/pl) and 1 pi (10 
units) Klenow fragment of DNA polymerase. The reaction mixture was incubated at 
37°C for 30 minutes and stopped by heating to 65°C for 5 minutes. Unincorporated 
nucleotides were removed by passing the final mixture through a Nuc-Trap column 
(Stratagene). This method generates probes of very high specific activity 108-109 
cpm/pg. Such high activity probes were used within a week of synthesis, as high 
energy a -32P emissions can cause destruction of the molecular structure of the 
nucleotide sequence.
2.20. Southern blotting.
Digested DNA was transferred from agarose gels to nitrocellulose as described 
by Southern (1975). Briefly, the DNA was depurinated in 0.25M HC1 for 30 minutes 
and denatured with 0.6M NaCl, 0.2M NaOH for 30 minutes. Neutral pH was restored 
with 1.5M NaCl, 0.5M Tris-HCl (pH 7.0) for 30 minutes. Fragments were then blotted 
by capillary transfer of 20x SSC overnight (Southern, 1975). DNA was fixed onto the 
membranes by baking at 80°C for 2 hours in vacuo. Filters were wetted in 5x SSC, 
rolled in nylon mesh and inserted into Hybaid hybridisation bottles. Blots were pre­
hybridised rotating in a Hybaid mini-hybridisation oven at 50°C in hybridisation 
solution (1% blocking reagent (Boehringer Mannheim), 5x SSC, 0.1% w/v Sarkosyl, 
0.02% w/v SDS) for at least one hour. This was then removed, and replaced with 10
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ml hybridisation solution containing 140 |il radiofabelled probe, prepared as described 
in section 2.19., denatured by heating to 95°C fo r 5 minutes. Following overnight 
hybridisation, filters were washed twice for 5 minutes at room temperature with 2x 
SSC containing 0.1% SDS, then twice for 10 minutes each with O.lx SSC containing 
0.1% SDS at 55°C (low stringency), 60°C (medium stringency) or 68°C (high 
stringency). Following stringency washes, blots were wrapped in cling film, and 
exposed to Kodak X-omat AR film at -70°C with intensifying screens for 6-48 hours, 
then developed according to manufacturer's instructions.
2.21. RNA analysis of E. faecalis EBH1.
In order to study regulation of expression of efaA at the transcriptional level, 
total cellular RNA was extracted from EBH1 following growth in a range of 
conditions, separated in denaturing agarose gels, transferred to nitrocellulose 
(Northern blotting) and probed with a 32P-labelled 405 bp internal restriction fragment 
of efaA. Prokaryotic mRNA is highly susceptible to degradation by RNAases, which 
are ubiquitous, and not destroyed by autoclaving alone. Hence all glassware used in 
RNA procedures was baked at 180°C for 8 hours prior to use. All solutions were 
treated with 0.1% diethyl pyrocarbonate (DEPC, a potent inhibitor of RNAases) 
overnight at 37°C, then autoclaved. All other equipment (including electrophoresis 
tanks, blotting tanks and hybridisation tubes) was soaked in 0.1% DEPC overnight at 
37°C.
2.21.1. Preparation o f total cellular RNA.
Total RNA was prepared by the hot phenol method (Tanimoto and Clewell, 
1993). An overnight culture of E. faecalis EBH1 in 1% yeast extract (Difco) was 
diluted 1:100 into pre-warmed medium and grown to mid log phase (OD60o= 0.5-1). 
Cells were chilled on ice, harvested and resuspended in 600 pi lysis buffer (20 mM
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Tris-HCl (pH 8.0), 3 mM EDTA, 200 mM NaCl).. To this was added 60 pi 10% SDS, 
and the mixture was maintained at 100°C for two minutes, with mixing. Six hundred 
microlitres of hot phenol saturated with lysis buffer were added, and the mixture 
maintained at 65°C for 5 minutes, with occasional mixing. Phases were separated by 
centrifugation, and the aqueous phase extracted twice further with phenol chloroform. 
RNA was precipitated with 0.1 volume of 3M sodium acetate and two volumes of 
ethanol, and resuspended in DEPC-treated water.
2.21.2. Denaturing agarose electrophoresis.
In order to maintain denaturing conditions during electrophoresis of RNA 
samples, formaldehyde/agarose gels were used. All procedures involving 
formaldehyde and formamide were carried out in a chemical hood. To 30 ml of a 
molten 1.28% agarose solution (DEPC treated) was added 9.4 ml of 5x formaldehyde 
gel-running buffer (0.1M MOPS (pH 7.0), 40 mM sodium acetate, 5 mM EDTA pH 
8.0) and 8.6 ml of 12.3M formaldehyde. Gels were cast, and allowed to set for at least 
30 minutes at room temperature.
RNA samples for electrophoresis were prepared as follows. Five to ten 
micrograms of RNA in 4.5 pi water were added to 2 pi 5x formaldehyde running 
buffer, 3.5 pi formaldehyde and 10 pi formamide in a sterile microfuge tube and held 
at 65°C for 15 minutes then chilled on ice. Two microlitres of formaldehyde gel- 
loading buffer (50% glycerol, 1 mM EDTA, 0.25% bromophenol blue), and 1 pi of 
ethidium bromide 1 mg/ml were added, and the samples electrophoresed at 10-20 
V/cm. Gels were viewed on UV light and photographed if required.
2.21.3. Northern blotting.
Transfer of RNA from denaturing agarose gels to nitrocellulose filters was 
carried out by a method similar to that of Southern blotting. All apparatus was treated 
with DEPC prior to use. Gels were soaked for 20 minutes in 0.05N NaOH, then rinsed
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in DEPC-water and soaked in DEPC 20x SSC for 45 minutes. Gels were then placed 
in contact with nitrocellulose and RNA transferred by capillary flow of 20x SSC as 
described for Southern blotting. Following transfer, nitrocellulose filters were 
oriented, washed in 5x SSC, then baked for 1 hour at 80°C in vacuo.
2.21.4. Northern hybridisation.
After baking, filters with bound RNA were incubated for at least 1 hour at 
45°C with northern pre-hybridisation buffer (7% SDS, 50 mM sodium phosphate 
buffer pH 7.0, 2% blocking reagent (Boehringer Mannheim) 5x SSC, 0.1% Sarkosyl). 
Filters were then hybridised with heat-denatured 32P-labelled probe in 10 ml northern 
pre hybridisation buffer at 45°C overnight. Probe solutions were removed and filters 
were twice washed for 5 minutes at room temperature in 2x SSC containing 0.1% 
SDS, then twice further for 15 minutes at 65°C in O.lx SSC containing 0.1% SDS. 
Filters were developed as described for Southern blotting. Following autoradiography, 
blots were stained with methylene blue to verify loadings. Dried filters were first 
soaked in 5% acetic acid for 10 minutes, then transferred to 0.04% w/v methylene 
blue in 0.5M sodium acetate (pH 5.2) for 10 minutes at room temperature and washed 
with distilled water.
2.22. Expression from cloned DNA.
Overnight cultures of E. coli GP19- and E. coli/pSK- were diluted 1:100 in 
pre-warmed LB medium and grown at 37°C with shaking for 2.5 hours. Pre-induction 
samples were removed (1.5 ml) and stored on ice. IPTG was added to 10 mM and 
growth allowed to continue. Further samples were taken 1, 2, 3 and 4 hours post 
induction and stored on ice until needed. Cells were harvested, resuspended at equal 
concentration in saline and whole cell extracts were subjected to SDS-PAGE and 
immunoblot analysis as described in section 2.2.
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2.23. Preparation of dialysis tubing
Prior to use, dialysis tubing was cut to an appropriate length and boiled for 10 
minutes in 2% w/v NaHC03 then placed into capped 20 ml universal tubes submersed 
in double distilled water and autoclaved for 15 minutes at 121°C.
2.24. Scanning densitometry
Autoradiographs and stained blots were scanned using a Bio-Rad scanning 
densitometer. Analysis of the digitised images was performed using the Bio-Rad 
Molecular Analyst software package. Molecular weights were determined using 
Profile Analysis software (Bio-Rad) in comparison with molecular weight standards. 
Quantification of bands was determined using Volume Analysis software (Bio-Rad).
2.25. Bacterial adherence to hydrocarbon (BATH) assay.
Bacterial hydrophobicity was assessed by a modification of the bacterial 
adherence to hydrocarbon (BATH) assay, as described by Rosenberg et al, (1980). 
Cells were harvested, washed twice, and resuspended to OD60q = 0.6 in 10 mM 
NaH2P 0 4/Na0H buffer (pH 7.0). Six hundred microlitres of cell suspension was 
added to an equal volume of hexadecane (BDH), and vortex mixed for 2 minutes. 
After phase separation (30 minutes standing at room temperature), the decrease in 
OD450 of the aqueous phase was used as a measure of cell surface hydrophobicity.
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Chapter 3: Cloning and expression.
The first step in characterising the 37 and 40 kDa endocarditis-specific 
antigens of E. faecalis was to isolate clones containing their structural gene(s). Since 
the only available means of identifying the antigens was polyclonal antiserum from an 
endocarditis patient, this was used to screen random AZAP II clones created from 
E. faecalis EBH1 genomic DNA. The work detailed below describes the isolation of 
recombinant lambda phage reactive with the patient antiserum, selection of the 
appropriate clones, and expression of protein from these clones in an E. coli host.
3.1. Construction of an EBH1 genomic library in AZAP II.
Chromosomal DNA was extracted from E. faecalis EBH1 as described in 
section 2.4. In order to ensure a fully representative library it was necessary to use a 
partial Alul chromosomal digest and ligate into EcoRI-cut AZAP II with the aid of 
synthetic linkers. Analysis of the constructed phage library on IPTG/X-Gal plates 
showed that it contained 7.5xl06 phage, (15,000 pfu/jil) of which 15% (1.13xl06) 
were recombinants. The probability of creating a recombinant containing the 
sequences of the gene of interest in the correct frame and orientation for expression is:
size of the coding region of the gene of interest 
size of genome (kb) x 6
Where P is the probability of creating a recombinant containing the sequence of 
interest in the correct reading frame and orientation for expression (Sambrook et al, 








Figure. 3.1. Immunoblot of E. faecalis EBH1 whole cells probed 
with serum from patient GP with E. faecalis endocarditis (lane 1), 
and antibodies affinity purified from immunoreactive plaque (lane 2).
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long. The genome size of E. faecalis is approximately 2,500 kb (Miranda et al 1992). 
Thus in this case P = 8xl0-5. The minimum number of recombinants to be screened is 
given by 1/P, ie 12,500.
3.2. Immunoscreening of A,ZAPII plaques.
Phage were plated at 15,000 pfu per 82mm plate, lifted onto nitrocellulose 
circles and screened with E. coli lysate-adsorbed GP antiserum (diluted 1:500 in 
TBS/1 % BSA) according to the picoBluc screening protocol (Stratagene). Screening 
20 plates (45,000 recombinants) revealed 29 immunoreactive plaques which were 
removed, eluted into SM buffer and purified by further screening at low numbers.
3.3. Verification of X.ZAP II immunoreactive clones.
GP antiserum contained a high titre of IgG to a number of E. faecalis EBH1 
proteins, including the 37,40 and 73 kDa proteins discussed earlier. This presented the 
problem of not knowing which, if any, of the immunoreactive clones contained genes 
encoding the proteins of interest. This was resolved using the affinity purification 
protocol described by Burnie and Clark (1989). Immunoreactive phage were plated at
15,000 pfu per plate and lifted onto nitrocellulose circles according to the 
immunoscreening protocol. After incubation with GP antiserum, antibodies were 
eluted, and used to probe strip blots of whole cell extracts of E. faecalis EBH1. One 
clone out of the 29 initial positives showed reactivity with both the 37 and 40 kDa 
proteins (figure 3.1.). This clone, designated GP19 was rescued in vivo as a 
pBluescript SK- phagemid and designated pGP19-. The corresponding SK+ phagemid 
was designated pGP19+. Phagemids were transformed into E. coli XLl-Blue.
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Figure 3.2 SDS-PAGE (panel A) and immunoblot (panel B) analysis of whole cell 
lysates from E. coli XLl-Blue/pSK- vector (lanes 2-4) and E. coli XLl-Blue/pGP19 
(lanes 5-7) before and after induction with lOmM IPTG. Lane 1, molecular weight 
markers; lanes 2 and 5, pre induction; lanes 3 and 6, 1 hour induction; lanes 4 and 7, 
4 hours induction.
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Figure 3.3. Immunoblot analysis of whole cell lysates from E. coli XLl-Blue/pGP19 
(lane 2), XLl-Blue/pGPH2 (lane 3) and XLl-Blue/pSK- vector (lane 4), after lh 
induction with 10 mM IPTG, probed with serum from patient GP with E.faecalis 
endocarditis. Lane 1 contans molecular weight markers.
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3.4. Restriction analysis of pGP19+/-.
Digestion of plasmid pGP19 with EcoRI revealed a single 1.7 kb insert in the 
pBluescript polylinker. pGP19 was then digested with all other available enzymes 
{Kpnl, BamRl, Xhol, Xbal, EcoRV, Smal, HindID, Sail, Seal, and PstT) of which only 
Hindm  cut within the insert, at 365 bp and 770 bp.
3.5. Expression from cloned DNA.
The cloned inserts in the pGP19 plasmids are under the control of the lacZ 
promoter, which suppresses expression in the absence of inducer, isopropylthio-p-D- 
galactopyranoside (IPTG). To examine the products of any open reading frames in the 
cloned inserts, expression was induced with lOmM IPTG as described in section 2.22. 
Whole cell extracts of induced E. coli XLl-Blue/pGP19 cells were analysed by SDS- 
PAGE and western blotting, and compared with the vector pSK- as a control. SDS- 
PAGE revealed the presence of an approximately 40kDa protein, which reacted 
strongly with GP antiserum on western blots (figure 3.2.). The protein was expressed 
weakly in the absence of IPTG, but maximal expression was achieved after 4h 
induction. The vector control was negative.
In order to determine which region of pGP19 was responsible for expression of 
the immunoreactive product, the 1.7 kb insert was restricted with HindUl and ZscoRI, 
and the smaller fragments unidirectionally subcloned as described in section 2.8. 
Correct orientation was established by nucleotide sequencing of the subclones. 
Expression was detected from pGP19, but not from plasmid pGPH2 (which contains 
an approximately lkb fragment from the 3' end of the pGP19 insert)(figure 3.3.). Thus 
it was deduced that the start codon of the open reading frame encoding the 
immunoreactive protein was within the first 700 bp at the 5! end of the insert.
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3.6. Discussion.
3.6.1. Isolation o f an immunoreactive clone.
Screening a genomic library of E. faecalis EBH1 with serum from an 
E.faecalis endocarditis patient produced several immunoreactive clones. Affinity 
purification demonstrated that one of these clones was cross reactive with both the 37 
and 40 kDa antigens of E. faecalis which have been shown to be of use in the 
serodiagnosis of infective endocarditis (Shorrock et al 1990, Aitchison et al 1987). 
This clone, designated GP19, was selected for subcloning and further analysis. Cross 
reactivity with the two antigens may have been due to GP19 containing the structural 
genes for both peptides, indicating that the 37 and 40 kDa proteins are from the same, 
or very close operons. This however, is not the case, since a single immunoreactive 
approximately 40 kDa protein is expressed from pGP19-, suggesting rather that the 
two E.faecalis antigens are antigenically very closely related. It is possible that the 
two antigens represent different forms of the same peptide, perhaps due to cleavage of 
a leader peptide. Conversely, the heavier protein may represent post-translational 
modification of the parent peptide, possibly by glycosylation. Previous studies on the 
37 and 40 kDa antigens have suggested some glycosylation of antigenic epitopes 
(Aitchison et al, 1986; 1987). Attempts were made to obtain the N-terminal amino 
acid sequences of the 37 and 40 kDa antigens by automated peptide microsequencing 
(Edman degradation), for comparison with the inferred amino acid sequence of the 
cloned gene so that this hypothesis could be tested. However, these attempts were 
unsuccessful, so no comparison could be made.
Bacterial proteins are frequently expressed as precursors which are modified 
substantially before achieving their final active conformation and location. This post- 
translational modification often involves a leader sequence which directs the immature 
peptide to a particular cell location, before being cleaved from the mature protein by a 
specific signal peptidase enzyme (Dawes and Sutherland, 1992). Removal of the
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leader may also involve addition of other compoinents. This raises the possibility that 
the 37 kDa antigen may represent the 40 kDa antigen with the leader sequence 
removed.
As well as the 40 kDa band, an immunoreactive 81 kDa band became visible 
after 4 hours induction of pGP19 (figure 3.2.). The band was not present in vector 
control cells. This may be due to aggregation of the cloned gene product into dimers, 
as has been shown for other similarly sized streptococcal surface proteins 
(Ganeshkumar et al, 1988; Oligino and Fives-Taylor, 1993). These polymeric forms 
were shown to be resistant to boiling in SDS and mercaptoethanol, as was the case for 
the pGP19 product. The nature and significance of the polymeric forms is not 
understood, but in the case of FimA, a fimbrial adhesin of S. parasanguis, it may be 
concerned with self assembly of fimbrial structural subunits (Oligino and Fives- 
Taylor, 1993). Polymerisation into larger units may also allow these relatively small 
proteins to be exposed at the surface of the cell, despite the presence of a thick cell 
wall (Jenkinson, 1994).
3.6.2. Expression from pGP19 in the absence of IPTG.
pUC-related cloning vectors, such as pBluescript, contain a polylinker of 
unique restriction sites oriented such that transcription of cloned DNA is under the 
influence of the lacZ promoter. In the absence of inducer, transcription is repressed to 
prevent the build up of potentially toxic products in the cell, whilst in the presence of 
inducer, such as IPTG, transcription occurs rapidly, allowing expression of large 
quantities of protein.
The addition of lOmM IPTG to a log phase culture of E. coli XLl-Blue/pGP19 
caused a large increase in production of the gene product, however some low level 
expression also occurred in the absence of IPTG. These data suggest that expression 
from pGP19 is under the influence of its own promoter, requiring E. coli RNA 
polymerase to recognise streptococcal promoter elements. The ability of E. coli
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transcription and translation mechanisms to accept more divergent promoter and 
initiation sequences than other (particularly Gram-positive) species is well recognised 
(McLaughlin et al, 1981; Moran et al, 1982). The expression seen in the absence of 
IPTG is weak, as would be expected if consensus sequences differ between species. A 
more likely explanation is that areas of high A-T content within the insert act as weak 
promoters. This situation is well documented among species of high chromosomal 
A-T content such as S. pneumoniae (Morrison and Jaurin 1990; Dillard and Yother 
1991). Random segments of S. pneumoniae DNA cloned into promoter probe 
plasmids in E. coli exhibit a higher frequency of strong promoter activity than 
similarly cloned E. coli fragments (Chen and Morrison 1987). This is explained by a 
higher frequency of random sequences falling into the E. coli consensus promoter 
sequences (TTGACA and TAT A AT) within the A-T rich S. pneumoniae chromosome. 
If this hypothesis is correct, then the S. pneumoniae RNA polymerase must have a 
more stringent consensus sequence requirement than that of E. coli. Indeed, Dillard 
and Yother (1991) have noted that S. pneumoniae sequences which act as promoters in 
E. coli do not necessarily do so in S. pneumoniae, whereas actual promoter sequences 
of S. pneumoniae may have increased strength in E. coli (McLaughlin et al 1981; 
Moran eta l 1982). Enterococcal DNA has a similarly high A-T content (58-66%, Holt 
et al, 1994), therefore it may be assumed that similar weak promoter sites exist in 
cloned E.faecalis DNA at a similar frequency to that seen in S.pneumoniae, with 
such sites resulting in low level expression of cloned inserts in E. coli, as is seen in 
this case. Although speculative, these findings suggest that stronger expression might 
have been expected had a true promoter been cloned.
A further manifestation of false promoter elements in cloned A-T rich DNA is 
that excessive transcription can interfere with plasmid replication and expression of 
plasmid-encoded genes. As a result, plasmids become unstable, and cloning of certain 
sequences becomes difficult unless transcriptional terminators are included (Dillard 
and Yother, 1991). Such difficulties were encountered during subcloning of pGPHl-
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for nucleotide sequencing. The problem was solved by using pBluescript KS-/+, a 
version of the plasmid in which the polylinker sequence is reversed.
3.6.3. Serodiagnosis o f E.faecalis endocarditis.
Diagnosis of the causative agent in endocarditis is an essential step in ensuring 
that the patient receives the appropriate antibiotic therapy. Blood cultures usually give 
the most accurate diagnosis, however, these can take up to 24 hours, and may be 
negative in certain cases (Tunkel and Kaye, 1992). Any technique capable of rapidly 
identifying or eliminating specific organisms in infected patients would be of great 
clinical value. The use of immunological methods in diagnosis provides a sensitive, 
specific and rapid alternative to culture techniques, especially in specimens where 
organisms cannot easily be identified by culture, such as sputum, or in cases where 
aggressive antibiotic therapy has been initiated (Lambert, 1990). Shorrock et al, 
(1990) devised an ELISA based upon the 37, 40 and 73 kDa endocarditis specific 
antigens of E. faecalis which successfully diagnosed E. faecalis endocarditis, whilst 
giving negative results for patients with either endocarditis due to other streptococci or 
E. faecalis infections other than endocarditis.
Since the cloned E. faecalis protein was shown to be cross reactive with the 37 
and 40 kDa antigens, then it may be of use in the serodiagnosis of endocarditis. The 
use of cloned protein in an ELISA would offer certain advantages over the use of 
purified whole cell extracts. Shorrock et al, (1990) partially purified the 37, 40 and 73 
kDa antigens from crude whole cell extracts of E. faecalis by ammonium sulphate 
precipitation. In a recombinant system, much larger quantities of a single, pure protein 
can be produced, which should give more reliable, reproducible results than cell 
extracts, where accurate reproduction of cell growth conditions and extraction 
procedures would be necessary. In the absence of N-terminal amino acid sequence for 
the 37 and 40 kDa antigens, the use of the cloned gene product in serodiagnosis may
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give further indication of the relationship with the 37 and 40 kDa antigens of 
E. faecalis.
In summary, a gene expressing an approximately 40 kDa protein has been 
cloned, which reacts strongly with antiserum from an E. faecalis endocarditis patient, 
and is cross reactive with both the 37 and 40 kDa antigens of E. faecalis. The nature of 
this protein will be determined by sequence analysis of the gene(s) within the cloned 
DNA insert.
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Chapter 4: Sequence analysis.
In this chapter, the determination of the nucleotide sequence of pGP19, and its 
subsequent analysis by translation into an amino acid sequence, and comparison with 
sequence databases is described. It is hoped that the data presented here, and in the 
subsequent discussion will provide an explanation of the results described in chapter 
3, and may also suggest a role for the cloned protein in the pathogenesis of E. faecalis.
4.1. Nucleotide sequencing of pGP19+/-.
Nucleotide sequencing was performed using single-stranded templates 
generated from the pBluescript phagemid system. Since plasmid pGP19- was too large 
to sequence directly without the aid of synthetic primers, it was digested, and 
subcloned in smaller pieces. Plasmid pGP19- consists of 3 HindJR fragments, each of 
which was subcloned unidirectionally into pSK- and pSK+, giving plasmids 
pGPHl+/-, pGPH2+/- and pGPH3+/-. Plasmids pGPHl+/- and pGPH3+/- contain 369 
bp and 405 bp, respectively, and could be sequenced from commercially obtained pSK 
primers. pGPH2+/- required the manufacture of synthetic primers to allow sequencing. 
The partial nucleotide sequence of pGP19 is shown in figure 4.1.
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1 0  2 0  3 0  40  5 0  6 0
GAATTCCGGCCGGAATTCCGGCTTCTGGTGCGACGATTGTTTTA&CCGCCGCCTTATTCT 6 0
TTTTATTGGCTTTCTTTTTCTCACCAAAGAAAGGCCTAGTATTTGT AAACCGTGAGAAAG 1 2 0
AAATGGAGGAATCAACGAATGAAAAAATTTAGTTTATTTTTTTTAACACTTTTAGCAGGG 1 8 0
SD M K K F S L F F L T  L L A G
TTAACGTTAGCTGCTTGCGGGAATCAAGCCGCTGAAAAGAAAGAAAAATTAGCAATTGTG 2 4 0
L T L A A C G N Q A A E K K E K L A I V
ACAACGAACTCGATCTTATCCGATTTAGTGAAAAATGTTGGGCAAGACAAAATTGAGCTG 3 0 0
T T N S  I  L S D L V K N V  G Q  D K I  E L
CATAGTATTGTGCCAATTGGGACAGACCCTCACGAATATGAACCGTTACCAGAAGACATT 3 6 0
H S  I V P  I  G T D P H E Y E P L  P E D I
GCGAAAGCTTCTGAAGCGGACATTTTATTCTTTAACGGCTTGAACTTAGAAACAGGCGGA 4 2 0
A K A S E A D I L F F N G L N L E T G G
AATGGCTGGTTTAACAAATTAATGAAAACGGCCAAAAAAGTTGAGAATAAAGATTACTTT 4 8 0
N G W F N K L M K T A K K V E N K D Y F
TCTACAAGCAAAAATGTTACGCCACAATATTTAACAAGTGCCGGTCAAGAACAAACAGAA 5 4 0
S T S K N V T P Q Y L T S A G Q E Q T E
GATCCGCATGCTTGGTTAGACATTGAAAATGGCATCAAATATGTAGAAAACATTCGTGAC 6 0 0
D P H A W L D I E N G I K Y V E N I R D
GTGTTAGTAGAAAAAGATCCAAAAAATAAAGATTTCTATACAGAAAACGCGAAAAATTAT 6 6 0
V L V E K D P K N K D F Y T E N A K N Y
ACCGAAAAACTTAGCAAACTACATGAGGAAGCCAAAGCTAAATTTGCTGATATTCCTGAT 7 2 0
T E K L S K L H E E A K A K F A D I P D
GATAAAAAATTATTAGTTACAAGTGAAGGTGCCTTTAAATATTTCTCCAAAGCTTATGAT 7 8 0
D K K L L V T S E G A F K Y F S K A Y D
TTAAATGCCGCTTATATTTGGGAAATTAACACAGAAAGTCAAGGAACACCTGAACAAATG 8 4 0
L N A A Y I W E I N T E S Q G T P E Q M
ACCACGATTATTGATACCATTAAGAAATCAAAAGCACCTGTGTTATTTGTTGAAACCAGT 9 0 0
T T I  I D T  I K K S K A P V L F V E T S
GTCGATAAACGTAGTATGGAACGGGTCTCAAAAGAAGTGAAACAGCCAATTTACGATACA 9 6 0
V D K R S M E R V S K E V K Q P I Y D T
CTTTTCACAGACTCCCTTGCCAAAGAAGGAACAGAAGGCGATACGTACTACAGCATGATG 1 0 2 0
L F T D S L A K E G T E G D T Y Y  S M M
AACTGGAATTTAACAAAAATCCATGATGGCTTAATGAGTAAATAAATAATAAAGAAGAAA 1 0 8 0
N W N L T K I H D G L M  S K *
Figure 4.1. Nucleotide sequence of GP19, and the inferred amino acid sequence. The 
putative Shine Dalgamo (SD) sequence is double underlined. The sequence used for 
probing Southern and northern blots is underlined.
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4.2. Nucleic acid and protein sequence analysis..
4.2.1. Open reading frames.
The partial nucleotide sequence of pGP19 was analysed for open reading 
frames (ORFs) using the PCGENE package (Intelligenetics). Three ORFs were 
identified, and are listed in table 4.1. in order of size.
Table 4.1. Open reading frames of pGP19.
Start codon. Stop codon. ORF length. Peptide length.
139 1062 924 bp 308 aa
442 1062 621 bp 207 aa
838 1062 225 bp 75 aa
The program identifies open reading frames by looking for potential start sites 
(ATG), then reading through until a stop codon (TAA, TAG, TGA) is reached. In the 
three ORFs identified above, only the largest is likely to be the true ORF, the smaller 
two represent the software interpreting methionine codons within the largest ORF as 
start codons. A potential ribosome binding site (GGAGGA) occurs 9-14 bp upstream 
of the start codon at position 139. Because of time restrictions, approximately 700 bp 
of nucleic acid material at the 3'-end of the cloned insert were not sequenced. Earlier 
experiments had indicated that the open reading frame of the cloned immunoreactive 
protein was within the 5-half of the insert, and that no reactive protein could be 
detected during expression from the unsequenced region of the insert (section 3.5.).
4.2.2 Analysis o f the deduced amino acid sequence.
Translation of the open reading frame detected in section 4.2.1. revealed a 308 
amino acid peptide with a predicted molecular weight of 34,768 Da and an isoelectric 
point of 5.04. The full protein sequence is shown in figure 4.1. This protein was taken 
to be the expression product of pGP19 identified in section 3.5. and was given the 
name EfaA (Enterococcus faecalis antigen A). The nucleic acid sequence of efaA has
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been deposited in the GenBank and EMBL databases under the accession number 
U03756.
Further analysis using the PCGENE package revealed that EfaA is hydrophilic 
except for residues 1-19. The hydrophilicity profile of EfaA is shown in figure 4.2. 
EfaA as a whole has an average hydropathy index of -5.27 (hydrophilic) whereas 
residues 1-19 have an index of 14.78 (hydrophobic) (Kyte and Doolittle, 1982; see 
also appendix A). Residues 2-21 were predicted to form a transmembrane a-helix, 
according to the method of Rao and Argos (1986). Analysis of the peptide sequence 
with the PROSITE package revealed the presence of a potential signal peptidase 
cleavage site (LAAC) at residues 17-20. This sequence corresponds to the consensus 
sequence Leu(Val,Ile)-Ala(Ser,Thr,Gly)-Gly(Ala)-Cys (von Heijne, 1989) for cleavage 
by signal peptidase II.
This suggests that the first 19 amino acids of EfaA comprise a leader sequence, 
which is cleaved before the mature protein is formed. The mature protein would be 
hydrophilic, and have a molecular weight of 32,701.
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Figure 4.2. Hydropathic index of EfaA, computed by the Kyte-Doolittle 'SOAP' 
package using an interval of 9 amino acids.
4.2.3. Nucleic acid and protein sequence analysis: Comparison with databases.
The nucleotide sequence of efaA and the amino acid sequence of EfaA were 
analysed for similarity with other sequences in the GenBank and EMBL databases. 
The comparisons were performed using the GCG package on the SERC Seqnet facility 
at Daresbury, UK.
The FAST A program was used to compare the nucleotide sequence of efaA 
directly with all other nucleotide sequences in the GenBank and EMBL databases. The 
TFASTA program was used to compare the amino acid sequence of EfaA with 
nucleotide sequences in the databases translated in all six reading frames. The two 
programs together give an indication of homology with sequences deposited in the 
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Fig 4.3 Sequence alignment of amino acid sequence of EfaA with SsaB (73% similar) and FimA (73% similar). 
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Fig 4.4. Sequence alignment of amino acid sequence of EfaA with ScaA (70% similar) and PsaA (72.5% similar). Sequence alignment was 
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Fig 4.5. Multiple sequence alignment of EfaA, FimA, PsaA, ScaA and SsaB, generated by CLUSTALV. Identical residues are indicated by (*), 
conserved residues are indicated by (.). Homology over all five sequences is 51.3% (158 residues). Similarity over all five sequences is 70%.
EfaA was found to possess significant homology with four previously cloned 
proteins as shown in table 4.2. Three of these proteins have adhesive functions. FimA 
of S. parasanguis and SsaB of S. sanguis 12 appear to be salivary adhesins whilst 
ScaA mediates coaggregation of S. gordonii with other oral bacteria such as 
Actinomyces naeslundii. No function has yet been ascribed to PsaA of S. pneumoniae.
Table 4.2. Cloned proteins with homology to EfaA.
Protein Species Amino acid Nucleic acid
FimA S. parasanguis 60.5% 61.8% Fenno et al (1989)
SsaB S. sanguis 12 57.7% 62.7% Ganeshkumar et al (1991)
PsaA S. pneumoniae 60.5% 61.2% Sampson et al (1994)
ScaA S. gordonii 55.5% 60.4% Kolenbrander (unpub)
Homology values were calculated by the FASTA and TFASTA programs. 
Individual sequence alignments were generated using the GAP program, which also 
calculated similarity values for the alignments. The alignments are shown in figures
4.3. and 4.4. Similarity values account for conserved amino acid substitutions rather 
than just identical residues. The values calculated for similarity to EfaA were: FimA, 
73%; SsaB, 73%; PsaA 72.5%; and ScaA, 70%. The sequences were also aligned 
using the multiple sequence alignment package ClustalV, which calculated an overall 
similarity between the 5 proteins as 70% (figure 4.5.).
The sequences can be found under the following GenBank accession numbers: 
FimA, M26130; SsaB, M37189; PsaA, L19055; ScaA, LI 1577.
4.2.4. Analysis o f DNA regions flanking efaA.
DNA flanking the fim A , psaA and scaA genes share a number of features, 
including flanking reading frames both upstream and downstream of their putative 
adhesin genes. The upstream reading frames encode proteins of approx 29.9 kDa, 
which are predicted to be extremely hydrophobic. Analysis of the 139 bases upstream 
of the ATG start codon of efaA within pGP19- by translation of the three potential
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reading frames revealed that frames 1 and 2 contained numerous stop codons, whilst 
frame 3 had none. Analysis of the amino acid translation of frame 3 revealed some 
homology to the open reading frames upstream of the fimA, psaA and scaA genes. An 
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Figure 4.6. ClustalV alignment of the regions upstream of the efaA, fimA, psaA and 
scaA genes. Identical residues are denoted (*), conserved residues are denoted ( .)
The translation continues to a stop codon (TAG) at base 150, thus the reading 
frame overlaps with that of efaA which begins at base 139, in frame 1. Within the 
fimA, psaA and scaA flanking sequences, the 29.9 kDa protein reading frames stop 12, 
12 and 22 bp upstream of the putative adhesin gene start sites, respectively, with no 
transcriptional terminators between the genes. This suggests that in each case, the 
genes could be transcribed as part of a polycistronic message. The similarity observed 
suggests a common origin for these genes, however, efaA homology with the upstream 
reading frames of fimA, psaA and scaA ceases at base 93, and no stop codon is present 
until several bases into the efaA reading frame. Because of the lack of sequence data, it 
is uncertain whether or not the 29.9 kDa hydrophobic protein is expressed in 
E. faecalis. No open reading frames are reported in the 1 kb of cloned DNA upstream 
of the ssaB gene of S. sanguis 12, however, translation of the available sequence into a 
hypothetical peptide reveals a very high level of homology with the 29.9 kDa proteins 
upstream of fimA, psaA and scaA. This peptide is apparently not expressed, since it is 
not within an open reading frame, so similarly to the situation in E. faecalis, the ssaB 
operon of S. sanguis 12 appears to have diverged from fimA, psaA and scaA.
Northern blot analysis of S. parasanguis cellular RNA showed that fimA is 
transcribed on a 3.2 kb message (Fives-Taylor et al, 1991), similarly, psaA has been
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shown to be transcribed on a 3 kb message (Sampson et al, 1994). These data are in 
keeping with the proteins being transcribed as a polycistronic message. Although no 
function has as yet been positively ascribed to these flanking genes, Andersen et al, 
(1994) who have sequenced over 6 kb of DNA flanking scaA, have noted similarities 
between the scaA operon and periplasmic binding protein systems in Gram-negative 
bacteria (discussed in section 4.5.19.). Such systems have also been reported in Gram- 
positive species (Alloing et al, 1990) suggesting that ScaA may be part of a 
lipoprotein-dependant membrane transport system. The evidence from the ssaB 
operon clearly indicates that the hydrophobic 29.9 kDa protein is not an essential 
requirement for saliva binding, however it may serve some other purpose in relation to 
the adhesins. A principal difference between FimA and SsaB is that FimA is present in 
surface fimbriae of S. parasanguis, whereas SsaB appears to be associated with short 
fibrils (Ganeshkumar et al, 1988), with fibrils being defined as structures extending 
from the cell surface which have a defined length, but no consistent width, probably 
because they clump (Handley et al, 1984). The manufacture of fimbriae in 
S. parasanguis has been shown to involve the interaction of a number of proteins 
(Fives-Taylor et al, 1991), so it may be that in losing the ability to express the 29.9 
kDa protein, S. sanguis 12 has lost the ability to include SsaB in long fimbriae, and 
instead, through some altered process expresses its adhesin in a different form. Some 
strains of Enterococcus faecalis have been shown to possess fimbriae (Handley and 
Jacob, 1981). The number of E.faecalis fimbriate cells in a population was shown to 
vary according to growth phase, and the pattern of appearance and disappearance of 
fimbriate cells varied according to the E.faecalis strain studied. Electron microscopy 
has shown that approximately 35% of log-phase E.faecalis EBH1 cells possess 
fimbriae, but that this figure drops to around 5% in stationary phase cells. 
Immunogold labelling of E.faecalis EBH1 cells using antiserum raised against the 37 
and 40 kDa antigens demonstrated that the antigens were present on the cell surface, 
but like SsaB, were not associated with fimbriae (Shorrock, 1990).
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Figure 4.7. Southern blot analysis of //mdlll digested genomic DNA 
from various enterococcal and streptococcal strains, probed with a 
0.4kb HindlW fragment of E.faecalis EBH1 efaA. The blot was washed 
in 0. lx SSC at 68°C for 20 minutes.
Lane 1, E.faecalis EBH1; lane 2, E. faecalis NCTC5957; 
lane 3, S. pneumoniae (blood isolate); lane 4, S. pneumoniae (sputum 
isolate); lane 5, S. parasanguis FW213; lane 6, S. gordonii Challis; 
lane 7, E.faecium ATCC10541; lane 8, S. salivarius NCTC8618; 
lane 9, S. bovis Beecham 5240453; lane 10, S. milleri NCTC7863.
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4.3. Southern Analysis.
Southern analysis was performed to determine whether genes homologous to 
efaA were present in other streptococci (See table 4.3.)* Chromosomal DNA was 
digested to completion with HindUl, separated on an agarose gel, and the fragments 
transferred to a nitrocellulose filter by capillary flow, as described by Southern et al 
(1975). Blots were probed with a 405 bp internal HindUl fragment, labelled with 32P. 
The sequence of this probe is underlined in figure 4.1.
Table 4.3. Bacterial strains analysed by Southern blotting.
Strain. Source.
E.faecalis EBH1 Endocarditis isolate, B'ham Heartlands Hosp.
E.faecalis (Docker 10482) Endocarditis isolate, B'ham Heartlands Hosp.
E. faecalis (Phillips 6546) Endocarditis isolate, B'ham Heartlands Hosp.
E. faecalis (LJ) Endocarditis isolate, B'ham Heartlands Hosp.
E. faecalis (MHC) Endocarditis isolate, B'ham Heartlands Hosp.
E. faecalis (777) Endocarditis isolate, B'ham Heartlands Hosp.
E. faecalis (SFB A) Endocarditis isolate, B'ham Heartlands Hosp.
E. faecalis v. zymogenes NCTC 05957
Strep, milleri NCTC 07863
Strep, mutans NCTC 10449
Strep, salivarius NCTC 08618
E. faecium ATCC 10541
Strep, bovis SmithKline Beecham 5240453
Strep, mitis Clinical isolate, Newcastle Dental School
Strep, parasanguis FW213 Dr P.S. Handley, Manchester University
Strep, gordonii challis Dr P.S. Handley, Manchester University
Strep, pneumoniae (blood isolate) Dr. I.D. Farrell, B'ham Heartlands Hosp.
Strep, pneumoniae (sputum isolate) Dr. I.D. Farrell, B'ham Heartlands Hosp.
The labelled probe reacted at high stringency with an approx 0.4 kb fragment 
from all E. faecalis strains tested, and hybridised weakly to an approximately 3 kb 
HindUl fragment of E.faecium  ATCC10541 (figure 4.7.). This band faded, but was
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not completely removed, by high stringency washes. No other strains reacted, even 
under conditions of low stringency.
4.4. Bacterial adherence to hydrocarbon assay (BATH assay).
Computer analysis of the amino acid sequence of EfaA predicted that the 
protein is very hydrophilic. Previous experiments by Lambert et al, (1990) have shown 
that expression of the 37 and 40 kDa antigens is regulated by serum. In order to 
determine the effects of serum-supplemented growth upon hydrophilicity of E. 
faecalis EBH1, BATH assays were performed. The BATH assay provides a measure 
of the surface hydrophilicity of a bacterium by measuring its association with a 
hydrophobic solvent (hexadecane). The reduction in OD450 of an aqueous bacterial 
suspension after mixing with hexadecane is proportional to the hydrophobicity of the 
cells. Results are shown as the OD450 of the hexadecane-extracted cells, expressed as a 
percentage of the OD450 of the original suspension. Thus the higher the percentage, the 
more hydrophilic the cells. In order to determine the effect of serum in the growth 
medium on EBH1 hydrophobicity, BATH assays were performed on cells grown in 
yeast extract, and in yeast extract supplemented with foetal calf serum (FCS). For each 
growth medium, three cultures were grown, and for each culture the experiment was 
performed in triplicate. Means were compared by unpaired students t-test.
Table 4.4. BATH assay of E. faecalis EBH1 cells in different culture media.
1% yeast extract. 1% yeast extract plus FCS.
Individual means:
37.6% (n=3) 60.5% (n=3)
50.5% (n=3) 60.1% (n=3)
37.8% (n=3) 68.9% (n=3)
Pooled means (± std deviation):
42(±7.4)% (n=9) 63.2(±4.9)% (n=9)
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The results indicate that addition of serum significantly increased the 
hydrophilicity of E.faecalis EBH1 cells (p < 0.05).
4.5. Discussion.
4.5.1. Plasmid pGP19 open reading frame.
Computer analysis of the complete nucleotide sequence of pGP19 revealed a 
single 924 bp open reading frame, encoding a 308 amino acid protein, with a predicted 
molecular weight of 34,768. As this was the only protein encoded by the cloned DNA, 
it was assumed that this represents the single band seen when GP19 was induced with 
IPTG. This is further supported by the presence of the polypurine sequence 
GGAGGAA, which agrees with the consensus sequence GGAGGA (Shine and 
Dalgamo, 1974) which is complementary to a 3' segment of prokaryotic 16S RNA 
necessary for ribosome binding to mRNA ahead of the start codon ATG.
4.5.2. Post-translational modification.
The predicted molecular weight of EfaA is somewhat smaller than that of the 
expressed peptide, as calculated by SDS-PAGE. The rate of migration of denatured 
proteins in a denaturing SDS-PAGE gel is assumed to be a function solely of its 
molecular weight, since all secondary structure is disrupted by boiling in the presence 
of SDS and mercaptoethanol, and the primary chain is then coated with negatively- 
charged dodecyl sulphate molecules. However, this method provides, at best, only an 
estimate of the true molecular weight of a mature protein. It is not unusual for the 
apparent molecular weight of a protein as determined by SDS-PAGE to differ from 
that calculated from its sequence data (Sela et al, 1993; Ichikawa et al 1994). Indeed a 
similar discrepancy is seen in the predicted and apparent weights of some of the EfaA 
homologues listed in section 4.2.3. (Fenno et al, 1989; Ganeshkumar et al 1991)
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The rate of protein migration through a polyacrylamide gel can be retarded by 
post-translational modifications to the polypeptide backbone such as glycosylation. 
Thus the apparent molecular weight of a glycosylated protein estimated by SDS- 
PAGE is not a true reflection of the weight of the peptide chain. On this basis, it is 
suggested that EfaA may undergo some post-translational glycosylation. This is in 
agreement with previous work by Aitchison et al (1986), which used lectins in ligand 
blotting and periodate treatment of western blots, and suggested that the 37 and 40 
antigens were glycosylated. Reports of glycosylation of bacterial proteins are rare, 
however those reported have included surface proteins which are thought to interact 
with eukaryotic receptors (Sambri et al, 1992; Hirt et al, 1993).
4.5.3. Analysis o f pGP 19- for promoter sequences.
Weak expression of EfaA from pGP19- in the absence of inducer prompted the 
theory that some promoter elements may have been cloned along with structural genes 
in pGP19 (See section 3.7.2.). Computer analysis of the nucleotide sequence of 
pGP19- revealed no potential promoter sequences upstream of the ATG start codon at 
base 139. The lack of any such potential promoter lends support to the theory that 
expression in the absence of inducer is due to random A-T rich sequences of 
E.faecalis DNA being recognised as promoters by E. coli RNA polymerase (see 
section 3.7.2.). It is noteworthy that cloned PsaA of S. pneumoniae, with which EfaA 
shares substantial homology, also exhibits significant expression from its cloning 
vector in the absence of inducer, despite there being no S. pneumoniae promoter 
elements in the cloned fragment (Sampson et al, 1994). This also has been attributed 
to random E. coli promoter-like sequences occurring in the A-T rich S. pneumoniae 
chromosome.
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4.5.4. Hydrophilicity analysis o f EfaA.
The Kyte and Doolittle computer software (SOAP) analyses the 
hydrophobicity and hydrophilicity of a protein according to its amino acid sequence, 
displaying the results graphically (Kyte and Doolittle, 1982). Such analysis also gives 
rise to a GRAVY score (GRAnd AVerage hydropathY) which is an indicator of the 
general hydrophilic or hydrophobic nature of the protein. The Kyte-Doolittle plot for 
EfaA is shown in figure 4.2. The GRAVY score of EfaA is -5.27, indicating that the 
protein is generally hydrophilic, and soluble in nature. Hopp and Woods (1981) 
deduced that the major antigenic determinants of a surface protein are most commonly 
those subsequences of greatest hydrophilicity, since these sections are exposed most 
prominently to the aqueous medium surrounding the organism. Furthermore, 
antigenicity can be correlated to segmental flexibility along the peptide chain (Van 
Regenmortel, 1986), with those regions of most pronounced flexibility combined with 
hydrophilicity being the most likely antigenic determinants. Computer analysis using 
the FLEXPRO package (PCGene, Intelligenetics), suggests that EfaA contains a large 
number of potential hydrophilic epitopes and a large proportion of 'flexible' residues as 
compared to 'rigid' residues, which would make it antigenic. This supports the 
evidence that EfaA represents one, or both, of the 37 and 40 kDa antigens of 
E.faecalis, which have been shown to elicit a strong antibody response both in 
humans, and in rabbits (Shorrock et al, 1990; Lambert et al, 1990).
If EfaA does represent the 37 and 40 kDa antigens, then its expression should 
be enhanced by growth in serum-supplemented media, and be accompanied by an 
increase in cell surface hydrophilicity, since the protein is very hydrophilic. BATH 
assays did indeed indicate that growth of E. faecalis cells in serum-supplemented 
media was associated with increased cell hydrophilicity. These data are in agreement 
with similar work by Guzman et al, (1991a), and further support the link between 
EfaA and the 37 and 40 kDa antigens of E. faecalis.
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4.5.5. Location o f EfaA.
Since EfaA is hydrophilic and sufficiently surface exposed to elicit a strong 
antibody response, then it must be assumed that a specific mechanism exists to attach 
the protein to the cell surface. Such an attachment must prevent loss of the protein, 
whilst allowing the hydrophilic backbone to extend into the aqueous medium to 
exercise its specific function. Examining the Kyte-Doolittle hydrophilicity profile of 
the protein may give an indication of the nature of this attachment. The exception to 
the hydrophilicity of the primary chain of EfaA is the N-terminal 19 amino acids. 
Taken separately, these 19 amino acids have a GRAVY score of 14.78 (very 
hydrophobic) leaving the remaining 289 residues with a GRAVY score of -6.59 
(hydrophilic). This hydrophobic region could have a membrane anchor function, the 
hydrophobic region of the protein being associated with the lipid bilayer of the cell 
membrane. Alternately, the hydrophobic region may represent a signal peptide, 
ultimately cleaved by a signal peptidase to form the mature lipoprotein.
Many surface proteins of Gram-positive cocci have been shown to be held at 
the cell surface by means of such a hydrophobic anchor (Fischetti et al, 1991; 
Schneewind et al, 1991; 1992). These proteins are characterised as having a C- 
terminal run of up to seven basic amino acids. Immediately N-terminal to this is a 15- 
22 residue hydrophobic region, the putative membrane anchor, followed by highly 
conserved hexapeptide with the consensus sequence LPXTGX (Fischetti et al, 1991), 
and a wall-associated region. Disruption of the C-terminus of one of these 
characterised surface proteins, CshA of S. gordonii, caused the truncated product to be 
secreted into the extracellular medium (McNab and Jenkinson, 1992), providing 
confirmation that this region is indeed vital for attachment to the cell surface. 
Furthermore, minor alterations to either the LPXTGX motif or to the charged C- 
terminal residues result in incorrect processing (Schneewind et al, 1992), indicating 
that these regions play central roles in surface protein localisation.
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This suggests a potential membrane anchor role for the hydrophobic region of 
EfaA. Clearly, however, the putative anchor region of EfaA is heterologous to those of 
the characterised Gram-positive surface proteins discussed above, since the 
hydrophobic region is N-terminal rather than C-terminal, and no sequence 
homologous to the LPXTGX hexapeptide is seen. It is therefore proposed that EfaA is 
attached to the cell surface by some other means.
Examination of the N-terminal sequence of EfaA reveals the amino acid motif 
L-A-A-C at residues 17-20. This sequence corresponds to the consensus sequence for 
cleavage by signal peptidase n, the enzyme which recognises and processes 
lipoprotein precursors in prokaryotes. This suggests that EfaA may itself be a 
lipoprotein, attached to the cell surface not by association of hydrophobic amino acids, 
but by means of an N-terminal lipo-amino acid anchor (Gilson et al, 1988).
4.5.6. Bacterial lipoproteins.
In prokaryotes, lipoproteins are translated as precursor proteins 
(prolipoproteins) containing an N-terminal signal peptide which is eventually cleaved 
by a specific lipoprotein signal peptidase (signal peptidase II). The lipoprotein signal 
peptide is characterised by a basic N-terminus, a hydrophobic core and a cleavage site. 
Since primary sequence homology among the signal sequences of prolipoproteins is 
low (other than within the cleavage site) it is likely that the conformation of the signal 
peptide, particularly the formation of an a-helix, is the conserved factor (Engelman 
and Steitz, 1981; Chou and Kendall, 1990). Within the cleavage site, the consensus 
sequence (L,V,I)-(A,S,T,G)-(G,A)-C is observed, requiring at least one match in the 
first two positions, and precise matches to the final two (von Heijne, 1989).
The signal sequence performs many functions, probably involving interactions 
with many cellular components common to both lipoprotein and non-lipoprotein 
signal peptides (von Heijne, 1989). Gierasch (1989) proposed a scheme in which 
SecA, a cytoplasmic protein, binds to the signal sequence of the growing polypeptide
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chain at the ribosome, and targets the protein to the cell membrane. This stage may 
also involve other factors such as SecB and 'trigger factor'. The prolipoprotein would 
then bind to the membrane, in a step mediated by PrlA, a membrane protein receptor, 
and then be translocated across the membrane before finally being processed into a 
mature lipoprotein.
The hydrophobic region of the signal peptide allows association of the 
precursor with the lipid bilayer of the cytoplasmic membrane, presenting the cleavage 
site (LAAC) to the membrane bound processing enzymes. The site is first recognised 
by prolipoprotein glyceryl transferases which modify the cysteine residue by transfer 
of glyceride to its sulphydryl group. The leader peptide is then cleaved by signal 
peptidase n, and the N-terminal cysteine amino group is acylated, forming the final 
lipoprotein (Hayashi and Wu, 1990; Dawes and Sutherland, 1992).
Signal peptidases are integral membrane proteins which reside in the plasma 
membrane. The active site is probably located within, or just external to, the lipid 
bilayer (Dalbey and von Heijne, 1992). Thus the signal peptide must act to present the 
cleavage site of the prolipoprotein accurately to the signal peptidase. Small alterations 
in the basic N-terminus and/or the length of the hydrophobic region can cause a shift 
of the signal peptide within the plasma membrane, greatly affecting processing 
(Nothwehr and Gordon, 1990; Chou and Kendal, 1990). Such alterations can result in 
the mutant prolipoprotein remaining permanently anchored to the cytoplasmic 
membrane via its signal peptide. Despite this lack of processing, such mutants can still 
function correctly (Fikes and Bassford, 1987), which prompts some debate as to the 
function of the lipid anchor. Clearly it exists to maintain the functional molecule 
within the vicinity of, or attached to, the cell, but the question remains as to why a 
lipid anchor, and not a hydrophobic amino acid anchor, as seen with other surface 
proteins (Fischetti et al, 1991)?
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4.5.7. Evidence that EfaA may be a lipoprotein.
The basic N-terminus, hydrophobic a-helix core and cleavage site of the EfaA 
signal peptide all correspond to the requirements of the prolipoprotein processing 
enzymes of prokaryotes. Furthermore, there are well documented cases of proteins 
with signal peptides homologous to that of EfaA being confirmed as lipoproteins, by 
incorporation of [3H] labelled palmitate, such as SarA of S. gordonii (Jenkinson, 
1992), SsaB of S. sanguis 12 (Ganeshkumar et al, 1993) and ScaA of S. gordonii 
(Andersen et al, 1994). Ganeshkumar et al (1993) further demonstrated by site 
directed mutagenesis that a cysteine at amino acid 20 of SsaB was required for the 
incorporation of the radiolabelled palmitate. This is in agreement with Nielsen and 
Lampen (1982) who first demonstrated the presence of glyceride-cysteine thioether 
lipoproteins in Gram-positive bacteria.
This evidence would suggest that EfaA is translated as a prolipoprotein, then 
modified at the plasma membrane by a glyceryl transferase and signal peptidase II. 
This would reveal a 32,701 Da hydrophilic mature protein, with an N-terminal 
cysteine covalently attached to a lipid moiety. This mature form of EfaA would be a 
surface-exposed protein, anchored to the cell membrane by its N-terminal lipid.
4.5.8. Southern analysis of streptococcal strains.
In Southern analysis, a radiolabelled efaA probe failed to hybridise to DNA 
from any streptococci (see table 4.3.). Other than E.faecalis, only one strain, 
Enterococcus faecium , was reactive with the probe. The lack of hybridisation with 
streptococcal strains is not surprising. Homology between efaA and the adhesin genes 
from other streptococci (60.4%-62.7%) is significant in terms of the similarity 
between the translated gene products, but clearly not sufficient to allow hybridisation 
of the nucleic acids at the stringencies used, since a final wash at 50°C in 2 x SSC
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would require approximately 75% homology to> the probe (Mason and Williams, 
1985). It is therefore apparent that the streptococci tested do not possess efaA-Wke 
genes other than the adhesins mentioned in section 4.2.3. Southern analysis by 
Andersen et al, (1993) using scaA and ssaB probes failed to show hybridisation with 
E. faecalis DNA, which is in agreement with the results presented here.
The reactivity of the efaA probe with E. faecium reflects the similarity between 
the species. The match is clearly not perfect since the band is feint, and shows 
restriction fragment length polymorphism. Furthermore, antiserum reactive with the 
37 and 40 kDa antigens of E. faecalis did not recognise any surface antigens of similar 
molecular weight in E. faecium (Aitchison et al, 1987), indicating that the gene 
products have different antigenic epitopes.
4.5.9. Homology analysis by comparison with databases.
Comparison of the primary amino acid sequence of EfaA with the GenBank 
and EMBL databases revealed homology with a group of previously cloned proteins 
from streptococci (FimA, SsaB, ScaA and PsaA, see table 4.2.). Homology with EfaA 
ranges from 55.5% to 60.5%, with greatest divergence at the N-terminal ends, which is 
in keeping with this region being a signal peptide. It has been established that the N- 
terminus of SsaB is a signal sequence, cleaved at Cys-20 by signal peptidase II 
(Ganeshkumar et al, 1993), and so it is likely that the N-termini of FimA, PsaA and 
ScaA are similar signal sequences. Homology studies and Southern hybridisation have 
shown that EfaA is not so closely related to FimA, SsaB, ScaA and PsaA as they are to 
each other (80-90%). Nevertheless, the high degree of homology between EfaA and 
this group of proteins indicates that a great deal of information about the function of 
EfaA can be gained by an examination of their properties.
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4.5.10. SsaB o f Streptococcus sanguis.
Members of the group of bacteria derived from Streptococcus sanguis 
(including S. sanguis 12, S. gordonii and S. parasanguis) are oral organisms that 
selectively adhere to the acquired salivary pellicle of the teeth. They also have the 
ability to bind other oral organisms, making them a major component (8 to 15%) of 
dental plaque (Gibbons and van Houte, 1975). Furthermore, this group of streptococci 
are a major cause of infective endocarditis (See section 1.1.1.).
Studies of the binding of wild type S. sanguis 12 to saliva-coated 
hydroxyapatite (SCHA) compared to a non-aggregating mutant suggested two separate 
means of binding to saliva (Morris and McBride, 1984). Morris et al (1985) 
characterised one of these mechanisms as being linked to fibrillar structures on the 
surface of S. sanguis 12. Monoclonal antibodies raised against these S. sanguis 12 
fibrils inhibited adherence to SCHA (Morris et al, 1987). The second salivary adhesin 
was identified by Ganeshkumar et al (1988) by screening an S. sanguis 12 genomic 
library with antiserum reactive with S. sanguis 12 whole cells. The adhesin was found 
to be a 36 kDa protein which was present on the cell surface of both wild type, and the 
non-aggregating mutants of S. sanguis 12, possibly as densely packed short fibrils. 
Purified SsaB partially inhibited binding of wild type S. sanguis 12 and abolished 
binding of non-aggregating mutants. This confirmed the two site salivary binding 
model of Morris and McBride (1984), with non-aggregating mutants lacking the long 
fibrillar adhesin, but retaining SsaB. Nucleotide sequencing of ssaB revealed a 34,684 
Da hydrophilic protein with a putative 19 amino acid signal peptide (Ganeshkumar et 
al, 1991), which was later confirmed as a lipoprotein (Ganeshkumar et al, 1993). The 
amino acid sequence of SsaB was found to be 87% homologous to FimA, a 
functionally similar protein from S. parasanguis (Fenno et al, 1989).
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4.5.11. FimA o f Streptococcus parasanguis.
Mutants of S. parasanguis FW213 (previously S. sanguis, Whiley et al, 1990) 
nonadherent to SCHA were characterised by Fives-Taylor and Thompson (1985) and 
found to lack fimbriae, which are present in the wild-type strain. Coaggregation with 
other oral bacteria was not affected. Antibodies raised against these fimbriae blocked 
adhesion of fimbriated cells to SCHA (Fachon-Kalweit et al, 1985), suggesting that 
fimbriae were directly involved in adhesion to components of saliva. The structural 
gene for an antigenic component of fimbriae was cloned and sequenced (Fives-Taylor 
et al, 1987; Fenno et al, 1989), and found to be a 36 kDa protein designated FimA. 
FimA was shown to have a high affinity for its substrate on the salivary pellicle, 
purified protein inhibited binding of S. parasanguis to SCHA, and displaced cells 
already bound to SCHA (Oligino and Fives-Taylor, 1993). Besides sharing sequence 
homology and function, both FimA and SsaB renatured as polymeric forms after 
purification, suggesting that both proteins may perform structural as well as adhesive 
functions. Polymeric forms of FimA were resistant to boiling in SDS and 
mercaptoethanol (Oligino and Fives-Taylor, 1993), whereas SsaB polymers were 
reduced to monomers by incubation with SDS at room temperature (Ganeshkumar et 
al, 1988). FimA is known to be associated with fimbria of S. parasanguis, so the 
suggestion is that it is a structural part of the fimbria as well as an adhesin. Such an 
appendage, with an adhesin present on each subunit, could allow strong adherence to 
the substrate (Oligino and Fives-Taylor, 1993). SsaB is not associated with the long 
fibrils seen on S. sanguis 12, however, immunogold labelling has shown the protein as 
a halo around the cell surface, possibly as densely packed short fibrils (Ganeshkumar 
et al, 1988).
4.5.12. ScaA o f Streptococcus gordonii.
ScaA, in contrast to FimA and SsaB, mediates coaggregation with other oral 
organisms, rather than adhesion to saliva. S. gordonii, previously classified as
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S. sanguis, coaggregates with Actinomyces naeslundii, another early coloniser of the 
oral cavity. Immunoblot analysis of S. gordonii using anti-5, gordonii serum, adsorbed 
with coaggregation-defective mutants, identified a 38 kDa surface protein of 
S. gordonii which appeared to mediate coaggregation with A. naeslundii 
(Kolenbrander and Andersen, 1990). The antiserum selectively inhibited 
coaggregation between A. naeslundii and S. gordonii, whilst not affecting any other S. 
gordonii coaggregations. Western blots probed with anti-ScaA antiserum, and 
Southern blots probed with the scaA gene both suggested the presence of a ScaA-like 
protein in a group of viridans streptococci including S. sanguis, S. parasanguis, 
S. oralis, S. milled and S. oralis, all of which, except S. parasanguis, exhibited 
coaggregation with A. naeslundii, which could be reversed with anti-ScaA serum 
(Andersen et al, 1993). No hybridisation or cross reactivity was detected with E. 
faecalis. It would appear that ScaA, FimA and SsaB are a distinct class of adhesin 
proteins, and that many other viridans streptococci possess similar, as yet 
uncharacterised proteins.
4.5.13. PsaA o f Streptococcus pneumoniae.
Streptococcus pneumoniae is a major respiratory pathogen, responsible for 
approximately 70% of cases of bacterial pneumonia. Pneumococci are common 
inhabitants of the human upper respiratory tract, present in up to 70% of the normal 
adult population. Community-acquired pneumococcal pneumonia is usually a sporadic 
disease in carriers with injury to pulmonary defence mechanisms resulting in reduced 
bacterial clearance (Roberts, 1990). The S. pneumoniae surface antigen PsaA was first 
reported by Russell et al (1990). Monoclonal antibodies recognised a 37 kDa protein 
present in 24 different types of S. pneumoniae but not in any of the 19 other genera 
tested. The genera tested were selected on the basis of their ability to cause lower 
respiratory tract disease, so no data on cross reactivity with FimA, SsaB or ScaA are 
available. Immunisation of mice with the 37 kDa protein was found to protect against 
S. pneumoniae challenge, indicating possible usefulness as a vaccine (Talkington et al,
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1992). Sequence analysis of the psaA gene revealed 90.5% homology to FimA and 
73.6% to SsaB (Sampson et al, 1994). No experimental evidence exists as to the 
function of PsaA, however, the significant sequence homology with previously cloned 
adhesins leads to the suggestion that PsaA could be involved in adherence to surfaces 
in the respiratory tract, and as such could have a significant role in pathogenesis.
4.5.14. Distribution o f the streptococcal adhesins.
This group of proteins represents a distinct, conserved class of streptococcal 
cell surface adhesins. Southern blot analysis by Andersen et al (1993) showed the 
presence of scaA-\\k& genes in a range of oral streptococci, however, the discovery of 
PsaA in S. pneumoniae, and EfaA in E. faecalis indicates that the proteins are not 
limited to those organisms present in the oral cavity. The lack of hybridisation and 
cross-reactivity seen with E. faecalis on western and Southern blots is probably due to 
the relatively low homology between ScaA and EfaA, as compared to FimA and SsaB. 
Western blots using an anti-E. faecalis serum previously showed no cross reactivity 
between the 37 and 40 kDa antigens and surface antigens of other streptococci, 
including S. sanguis (Aitchison et al, 1987). Similar work using monoclonal 
antibodies to PsaA failed to detect cross-reactivity with any species other than 
S. pneumoniae, although the species tested were chosen on the basis of their ability to 
cause respiratory infections, and so did not include oral streptococci (Russell et al, 
1990).
Because of the significant homology between the proteins, it is assumed that 
they perform similar functions in their respective hosts, ie adhesion, or coaggregation 
with other organisms present in the same environment. Either of these two functions 
would represent a significant virulence factor.
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4.5.15. Oral adhesion.
Whilst adhesion to the target tissue is a major factor in colonisation of the host, 
the establishment of an oral bacterial population is promoted by both intra and 
intergeneric coaggregation of the colonising organisms (Kolenbrander et al 1990). An 
adhesin molecule which performs both of these functions would give the pathogen a 
distinct advantage. It seems likely that SsaB functions both in coaggregation and 
adhesion, however, S. parasanguis does not coaggregate with actinomyces, so clearly 
FimA does not mediate coaggregation in the same way as SsaB and ScaA, but does 
function as a salivary adhesin. (Andersen et al, 1993; Oligino and Fives-Taylor, 1993). 
ScaA has been shown to mediate coaggregation of S. gordonii with actinomyces, but 
no data are available concerning its ability to bind to saliva. An examination of the 
distribution of the oral flora by Frandsen et al, (1991) found that whilst S. sanguis was 
present in early plaque (within 4 hours of cleaning teeth), S. gordonii was present only 
in mature plaque. This is in keeping with S. sanguis being able to bind to, and colonise 
the acquired salivary pellicle of newly cleaned teeth, with S. gordonii acting as a 
secondary coloniser, through coaggregation with other oral bacteria. S. gordonii has 
been shown to adhere to some components of saliva (Gibbons et al, 1991; Jenkinson 
et al, 1993), but the presence of other streptococci and lactobacilli in the oral cavity 
may prevent its early establishment (Loach et al, 1994).
The accretion of dental plaque is a complex phenomenon, involving many 
different bacterial surface components, which may act as specific or non-specific 
adhesins (Busscher et al 1992). Following initial adhesion, coaggregation appears to 
play a pivotal role in accretion and maintenance of dental plaque (Kolenbrander et al 
1990). In general the early colonisers of freshly cleaned teeth, ie mainly streptococci 
and actinomyces, coaggregate with other early colonisers, and with fusobacteria. Late 
colonisers coaggregate almost exclusively with fusobacteria. Thus, coaggregation 
partners are temporally related with respect to formation of plaque (Kolenbrander et 
al, 1993). Early colonisation of the tooth surface is by direct attachment to the
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acquired salivary pellicle, which covers teeth following cleaning. Initial binding of 
streptococci may involve salivary acidic proline rich proteins (Gibbons et al, 1991), or 
bacterial components such as cell wall fragments and membrane proteins, following 
which, intrageneric coaggregation helps to establish the early colonisers 
(Kolenbrander eta l 1993).
Coaggregation among resident bacteria appears to be a characteristic unique to 
the oral ecosystem (Kolenbrander and London 1993), although recent reports suggest 
that the ability of E. faecalis to express aggregation substance, an adhesin which 
causes clumping of E. faecalis cells, can contribute to pathogenicity in endocarditis 
(Chow e ta l, 1993).
Enterococci are often found in the oral cavity, but their numbers are low, 
particularly when compared to species such as S. sanguis, S. mitis, S. salivarius and 
S. mutans. This may be due to evolutionary changes which have lead to a loss of the 
ability of enterococci to colonise the mouth. The relatively low homology between 
EfaA and the salivary adhesins, as compared to homology within the group, may 
explain the loss of the organism's ability to bind components of saliva. However, the 
fact that the gene has been retained through evolution suggests that it still serves an 
important function to the cell, possibly mediating coaggregation, or adhesion to some 
other host substrate(s). Similarly, PsaA of S. pneumoniae may promote adhesion to 
host tissues, particularly in the respiratory tract, but not in the oral cavity. This is more 
difficult to explain, because of the very high (92.3%) homology to FimA, a known 
salivary adhesin. The most probable reason is that small changes in the primary amino 
acid sequence give rise to more significant alterations in tertiary structure, which 
destroy the active sites necessary for saliva binding. When Oligino and Fives-Taylor 
(1993) used purified FimA to block binding of S. parasanguis to SCHA, they found 
that only fully renatured protein was effective, indicating that the ability of FimA to 
bind to its receptor is dependent on a specific three-dimensional conformation of its 
peptide chain.
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4.5.16. Adhesion in the pathogenesis of endocarditis.
It is significant that oral streptococci are a major cause of infective 
endocarditis, particularly after dental procedures. These organisms must possess 
virulence factors which allow routine colonisation of the oral cavity, and also 
opportunistic colonisation of the endocardium. Whether or not the adhesive factor(s) 
involved are common to both sites is yet to be determined. Animal models have 
demonstrated that infective endocarditis is far more common following extraction of 
teeth with periodontal disease than healthy teeth, but that there is no direct correlation 
between the number of bacteria introduced into the bloodstream during extraction, and 
the incidence of endocarditis. This suggests that the incidence of infective endocarditis 
following tooth extraction is affected not so much by the number of bacteria entering 
the blood stream, as the properties of the organisms, such as their ability to adhere 
(Moreillon eta l, 1988;Barco, 1991).
The ability of E. faecalis to cause endocarditis is well known, it is the third 
most common cause of the disease behind oral streptococci and staphylococci, causing 
5-15% of cases. In contrast to oral streptococci, the sources of infection are most 
commonly surgical procedures involving the genito-urinary tract, procedures 
secondary to childbirth and use of contaminated equipment by intra-venous drug 
abusers. The ability of E. faecalis to cause endocarditis is most likely enhanced by its 
ability to adhere to heart valves once introduced into the blood stream. Gould et al 
(1975) demonstrated a correlation between an organisms ability to adhere to heart 
valve tissue in vitro and its ability to cause endocarditis. In this study, enterococci 
adhered to heart valves more readily than viridans streptococci or staphylococci. Thus 
enterococci appear to possess an adhesive factor which allows them to attach to the 
heart valve more avidly than other organisms. It is possible that EfaA might represent 
such a factor. It has been shown above (section 3.3.) that EfaA is cross reactive with 
the 37 and 40 kDa antigens of E. faecalis, and probably represents the 40 kDa antigen. 
These antigens have been shown to be endocarditis-specific, ie expressed by
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E. faecalis specifically during infection of the heart valve (Shorrock et al, 1990). Thus 
the antigens appear to be somehow involved in endocarditis, and the homology studies 
on EfaA suggest an adhesive function. It must be pointed out, however, that there is as 
yet no experimental evidence indicating a role for EfaA. Expression of the 37 and 
40 kDa antigens can be induced by growth in serum, suggesting that the antigens are 
expressed prior to colonisation of the myocardium, which is in agreement with their 
being necessary to attach to the site of infection. Guzman et al (1989) noted that 
E. faecalis strains isolated from urinary tract infections (UTIs) adhered to urinary tract 
epithelial cells more efficiently than to heart cells, and that strains isolated from 
endocarditis adhered to heart cells more efficiently than UTI isolates. This suggested 
that specific adhesive factors were being expressed according to the growth 
environment, which best allowed cells to colonise the surrounding tissue. Growth in 
serum enhanced E. faecalis adherence to heart cells by up to 8-fold, whilst reducing 
their association with polymorphonuclear leukocytes (PMNs) by up to 5-fold, 
suggesting that persistence in the circulation might prime cells for colonisation of 
heart tissue. It was later proposed that the serum-enhanced adhesion involved 
carbohydrate-containing moieties on the bacterial cell surface (Guzman et al, 1991). 
Expression of adhesins mediating aggregation of E. faecalis cells in response to 
pheromone have also been shown to be regulated by serum (Kreft et al, 1992), 
moreover, these adhesins mediate binding to eukaryotic cells via RGDS motifs (Arg- 
Gly-Asp-Ser, Galli et al, 1990) which bind to integrins. Thus, persistence in serum 
stimulates increased expression of a number of virulence factors which could enable 
E. faecalis to colonise the heart valve. No RGD motifs exist within the amino acid 
sequence of EfaA, nor do any other areas of homology with aggregation substances 
exist, but since it is reported that some proteins which bind to integrins do not possess 
RGD motifs (Falkow, 1991; Isberg 1991), EfaA binding to eukaryotic cells should not 
be eliminated.
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4.5.17. EfaA in the pathogenesis o f endocarditis.
If EfaA is an adhesin, then it must have a specific substrate. It is unlikely that 
the substrate is any component of saliva, since enterococci found in the mouth are 
rarely, if ever, found in the salivary pellicle, but more commonly in the gingival 
crevice (Gibbons and van Houte, 1975). The similarity between efaA and the oral 
adhesin operons suggests a common evolutionary source for the loci, but clearly both 
efaA and psaA have diverged sufficiently to alter antigenic cross-reactivity and 
substrate specificity. Indeed, the presence of efaA may simply be a relic of the 
common evolutionary source of the enterococci and streptococci, and as such may be 
vestigial, having lost its ability to bind substrate. Furthermore, the oral streptococci 
appear to express their adhesins alongside other proteins transcribed from the same 
operon, and analysis of the genetic material upstream of efaA has indicated substantial 
differences in this region. However, the presence of the 37 and 40 kDa antigens in 
E. faecalis endocarditis has been demonstrated by the use of the purified antigens in 
serodiagnosis. The antigens appear to remain unexpressed until induction by some 
component(s) of serum. The expression of a non-functioning protein by an organism 
would be a wasteful process, and one which would most likely be deleted through 
natural selection. A more likely explanation is that in E. faecalis, the efaA operon has 
become specialised towards an endocarditis-specific function, possibly, but not 
necessarily, as an adhesin.
4.5.18. Extracellular matrix-binding proteins.
There are many possible substrates for a potential endocarditis adhesin. One of 
the major candidates being fibronectin. The importance of fibronectin in infective 
endocarditis is well recognised (Hamill, 1987). Some of its major features in this 
respect include its ability to bind various eukaryotic tissues such as fibrin, platelets 
and collagen, as well as prokaryotic cells, including staphylococci and streptococci 
(reviewed by Westerlund and Korhonen, 1993) and also E. faecalis (Shorrock and
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Lambert, 1989). Fibronectin is a large fibril-forming glycoprotein, which can exist in 
either a soluble or insoluble form. In the extracellular matrix, it is present in its 
insoluble form, promoting cell adhesion to the matrix. Soluble plasma fibronectin 
circulates in body fluids, binding wherever damage to the endothelium reveals 
collagen and other extracellular matrix components. In this situation it binds 
circulating platelets and fibrin, promoting formation of a clot. When such damage 
occurs on the heart valve, an NBTE forms, consisting of platelets, fibrin and 
fibronectin. Many bacterial species have been shown to bind to fibronectin, by way of 
specific surface adhesins such as the FnBPA and FnBPB proteins of S. aureus (Signas 
et al, 1989; Jonsson et al, 1991) and the environmentally-regulated protein F of 
S. pyogenes (Sela et al, 1993; VanHeyningen et al, 1993) among others (Westerlund 
and Korhonen, 1993). These adhesins share common features, including a region 
composed of three to five repeats of approximately 37 amino acids in length, 
containing short conserved sequences enriched in acidic amino acids, and two adjacent 
glycines. Carboxyl side chains of glutamic and aspartic residues in the acidic region 
have been shown to be essential for binding to fibronectin (McGavin et al, 1991). The 
repeat region of protein F of S. pyogenes has been shown to bind to the 30 kDa N- 
terminus of fibronectin, and it is thought that a second binding domain, close to the 
repeat section, binds to the C-terminus of fibronectin (Sela et al, 1993). Thus many 
bacteria are capable of binding to fibronectin at the site of NBTE, as the first step in 
colonisation of the myocardium. The importance of fibronectin binding proteins in 
pathogenesis has been demonstrated by Lowrance et al (1990) who demonstrated that 
non-fibronectin binding mutants of S. sanguis were less virulent in an endocarditis 
model than the fibronectin-binding wild type. Also, Hanski and Caparon, (1992), 
showed that mutants of S. pyogenes deficient in production of protein F exhibited a 
100-fold reduction in ability to colonise cultured respiratory epithelial cells.
It is important to establish that whilst such adhesive processes are important in 
their own right, the establishment of infection is likely to be multifactorial, probably
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requiring many ligand-receptor intractions. Cheung et al, (1994) identified a S. aureus 
regulatory locus, sar, which is involved expression of a number of cell wall proteins 
important in the pathogenesis of endocarditis. A sar~ mutant strain, deficient in several 
cell wall proteins, was less adherent to cultured human endothelium than the parent 
strain, but was still able to bind to sterile vegetations to some extent, despite a 
reduction in fibronectin binding (Cheung et al, 1992; Cheung et al 1994).
As mentioned previously, E. faecalis has been shown to bind fibronectin 
(Shorrock and Lambert, 1989), through a receptor which is yet to be fully 
characterised, and it has also been shown that the ability of bacteria to bind fibronectin 
is directly related to their ability to cause endocarditis (Lowrance et al, 1990). 
However, the amount of fibronectin bound by E. faecalis was approximately 1000 fold 
lower than that of other streptococci, and the fibronectin binding ability of E. faecalis 
was significantly increased following the introduction of a protein F gene (Hanski et 
al, 1992). Thus it would appear that fibronectin binding is of relatively minor 
importance in E. faecalis. Antiserum raised against the 37 and 40 kDa antigens had no 
effect upon the binding of E. faecalis to fibronectin. This argues against EfaA being 
involved in fibronectin binding, although the experimental conditions were such that 
sub-maximal expression of the antigens would be occurring. EfaA does not share any 
structural similarities with the previously characterised fibronectin binding proteins, 
which are expressed constitutively. This still leaves the possibility that EfaA, which 
appears to be expressed only during endocarditis, may represent a specialised adhesin 
which is induced by some host factor.
Sommer et al (1992) have characterised just such an inducible adhesin in 
S. gordonii, which binds to laminin, a protein secreted by endothelial cells as part of 
the basal laminae. It is not normally exposed, except during damage to the 
endothelium. A doublet of proteins (142 and 145 kDa) recognised by sera from 
patients with S. gordonii endocarditis, but not by sera from patients with non infective 
valvulopathies, was found to be lacking in non-laminin binding variants. Expression
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of the proteins could be restored by growth in BHI or serum, but was eliminated by 
subculture in a chemically-defined medium (CDM). Moreover, expression was 
induced by addition of laminin or collagen I to the culture medium. Since laminin and 
collagen do not share structural features, the authors suggested that a non-specific 
event, such as bacterial agglutination, was the signal involved in up regulation. 
Laminin binding is common amongst streptococci, and may represent one major 
difference between non-invasive viridans streptococci and their endocarditis-causing 
counterparts. Switalski et al (1987), examined the laminin-binding ability of various 
streptococcal strains, and found that most isolates from the blood or heart valves of 
patients with endocarditis expressed laminin receptors, as compared to only a few oral 
isolates. Furthermore, the tested strains expressed laminin-binding components to a 
higher extent when grown in BHI as compared to a CDM. These data support a role 
for laminin binding in the pathogenesis of endocarditis, and the system described by 
Sommer et al (1992), shows obvious similarities to the 37 and 40 kDa antigens of 
E. faecalis, although the proteins are much heavier than those of E. faecalis, and it 
remains to be seen whether EfaA expression can be induced by laminin or collagen. 
However, in the study by Switalski et al (1987) E. faecalis exhibited a very low 
laminin binding ability, thus laminin binding may be of lower significance in 
E. faecalis endocarditis.
Streptococcus pyogenes also expresses a surface protein with affinity for the 
basal laminae of human cardiac muscle (Winters et al, 1993). The 9 kDa 
glycosaminoglycan-binding protein (GAG-BP) is immunologically cross reactive with 
similarly sized proteins from other streptococcal strains. These proteins appear to be 
released by the cells at a localised site of infection. It is hypothesised that they are 
carried to target organs, such as the heart and kidney, where they accumulate by direct 
binding. Once located, these proteins elicit an immune response which leads to acute 
inflammation and tissue injury, as a result of which extracellular matrix components 
become exposed (Winters et al, 1993).
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Collagen, another major component of the extracellular matrix, is also exposed 
at sites of endothelial damage, and so may represent a potential target for adhesion of 
circulating bacteria prior to endocarditis. Bacteria appear to bind to collagen through 
both specific adhesion, and indirectly via fibronectin. Fibronectin binds collagen at a 
site distinct from the bacterial binding site, and so can bind both at once, effectively 
cross-linking the bacteria to collagen (Hamill, 1987). Patti et al (1992) cloned a 
S. aureus specific type II collagen adhesin protein, which may represent an additional 
direct method of binding to damaged host epithelium, although the authors suggest 
that the collagen binding activity would be of greater significance in bone infections, 
where the target tissue is more collagen rich.
4.5.19. Lipoprotein dependent transport systems of Gram-positive bacteria.
In Gram-positive organisms, lipoproteins have been implicated in various 
recognition and transport systems, some of which show similarity to ATP binding 
cassette-type (ABC-type) periplasmic binding systems of Gram-negative species 
(Kolenbrander and London, 1993). Such systems commonly include one or two 
transmembrane proteins, one or two ATP-binding proteins located on the cytoplasmic 
side of the membrane and a single high-affinity periplasmic-substrate-binding protein 
(Tam and Saier, 1993). In the absence of outer membranes, the substrate binding 
proteins of Gram-positive systems appear to be anchored at the cell surface by means 
of an N-terminal lipid anchor (Alloing et al 1990; Sutcliffe et al 1993). Jenkinson 
(1992) proposed that as well as being involved in uptake processes, lipoproteins in 
streptococci may be important in adherence-related functions. Specifically, S. gordonii 
mutants deficient in production of a 76 kDa surface lipoprotein were impaired in their 
ability to aggregate in saliva or serum, and to coaggregate with certain Actinomyces 
species (Jenkinson and Easingwood, 1990; Jenkinson 1992). The EfaA homologues 
FimA, SsaB and ScaA, which are known to be lipoproteins, have been implicated in 
adhesion functions. Furthermore, the scaA operon has shown similarities to the ABC- 
type transport systems mentioned above (Andersen et al, 1994). It may then be
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speculated that the processes of adhesion and transport in Gram-positive species are 
linked. In the absence of an outer membrane, a Gram-positive organism's substrate- 
binding protein may encounter its substrate eg saccharides or peptides, in complexed 
forms, such as on the surface of another bacterium, or in the salivary pellicle, thus 
acting as an adhesin (Jenkinson, 1994). Whether the lipoproteins have a dual role in 
both transport and adhesion, or whether the adhesive functions have evolved from 
transport systems is not known.
These facts further support a role for EfaA in adhesion, and may suggest an 
extra function related to solute transport. Nucleotide sequence data for regions 
flanking the efaA gene are limited, therefore it is not possible to determine whether a 
full set of proteins homologous to ATP-binding cassette systems are present adjacent 
to efaA. However, the limited sequence upstream of efaA suggests that significant 
similarities exist (See section 4.2.4.). Even if the ATP-binding proteins are not present 
adjacent to efaA, the potential role for EfaA in adhesion remains.
4.5.20. Avoidance of polymorphonuclear leukocytes.
Guzman et al (1989) demonstrated that E. faecalis UTI isolates associate with 
human polymorphonucleocytes (PMNs) more efficiently than endocarditis isolates. 
Furthermore, growth in serum decreased the association of all E. faecalis isolates with 
PMNs. Clearly, growth in serum affects surface properties of E. faecalis cells, 
decreasing their association with PMNs, whilst at the same time increasing adherence 
to heart cells. Growth in serum was associated with a decrease in hydrophobicity 
(Guzman et al, 1991a), which could account for some loss of association with PMNs, 
but since association with heart cells was shown to be enhanced in spite of the 
decreased hydrophobicity, it was proposed that specific adhesins were present which 
had a high affinity for heart cells.
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It remains a viable possibility that the properties of E. faecalis described by 
Guzman et al (1989; 1991a; 1991b) are due to serum dependent expression of the 37 
and 40 kDa antigens, and hence EfaA. Increased adhesion to heart cells, decreased 
association with PMNs and increased hydrophilicity were observed after growth in 
serum. EfaA has been predicted to be hydrophilic, which may contribute to increased 
cell hydrophilicity following growth in serum. Guzman et al (1991a; 1991b) found 
that the properties associated with growth in serum were mediated by certain 
D-galactose- and L-fucose-containing residues present on the bacterial cell surface. 
Aitchison et al (1986) demonstrated that the 37 and 40 kDa antigens of E. faecalis 
were glycosylated, with several residues including glucosyl, mannosyl and particularly 
fucosyl residues, detected by ligand blotting. This is consistent with the hypothesis 
that EfaA is the structure displaying these residues.
In summary, sequence analysis of pGP19 has indicated that the 
immunoreactive expression product described in section 3.5. is encoded by a 924 bp 
open reading frame, which translates into a 308 amino acid protein, designated EfaA, 
which has a predicted molecular weight of 34,768 Da. Comparison of the amino acid 
sequence with the GenBank and EMBL databases revealed similarity with a group of 
streptococcal proteins, some of which have been shown to be lipoprotein adhesins. On 
the basis of this homology, the potential role of EfaA in the pathogenesis of 
endocarditis has been discussed. In the absence of experimental data, no firm 
conclusions can be drawn as to the function of EfaA, however, it is hoped that the 
above discussion will provide the basis for further experimental work to this end.
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Chapter 5: Regulation of expression of EfaA.
5.1. Previous work.
Shorrock et al (1990) showed that expression of the 37 and 40 kDa antigens of 
E. faecalis was under positive control by components of serum, and that expression of 
the antigens was specific to E. faecalis endocarditis. Expression of the antigens, 
analysed by western blotting, was minimal during growth of the cells in chemically- 
defined medium (CDM), but could be stimulated by supplementation of the growth 
medium with small amounts of serum (Aitchison et al 1986; Lambert et al 1990) with 
maximal expression during growth in serum. Furthermore, in vivo expression was 
demonstrated by growth of cells on silastic discs implanted into rabbit peritoneal 
chambers (Lambert et al 1990). To demonstrate conclusively whether expression of 
EfaA was influenced by serum, a series of northern analyses was performed. Such 
experiments give an indication of the size and relative abundance of RNA species 
within the cell population.
5.2. Northern analysis: size of message.
Total cellular RNA was prepared as described in section 2.21.1. Total RNA 
from cells grown under various conditions were electrophoresed in a 1% denaturing 
(formamide/formaldehyde) agarose gel, transferred to nitrocellulose membranes and 
probed with a 32P-labelled internal efaA probe. The size of the message to which the 
probe hybridised was determined by comparison with RNA size markers.
The radiolabelled efaA probe hybridised to a mRNA species of approximately 
3 kb in length. The stained northern blot and developed autoradiograph are shown in
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Figure 5.1. Northern blot of E. faecalis EBH1 RNA after growth in 
1% YE (lane 1), 1% YE/0.1 % FCS (lane 2) and 1% YE/1% FCS (lane 3). 
The blot was stained with methylene blue.
1 2 3
Figure 5.2. Developed autoradiograph of northern blot shown in figure 5.1,
probed with a 0.4 kb Hindlll fragment from E. faecalis EBH1 efaA.
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figures 5.3. and 5.4. Some smearing of the transcript band was evident. This was most 
likely due to partial degradation of the RNA during extraction and handling.
5.3. Induction of transcription of efaA.
To determine whether addition of serum to the growth medium was sufficient 
to stimulate transcription of efaA, E. faecalis EBH1 cells were grown in 1% yeast 
extract overnight, then subcultured 1:100 into three flasks of pre-warmed 1% yeast 
extract (YE), two of which contained foetal calf serum (FCS) at 0.1% and 1%. Cells 
were then grown for a further 3 hours, harvested, and RNA was extracted. Equal 
quantities (5-8 fig) of RNA thus extracted were analysed by northern blotting and 
hybridisation with the efaA probe. The developed autoradiograph is shown in figure
5.2. Band densities, determined by scanning densitometry volume analysis (as 
described in section 2.25., are shown in table 5.1. To account for any error introduced 
by uneven loading of RNA onto the gel, densities were normalised by dividing the 
autoradiograph density by the density of the mehylene blue stained blot.
Table 5.1. Band densities from northern blot autoradiograph (figures 5.1. and 5.2.).
Growth Medium. Autorad Density Blot density Adjusted
1% YE 0.45% 3.62% 0.12
1% Y E + 0.1% FCS 27.76% 5.94% 4.67
1% Y E +1%  FCS 20.50% 5.23% 3.92
The intensity of the radioactive signal is proportional to the amount of 
radiolabelled probe which hybridised to the immobilised RNA. Thus the densities of 
the bands on the autoradiograph are approximately proportional to the quantity of 




Figure 5.3. Northern blot of E. faecalis EBH1 RNA following induction with 
FCS. Lane 1, molecular weight markers; Lane 2, pre-induction; Lane 3,
15 minutes induction; Lane 4, 30 minutes; Lane 5, 60 minutes;
Lane 6, 120 minutes induction.
1 2 3 4 5 6
Figure 5.4. Developed autoradiograph of northern blot shown in figure 5.3,
probed with a 0.4 kb Hindlll fragment from E. faecalis EBH1 efaA.
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of RNA quantity, but are not 100% accurate, as will be discussed later (Britten and 
Davidson, 1985; Anderson and Young, 1985).
The results shown here indicate that transcription of the efaA message is 
minimal during growth in 1% YE, but addition of as little as 0.1% FCS is sufficient to 
enhance transcription by approximately 35-fold.
5.4. Time course of efaA induction by serum.
As a further confirmation of the ability of FCS to stimulate transcription of the 
efaA message, and to characterise partially the response to FCS, the experiment 
described above was modified. Following overnight growth in 1% YE, cells were 
subcultured, grown to early log phase (OD600 = 0.1), and FCS was added to 1%. 
Twenty millilitre samples were extracted at time = 0, 15, 30, 60 and 120 minutes, and 
total RNA extracted as described in section 2.21.1. The stained northern blot and 
corresponding autoradiograph are shown in figures 5.3. and 5.4. The results were 
analysed and normalised by scanning densitometry as described in section 5.3, and are 
shown in table 5.2.
Table 5.2. Band densities of northern blot and autoradiograph (figures 5.3. and 5.4.)
Time after induction Autorad Density Blot density Adjusted
0 0.00 8.02 0.00
15 0.45 8.41 0.05
30 3.64 7.92 0.46
60 16.00 8.06 1.99
120 22.40 6.49 3.45
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Figure 5.5. Immunoblot analysis of E. faecalis EBH1 whole cells following induction 
with FCS. Lane 1, molecular weight markers; Lane 2, pre-induction;
Lane 3, 15 minutes; Lane 4, 30 minutes; Lane 5, 60 minutes;
Lane 6, 120 minutes induction.
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5.5. Time course of EfaA expression following induction with serum.
The experiments above confirmed that transcription of efaA was enhanced 
following addition of serum to the growth medium. To correlate this finding with 
expression of protein, cells from the experiment described in section 5.4. were 
subjected to SDS-PAGE and immunoblotting. Immunoblots were probed with serum 
from an endocarditis patient with a high IgG titre against E. faecalis (GP serum). The 
immunoblot is shown in figure 5.5. The immunoblot demonstrates that prior to 
induction, the 37 and 40 kDa antigens are barely visible, but that expression is 
stimulated following addition of serum. Thus it would appear that the antigens are 
indeed expressed in response to serum, with the 37 kDa protein expressed first, and 
the 40 kDa protein appearing slightly later.
5.6. Investigation of the inducing factor(s) in serum.
In order to determine which components of serum were affecting transcription 
of efaA, the serum was pre-treated in a number of ways prior to addition to the culture 
medium. Pre-treatments were; i) Saturation of the serum with ImM FeCl3, ii) dialysis 
against sterile distilled water, to remove low molecular weight species and iii) heating 
to 65°C for 15 minutes. To investigate the effect any components secreted into the 
culture supernatant may have had, one batch of cells was harvested and washed in 
0.9% NaCl, then the supernatant was replaced with fresh pre-warmed 1% YE prior to 
addition of serum. Finally, one batch of cells was subcultured into Difco brain heart 
infusion (BHI), to see whether transcription could be induced by this medium, as 
suggested by Shorrock (1990).
Cells were grown for 1 hour after induction, then northern analysis and 
subsequent densitometry of the developed autoradiograph was performed as described
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1 2 3 4 5 6
Figure 5.6. Northern blot of E.faecalis RNA grown in: Lane 1,1% YE;
lane 2, 1% YE/1% FCS; lane 3, 1% YE/1% FCS (dialysed); 
lane 4, 1% YE/1% FCS + ImM FeCl3; lane 5, 1% YE/1% FCS (heated);
lane 6, Difco BHI.
1 2 3 4 5 6
Figure 5.7. Developed autoradiograph of northern blot shown in figure 5.6,
probed with a 0.4 kb Hindlll fragment from E.faecalis EBH1 efaA.
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above. The stained blot and developed autoradiograph are shown in figures 5.6. and 
5.7., respectively.
Table 5.3. Band densities of northern blot and autoradiograph in figures 5.6. and 5.7.
Cell treatment. Autorad density Blot density Adjusted
None 0.6% 4.42% 0.14
1%FCS 2.42% 4.60% 0.53
1% FCS (Dialysed) 0.73% 4.54% 0.16
1% FCS + ImM FeCl3 2.24% 4.41% 0.51
1% FCS (Heated) 3.27% 5.41% 0.60
BHI 3.36% 5.78% 0.58
5.7. Discussion.
5.7.7. Transcript size.
The radiolabelled efaA probe hybridised to a 3 kb RNA species. This suggests 
that efaA (927 bp) may be transcribed as part of a polycistronic message. Analysis of 
DNA regions flanking the fimA, ssaB, scaA and psaA genes has shown them to be 
homologous, and it would appear that in all four homologues, other smaller genes are 
transcribed on the same message as the putative adhesin genes, as discussed in section
4.2.4. Transcript sizes for the efaA homologues fimA and psaA have been shown to be 
approximately 3.2 kb and 3.0 kb, respectively (Fives-Taylor et al, 1991; Sampson et al 
1994), i.e., very similar to that of efaA. These data lend further support to the idea that 
the five homologous operons share a common evolutionary source, and that each 
species has diverged, such that the specific functions of the genes involved have 
become altered.
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5.7.2. Induction by element(s) o f serum.
The addition of as little as 0.1% of serum to the culture medium was shown to 
induce transcription of efaA. This is in agreement with work by Shorrock et al, (1990) 
who showed that expression of the 37 and 40 kDa antigens was strongly influenced by 
growth in serum. The amount of efaA transcription in the absence of serum was very 
low, and was sometimes undetectable. Thus it would appear that EfaA is expressed 
specifically in response to some element of serum. It has been proposed that 
persistence of E.faecalis in the circulation during bacteraemia is necessary for the 
expression of surface components which allow colonisation and invasion of 
endothelial cells (Guzman et al, 1991b). Since in vitro bacterial growth in serum 
mimics in vivo persistence in blood, it would appear that EfaA could be one such 
factor. Furthermore, the similarities which can be drawn between EfaA and the as yet 
uncharacterised surface structures described by Guzman et al, (1989, 1991a, 1991b) 
suggest that EfaA may be responsible for the serum-dependent changes of E. faecalis, 
as discussed in section 4.5.20.
5.7.3. Time course o f transcription induction.
Results shown in table 5.2. show that induction by serum was detectable after 
15 minutes, and continued to increase over two hours. The response appears to level 
off towards 120 minutes. This phenomenon may indicate that a maximal level of 
transcription is being reached. Alternatively, it may be an artefact of the filter 
hybridisation method used. A curve relating signal intensity to quantity of RNA is 
only linear for limited amounts of filter-bound RNA, since at higher levels, the filter- 
bound sequences may be in excess of the probe. Furthermore, overloading of the filter, 
such that sequences are not fully accessible to the probe, and overexposure of the 
autoradiograph, can contribute to inaccuracy (Britten and Davidson, 1985; Anderson 
and Young, 1985).
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5.7.4. Time course o f protein expression.
Western blot analysis of E.faecalis whole cells following induction with 
serum, showed an increase in expression of both 37 and 40 kDa antigens, the 37 kDa 
antigen appearing earlier and more prominently than the 40 kDa antigen during the 
two hour induction phase. Thus the expression of protein was correlated to enhanced 
transcription of efaA message. It was suggested earlier (section 3.7.1.) that the 37 and 
40 kDa antigens may represent unmodified and mature EfaA, respectively. If this is 
indeed the case, then the following speculative theory may explain the sequential 
appearance of the two antigens. Initially, following induction with serum, the rate of 
efaA transcription was low, allowing translation of message into EfaA, and rapid 
conversion to the mature, surface exposed lipoprotein, as seen by the early appearance 
of the 37 kDa antigen. As induction continued, the amount of cellular efaA message 
increased, so the rate of production of EfaA would also increase, such that processing 
of EfaA becomes rate-limiting, causing a build up of the 40 kDa antigen. N-terminal 
sequencing of the 37 and 40 kDa proteins would establish the accuracy of this theory, 
however, attempts at sequencing were unsuccessful due to contamination by other cell 
proteins.
The time scale of induction was similar to that seen by Guzman et al, (1989), 
who detected increased adhesion to heart cells, and decreased association with PMNs 
within 1 hour of serum induction. EfaA protein was detectable in E. faecalis whole 
cells approximately 1 hour after induction, suggesting that it may have been at least 
partially responsible for these serum inducible changes in E. faecalis properties.
5.7.5. The nature o f the inducing factor.
The results shown in table 5.3. indicate that the inducing factor was present in 
both serum and BHI, was resistant to heat (BHI was sterilised by autoclaving) and was 
apparently not related to iron levels. The ability of serum to induce expression was 
removed after overnight dialysis against sterile double distilled water, indicating that
128
its molecular weight was smaller than 10-12 kDa. Changing the culture supernatant 
prior to induction had no effect, thus induction was probably not due to the action of 
extracellular factors acting on serum. Thus the nature of the inducing factor is still 
unknown, other than that it is heat stable, and no larger than 12 kDa. If the inducer is a 
peptide, then its heat stability suggests either that it does not have appreciable tertiary 
structure, since this would be lost during autoclaving, or that the region of the 
molecule responsible for induction is not involved in the tertiary structure of the 
molecule.
5.7.6. Gene regulation in response to the environment: Virulence factors.
Pathogenic bacteria have a highly adapted lifestyle which requires survival and 
multiplication within a living organism. The particular strategies used in this respect 
distinguish pathogens from innocuous flora or bacteria which can infect only 
compromised hosts. The ability to proliferate in various niches within the host, and to 
survive the transition to and from the host, requires considerable adaptability on the 
part of the pathogen, and such pressures have probably directed the evolution of 
specialised systems regulating the expression of virulence factors. A virulence factor 
need not be designed to damage specifically the host, but more often allows the 
pathogen to compete with the host for nutrients, or to survive within the hostile 
environment of the host's tissues. A successful bacterial pathogen must maintain a 
balance in its pathogenic cycle which optimises the survival and multiplication within 
the individual host as well as within the population as a whole. Disease is merely a 
manifestation of the complex interaction between host and pathogen (Mekalanos, 
1992), the degree of host injury does not always correlate with success of the 
pathogen, and death of the host is usually considered counterproductive to the 
pathogen. Indeed, for virtually all pathogens, subclinical infections outnumber those 
which cause overt disease (Dirita and Mekalanos, 1989). The fact that most bacterial 
pathogens do not constitutively express their virulence factors demonstrates the
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important role that tight regulation of these factors must play in the success of a 
pathogen (Dirita and Mekalanos, 1989).
Often virulence factors are under the control of a global regulatory system, 
such as the sar locus of S. aureus (Cheung et al, 1992; 1994). These systems are 
defined by a common environment sensing system, which influences expression of a 
wide range of virulence determinants. Thus bacterial pathogenesis is a process 
whereby the pathogen is constantly sensing its environment and responding 
appropriately (Miller et al, 1989; Finlay and Falkow, 1989). There are many potential 
cues for initiation of virulence gene expression, including specific host factors such as 
temperature and pH (Pepe et al, 1994) and iron concentration (Griffiths, 1991).
5.7.7. Gene regulation in response to the environment: Signal transduction.
A two-component model for the process of environmental sensing and signal 
transduction in bacteria has been proposed (reviewed by Parkinson, 1993). The model 
consists of a cytoplasmic membrane-spanning sensor/transmitter protein and a 
cytoplasmic receiver/regulator protein. Upon sensing the appropriate environmental 
signal, the transmitter protein activates its corresponding cytoplasmic receiver, which 
in turn can exert a regulatory effect upon cell processes. Receiver proteins usually 
contain DNA binding regions, so it is likely that activation alters the ability of this 
region to bind to the operator region of the relevant gene(s).
Such two-component mechanisms lend flexibility to the system whereby a 
single sensor protein can interact with multiple regulatory components, allowing large 
scale changes in cell function in response to a single environmental cue (Kofoid and 
Parkinson, 1988; Ninfa et al, 1988). Conversely, specificity is of great importance, 
since an organism may have approximately 50 transmitter-receiver pairs, and 
inappropriate cross talk between them is minimal (Parkinson 1993).
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Alterations of gene expression at the transcriptional level are usually achieved 
by binding of regulator proteins to areas of DNA known as operator sites, which either 
stimulate or inhibit RNA polymerase binding and subsequent transcription of the 
particular genes. Where the binding of a regulator protein to an operator site enhances 
transcription, the gene is said to be under positive regulation, and conversely, when a 
regulator inhibits transcription, the gene is under negative regulation. In either 
situation, alterations in the conformation of the regulator protein dictated by various 
cellular processes can either enhance or inhibit transcription of a particular gene 
(Alberts eta l 1989).
5.7.8. The response o f E.faecalis to serum.
The results in sections 5.3-5.6. indicate that expression of EfaA is stimulated 
by exposure of the cells to serum, an event which mimics growth in the circulation. 
The transition of a bacterium from a site of primary infection to the circulation 
represents a change in environment for the organism. Serum contains numerous host 
defence mechanisms, and an invading cell must evade these, whilst competing for 
available nutrients. To ensure survival, an organism must undergo certain changes 
once introduced into the circulation. Such changes must ensure survival in the host, 
and as such, may be termed virulence factors. Other serum-induced virulence-related 
events have been characterised in E. faecalis. Kreft et al (1992) found that synthesis of 
aggregation substance was induced by some component(s) of serum. Aggregation 
substance normally causes clumping of E.faecalis cells in response to sex- 
pheromones, however, Galli et al (1990) noted that the amino acid sequence of 
aggregation substance contained RGD motifs, which are known to bind to receptors on 
eukaryotic cells. Kreft et al (1992) confirmed that aggregation substance could bind to 
eukaryotic cells, and showed that expression could be induced by serum. 
Subsequently, Chow et al, (1993) examined the virulence of several E.faecalis strains 
harbouring various mutations of pADl, and showed that expression of aggregation 
substance, along with hemolysin production was associated with increased mortality in
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an endocarditis model. Thus, pADl-encoded aggregation substance may be a 
virulence factor. As has been described above, Guzman et al (1989, 1991a, 1991b) 
have shown that the surface properties of E. faecalis in relation to its binding to 
endothelial cells and interaction with PMNs are profoundly affected by growth in 
serum.
5.7.9. Expression o f EfaA in response to serum.
Since EfaA is expressed during growth in serum, then it may be assumed that 
its expression is required for optimal growth in vivo, and so EfaA may be termed a 
virulence factor. Its function has yet to be determined, but many of the potential 
functions discussed above, such as adhesion to endothelial cells, and avoidance of 
PMNs would give the cell a greater chance of survival in a hostile host environment. It 
seems likely then, that the ability of E.faecalis to sense its surroundings is of 
importance during the course of infection. Induction of expression was detectable after 
the addition of only 0.1% FCS, so the sensing mechanisms would appear to be 
responding to a specific element within serum, possibly some nutrient not found 
elsewhere in the host. The inducing factor appears to be smaller than 10-12,000 Da, 
since it was removed from serum by dialysis. Furthermore, the inducer is heat stable, 
which reduces the likelihood of it being a complex protein. Studies of the scaA operon 
have revealed similarities with periplasmic binding proteins of gram negative 
organisms, suggesting that this particular homologue of EfaA may be involved in 
some form of membrane transport in S. gordonii (Andersen et al, 1994), as well as 
mediating coaggregation with A. naeslundii. If EfaA also performs a transport 
function, then there may be some mechanism by which the presence of substrate 
switches on the uptake function. It may be then that the inducing factor in serum is a 
nutrient not available in other growth media, such as oligopeptides, or sugars, both of 
which are transported by lipoproteins in other species (Pearce et al, 1992; Sutcliffe et 
al, 1993). The fact that DNA flanking the efaA gene differs in certain elements present 
upstream of scaA may indicate a loss of the ability of EfaA to participate in transport,
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but not a loss in the ability to respond to the inducing factor. Such a situation would 
allow EfaA to evolve to some other function specific to presence in serum, such as 
adhesion to certain target molecules. The cloning and sequencing of more DNA 
upstream and downstream of efaA will be required in order to determine whether 
genes homologous to ATP-binding cassette operons are present, as is the case for scaA 
of S. gordonii (Andersen et al, 1994).
Similarities between EfaA and the putative laminin binding protein of 
S. gordonii (Sommer et al, 1992), are apparent. The proteins were recognised by sera 
from patients with endocarditis, but only weakly by sera from patients with non­
infected valvulopathies, and expression was enhanced by growth in serum, BHI, 
laminin or collagen. The induction studies performed on efaA did not include addition 
of elements of the extracellular matrix, so comparisons cannot be made in this respect. 
However, since laminin and collagen do not share any common structural features, the 
authors suggested that the positive signal may be some non-specific event related to 
laminin or collagen, which could also be the case for induction by serum or BHI.
In summary, efaA appears to be transcribed as part of a 3 kb message, a size 
which is very similar to that determined for homologous genes. Its transcription is 
strongly influenced by low molecular weight components of serum. These data are in 
agreement with previous findings, and support the hypothesis that EfaA is expressed 
when E. faecalis makes the transition from a primary infection site to the circulation, 
possibly priming the organism for colonisation of the endocardium.
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Chapter 6: Concluding discussion.
Enterococcusfaecalis endocarditis is causing increasing concern, carrying 
significant mortality, and often leaving permanent damage to the heart valve. 
Treatment is increasingly difficult, since E.faecalis is rapidly becoming resistant to 
many drugs. The continued widespread use of antibiotics in hospitals means that 
emergence of resistance is likely to continue until all bactericidal drugs are of little 
use. In such cases, the prognosis of enterococcal endocarditis is almost certainly death. 
In the future, treatment may rely on a whole new generation of antimicrobials. In order 
to design such treatments, a detailed understanding of the pathogenic mechanisms of 
the causative organisms is required.
Growth in serum, approximating to growth in the circulation, is known to 
enhance the adhesion of E. faecalis to heart cells. Furthermore, an examination of the 
antigenic profile of serum-grown E.faecalis cells reveals enhanced expression of 
certain surface proteins. These antigens appear to be specific to endocarditis, and so 
may contribute to pathogenicity of E.faecalis in this condition. Characterisation of 
these serum-regulated surface components and determination of their role in 
endocarditis may provide new targets for therapy of this disease.
This study was designed to exploit the antigenicity of two serum-regulated 
proteins, the 37 and 40 kDa antigens, in order to isolate clones containing their 
structural genes. A gene expressing an approximately 40-kDa protein which was 
antigenically cross-reactive with the 37 and 40 kDa antigens was cloned, suggesting 
that they may represent different forms of the same protein. Nucleotide sequence 
analysis revealed an open reading frame encoding a protein with a predicted molecular 
weight of 34,768 designated Enterococcus faecalis antigen A (EfaA). Confirmation of 
the relationship of the 37 and 40 kDa antigens to each other and with EfaA requires 
amino acid sequence analysis of the purified antigens. There is a lipoprotein-type
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consensus sequence at the N-terminus, suggesting EfaA is anchored via an aminoacyl 
group after cleavage of a leader sequence. Incomplete processing of the leader peptide 
may provide one possible explanation for the occurrence of the two antigens in whole 
cell extracts.
EfaA shows 55-60% homology to a group of streptococcal adhesins, 
suggesting a role in adhesion. Recent studies on genes flanking scaA in S. gordonii 
indicate a similarity with lipoprotein-dependent solute transport systems. In gram 
positive species it has been proposed that the solute-binding component of these 
systems may act as an adhesin when its substrate is encountered on a solid surface. 
The finding that EfaA expression is regulated at the transcriptional level by 
components of serum is consistent with it being involved with solute transport 
systems, since expression of the transport proteins is often enhanced by their substrate. 
The nature of the inducing component in serum remains to be elucidated, however, it 
appears to be heat stable, and of low molecular weight. In this respect, a connection 
with pheromone sensing mechanisms of E. faecalis has been suggested (G Dunny, 
personal communication).
Identification of EfaA represents the discovery of common ground between the 
enterococci and the oral streptococci, which between them account for the large 
majority of all cases of infective endocarditis. These data highlight the possibility that 
the adhesins identified amongst the oral streptococci should be investigated in the 
pathogenesis of streptococcal endocarditis.
6.1 Further work.
At present, no experimental evidence exists to establish the function of EfaA in 
infective endocarditis. A major step towards this end would be the creation of an 
E.faecalis EfaA-deficient mutant. It would then be possible to compare the mutant 
with the parent strain in an experimental endocarditis model. Furthermore, the role of 
EfaA in adhesion could be investigated by making similar parent/mutant comparisons
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in binding assays, using substrates such as intact cardiac endothelium, blood clots, 
fibronectin, and other extracellular matrix components.
Knowledge of the role of EfaA in the pathogenesis of E. faecalis endocarditis 
may indicate new treatment strategies, perhaps based on anti-adhesion agents or 
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APPENDICES
Appendix A: Amino acids.
Amino acid. Abbreviation. Code Letter. Mass. Properties (hydrophilicity).
Alanine Ala A 89.09 Neutral, (-0.5)
Arginine Arg R 174.2 Basic, (3.0)
Asparagine Asn N 132.1 Neutral, (0.2)
Aspartic acid Asp D 133.1 Acidic, (3.0)
Cysteine Cys C 121.12 Neutral, (-1.0)
Glutamic acid Glu E 147.13 Acidic, (3.0)
Glutamine Gin Q 146.15 Neutral, (0.2)
Glycine Gly G 75.07 Neutral, (0.0)
Histidine His H 155.16 Basic, (-0.5)
Isoleucine lie I 131.17 Neutral, (-1.8)
Leucine Leu L 131.17 Neutral, (-1.8)
Lysine Lys K 146.19 Basic, (3.0)
Methionine Met M 149.21 Neutral, (-1.3)
Phenylalanine Phe F 165.19 Neutral, (-2.5)
Proline Pro P 115.13 Neutral, (0.0)
Serine Ser S 105.09 Neutral, (0.3)
Threonine Thr T 119.12 Neutral, (-0.4)
Tryptophan Trp W 204.22 Neutral, (-3.4)
Tyrosine Tyr Y 181.19 Neutral, (-2.3)
Valine Val V 117.15 Neutral, (-1.5)
Hydrophilicity value according to Hopp and Woods (1981)
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Appendix B: Codon Usage in Streptococci.
Codons per thousand base pairs (Wada et al, 1992).


























CYS: UGC 1.0 
UGU 2.3
MET: AUG 17.8












LYS: AAA 55 
AAG 27.8
ASN: AAC 20.2 
AAU 39.1
PHE: UUC 12.5 
UUU 23.9
TRP: UGG 9.8




GLU: GAA 53.9 
GAG 16.8
ASP: GAC 19.4 
GAU 44.8









Appendix C: Molecular Weight Markers.
For agarose gel electrophoresis, markers consisted of EcoRl/Hind ID-cut lambda 
DNA(Northumbria Biologicals). The digest consists of DNA fragments of the 
following sizes (Base pairs):
1 21226 8: 1584
2 5148 9: 1375
3 4973 10: 947
4 4268 11: 831
5 3530 12: 564
6 2027 13: 125
7 1904
For SDS-PAGE and immunoblotting, pre-stained markers (Sigma) consisted of;
Protein Molecular Weight
Phosphorylase B 106 kDa
Bovine serum albumin 80 kDa
Ovalbumin 49.5 kDa
Carbonic anhydrase 32.5 kDa
Soybean trypsin inhibitor 27.5 kDa
Lysozyme 18.5 kDa
For denaturing agarose gel electrophoresis, RNA markers (Sigma) consisted of (bp);
1: 9488 5: 1898
2: 6225 6: 872
3: 3911 7: 562
4: 2800 8: 363
166
Appendix D: Media and Solutions.
Where appropriate, media and solutions were sterilised by autoclaving for 20 minutes 
at 15 lbs/sq inch (121°C) on a liquid cycle.
BHI: Bacto brain heart infusion agar and broth (Difco.)
Chloroform:isoamyl alcohol: Chloroform mixed with isoamyl alcohol 24:1 
(Amresco)
DNA denaturing buffer: 0.2M NaOH, 0.2mM EDTA, pH 8.0.
DNA loading buffer: 0.5% SDS, 25% glycerol, 0.25% bromophenol blue, 0.05M 
EDTA.
LB medium (Luria-Bertani Medium): (per litre) lOg Bacto tryptone (Difco), 5g Bacto 
yeast extract (Difco) and lOg NaCl, pH adjusted to 7.0 with NaOH. LB plates were 
made from 1 litre of LB medium plus 20g agar (Difco).
NZCYM broth: 1 litre of NZY broth plus lg casamino acids (Difco), pH 7.0.
NZY Broth: (per litre) 5g NaCl, 2g MgS0 4 , 5g Bacto yeast extract (Difco) and lOg 
NZ amine (ICN) pH 7.5. NZY plates were made from 1 litre of NZY broth plus 20g 
agar (Difco).
SB (Super Broth) Per litre: 35g Bacto tryptone (Difco), 20g Bacto yeast extract 
(Difco), 5g NaCl pH7.5
SSC (lx): 0.15M NaCl, 0.015M trisodium citrate pH 7.0
SM (Phage dilution buffer): (per litre) 5.8g NaCl, 2g MgSC>4 , 50ml 1M Tris pH 7.5 
and 5ml 2% gelatin.
SOC: 2% Bacto tryptone (Difco), 0.5% Bacto yeast extract (Difco), lOmM NaCl, 
2.5mM KC1, lOmM MgCl2, lOmM MgS04, 20mM glucose.
TB (Terrific broth): (per litre) 5g NaCl and lOg Bacto tryptone (Difco), pH adjusted to 
7.4 with NaOH.
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TBE (lx): (per litre) 10.8g Tris base, 5.5g boric acid, 0.93g Na2EDTA.H20, pH 8.3
TBS: 0.9% w/v NaCl in lOmM Tris HC1 pH 7.4.
TBS-Tween: 0.3% w/v Tween 20 in TBS.
TE: lOmM Tris-HCl, lmM EDTA pH 7.0
TE Glucose: 25% w/v glucose, lOOmM Tris, lOmM EDTA pH 7.0
Tris-Phenol: Phenol/0.1% hydroxyquinolone, equilibrated with 0.5M, then several 
changes of 0.1M Tris HC1 pH 8.0 until pH is greater than 7.8.
Phenol/chloroform: Tris Phenol: Chloroform : Isoamyl alcohol 25:24:1 (Amresco)
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